# EDGAR Filing Document

**Accession Number:** 0002027033
**File Stem:** 0002027033-26-000006
**Filing Date:** 2026-5
**Character Count:** 300271
**Document Hash:** 504616dc8cdd4ee6ec0e17d3c53979c4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002027033-26-000006.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0002027033-26-000006

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 65

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Eagle Point Trinity Senior Secured Lending Co
- **CENTRAL INDEX KEY:** 0002027033

**ORGANIZATION NAME:**
- **EIN:** 992899518
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 814-01890
- **FILM NUMBER:** 26987440

**BUSINESS ADDRESS:**
- **STREET 1:** 600 STEAMBOAT ROAD, SUITE 202
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 203-340-8500

**MAIL ADDRESS:**
- **STREET 1:** 600 STEAMBOAT ROAD, SUITE 202
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EPT 16 LLC
- **DATE OF NAME CHANGE:** 20240624

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EPT SPV 16 LLC
- **DATE OF NAME CHANGE:** 20240613

?xml version='1.0' encoding='ASCII'? ept-20260331

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

-----------------------------------------------------------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark One)

⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2026

OR

□ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-39958

**Eagle Point Trinity Senior Secured Lending Company**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **99-2899518** |
| (State or other jurisdiction of incorporation or<br>organization) | (IRS Employer Identification No.) |

---

---

| | |
|:---|:---|
| **600 Steamboat Road, Suite 202**<br>**Greenwich, CT** | **06830** |
| (Address of principal executive offices) | (Zip Code) |

---

**(203) 340-8500**

(Registrant's telephone number, including area code)

**Securities registered pursuant to Section 12(b) of the Act: None.**

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes □ No ⌧

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ⌧ No □

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act:

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | □ | Accelerated filer | □ |
| Non-accelerated filer | ⌧ | Smaller reporting company | □ |
| | | Emerging growth company | ⌧ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes □ No ⌧

As of May 1, 2026, the registrant had 6,070,384 shares of beneficial interest outstanding.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY** 

**FORM 10-Q** 

**FOR THE QUARTER ENDED MARCH 31, 2026**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **PAGE**<br>**NO.** |
| **<u>[PART I](#i0ccf65f3dff14a6588f8857707bc3ee6_10)</u>** | **<u>[FINANCIAL INFORMATION](#i0ccf65f3dff14a6588f8857707bc3ee6_10)</u>** | [3](#i0ccf65f3dff14a6588f8857707bc3ee6_10) |
| <u>[Item 1.](#i0ccf65f3dff14a6588f8857707bc3ee6_13)</u> | <u>[Consolidated Financial Statements](#i0ccf65f3dff14a6588f8857707bc3ee6_13)</u> | [3](#i0ccf65f3dff14a6588f8857707bc3ee6_13) |
|  | <u>[Consolidated Statements of Assets and Liabilities as of March 31, 2026 (unaudited) and December 31, 2025](#i0ccf65f3dff14a6588f8857707bc3ee6_16)</u> | [3](#i0ccf65f3dff14a6588f8857707bc3ee6_16) |
|  | <u>[Consolidated Statements of Operations for the Three Months Ended March 31, 2026 (unaudited) and March 31, 2025 (unaudited)](#i0ccf65f3dff14a6588f8857707bc3ee6_19)</u> | [4](#i0ccf65f3dff14a6588f8857707bc3ee6_19) |
|  | <u>[Consolidated Statements of Changes in Net Assets for the Three Months Ended March 31, 2026 (unaudited) and March 31, 2025 (unaudited)](#i0ccf65f3dff14a6588f8857707bc3ee6_22)</u> | [5](#i0ccf65f3dff14a6588f8857707bc3ee6_22) |
|  | <u>[Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 (unaudited) and March 31, 2025 (unaudited)](#i0ccf65f3dff14a6588f8857707bc3ee6_25)</u> | [6](#i0ccf65f3dff14a6588f8857707bc3ee6_25) |
|  | <u>[Consolidated Schedule of Investments as of March 31, 2026 (unaudited)](#i0ccf65f3dff14a6588f8857707bc3ee6_28)</u> | [7](#i0ccf65f3dff14a6588f8857707bc3ee6_28) |
|  | <u>[Consolidated Schedule of Investments as of December 31, 2025](#i0ccf65f3dff14a6588f8857707bc3ee6_31)</u> | 25 |
|  | <u>[Notes to Consolidated Financial Statements (unaudited)](#i0ccf65f3dff14a6588f8857707bc3ee6_34)</u> | [43](#i0ccf65f3dff14a6588f8857707bc3ee6_34) |
| <u>[Item 2.](#i0ccf65f3dff14a6588f8857707bc3ee6_82)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i0ccf65f3dff14a6588f8857707bc3ee6_82)</u> | [69](#i0ccf65f3dff14a6588f8857707bc3ee6_82) |
| <u>[Item 3.](#i0ccf65f3dff14a6588f8857707bc3ee6_115)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i0ccf65f3dff14a6588f8857707bc3ee6_115)</u> | [80](#i0ccf65f3dff14a6588f8857707bc3ee6_115) |
| <u>[Item 4.](#i0ccf65f3dff14a6588f8857707bc3ee6_118)</u> | <u>[Controls and Procedures](#i0ccf65f3dff14a6588f8857707bc3ee6_118)</u> | [81](#i0ccf65f3dff14a6588f8857707bc3ee6_118) |
| **<u>[PART II](#i0ccf65f3dff14a6588f8857707bc3ee6_121)</u>** | **<u>[OTHER INFORMATION](#i0ccf65f3dff14a6588f8857707bc3ee6_121)</u>** | [83](#i0ccf65f3dff14a6588f8857707bc3ee6_121) |
| <u>[Item 1.](#i0ccf65f3dff14a6588f8857707bc3ee6_124)</u> | <u>[Legal Proceedings](#i0ccf65f3dff14a6588f8857707bc3ee6_124)</u> | [83](#i0ccf65f3dff14a6588f8857707bc3ee6_124) |
| <u>[Item 1A.](#i0ccf65f3dff14a6588f8857707bc3ee6_127)</u> | <u>[Risk Factors](#i0ccf65f3dff14a6588f8857707bc3ee6_127)</u> | [83](#i0ccf65f3dff14a6588f8857707bc3ee6_127) |
| <u>[Item 2.](#i0ccf65f3dff14a6588f8857707bc3ee6_130)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i0ccf65f3dff14a6588f8857707bc3ee6_130)</u> | [83](#i0ccf65f3dff14a6588f8857707bc3ee6_130) |
| <u>[Item 3.](#i0ccf65f3dff14a6588f8857707bc3ee6_133)</u> | <u>[Defaults Upon Senior Securities](#i0ccf65f3dff14a6588f8857707bc3ee6_133)</u> | [84](#i0ccf65f3dff14a6588f8857707bc3ee6_133) |
| <u>[Item 4.](#i0ccf65f3dff14a6588f8857707bc3ee6_136)</u> | <u>[Mine Safety Disclosures](#i0ccf65f3dff14a6588f8857707bc3ee6_136)</u> | [84](#i0ccf65f3dff14a6588f8857707bc3ee6_136) |
| <u>[Item 5.](#i0ccf65f3dff14a6588f8857707bc3ee6_139)</u> | <u>[Other Information](#i0ccf65f3dff14a6588f8857707bc3ee6_139)</u> | [84](#i0ccf65f3dff14a6588f8857707bc3ee6_139) |
| <u>[Item 6.](#i0ccf65f3dff14a6588f8857707bc3ee6_142)</u> | <u>[Exhibits](#i0ccf65f3dff14a6588f8857707bc3ee6_142)</u> | [85](#i0ccf65f3dff14a6588f8857707bc3ee6_142) |
| **<u>[SIGNATURES](#i0ccf65f3dff14a6588f8857707bc3ee6_145)</u>** |  | [86](#i0ccf65f3dff14a6588f8857707bc3ee6_145) |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**PART I: FINANCIAL INFORMATION**

**Item 1. Consolidated Financial Statements**

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Statements of Assets and Liabilities**

**(In thousands, except share and per share data)**

---

| | | |
|:---|:---|:---|
| | **March 31, 2026**<br>(Unaudited) | **December 31, 2025** |
| **ASSETS** |  |  |
| &nbsp;&nbsp;&nbsp;Investments at fair value: |  |  |
| &nbsp;&nbsp;&nbsp;Non-controlled/non-affiliated investments (amortized cost of $129,376 and $121,142, respectively) | $131353 | $123127 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | 586 | 576 |
| &nbsp;&nbsp;&nbsp;Interest receivable | 1176 | 1099 |
| &nbsp;&nbsp;&nbsp;Deferred credit facility costs | 336 | 390 |
| &nbsp;&nbsp;&nbsp;Due from affiliates | 34 | 1274 |
| &nbsp;&nbsp;&nbsp;Other assets | 256 | 307 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total assets** | $**133741** | $**126773** |
| **LIABILITIES** |  |  |
| &nbsp;&nbsp;&nbsp;KeyBank Credit Facility | $43000 | $36700 |
| &nbsp;&nbsp;&nbsp;2028 Series A Notes, net of $369 and $425, respectively, of unamortized deferred financing costs | 24631 | 24575 |
| &nbsp;&nbsp;&nbsp;Management fees payable | 560 | 532 |
| &nbsp;&nbsp;&nbsp;Incentive fees payable | 377 | 153 |
| &nbsp;&nbsp;&nbsp;Contingent incentive fees payable | 609 | 484 |
| &nbsp;&nbsp;&nbsp;Interest payable | 548 | 974 |
| &nbsp;&nbsp;&nbsp;Security deposits | 227 | 248 |
| &nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | 2092 | 1508 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total liabilities** | $**72044** | $**65174** |
| Commitments and contingencies (Note 6) |  |  |
| **NET ASSETS** |  |  |
| &nbsp;&nbsp;&nbsp;Common shares of beneficial interest, unlimited shares authorized (6,040,715 and 6,017,855 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively) |  |  |
| &nbsp;&nbsp;&nbsp;Paid-in capital in excess of par | 61129 | 60896 |
| &nbsp;&nbsp;&nbsp;Distributable earnings/(accumulated deficit) | 568 | 703 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total net assets** | **61697** | **61599** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities and net assets** | $**133741** | $**126773** |
| **NET ASSET VALUE PER SHARE** | $**10.21** | $**10.24** |

---

See accompanying notes to unaudited consolidated financial statements.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Statements of Operations**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31, 2026** | **Three Months Ended<br>March 31, 2025** |
| **INVESTMENT INCOME:** | | |
| &nbsp;&nbsp;&nbsp;Interest income from non-controlled/non-affiliated investments | $4340 | $2471 |
| &nbsp;&nbsp;&nbsp;Fee income from non-controlled/non-affiliated investments | 288 | 23 |
| **Total investment income** | 4628 | 2494 |
| **EXPENSES:** |  |  |
| &nbsp;&nbsp;&nbsp;Origination fees | 150 | 60 |
| &nbsp;&nbsp;&nbsp;Management fees | 560 | 306 |
| &nbsp;&nbsp;&nbsp;Incentive fees | 377 | 327 |
| &nbsp;&nbsp;&nbsp;Contingent incentive fees | 125 | 26 |
| &nbsp;&nbsp;&nbsp;Offering Fees | 161 |  |
| &nbsp;&nbsp;&nbsp;Professional fees | 507 | 104 |
| &nbsp;&nbsp;&nbsp;Interest expense and other debt financing costs | 1286 | 391 |
| &nbsp;&nbsp;&nbsp;Other expenses | 87 |  |
| &nbsp;&nbsp;**Total expenses** | 3253 | 1214 |
| **NET INVESTMENT INCOME** | 1375 | 1280 |
| **NET REALIZED GAIN/(LOSS) FROM INVESTMENTS:** |  |  |
| &nbsp;&nbsp;&nbsp;Non-controlled/non-affiliated investments | 16 |  |
| **Net realized gain/(loss) from investments** | 16 |  |
| **NET CHANGE IN UNREALIZED APPRECIATION/(DEPRECIATION) FROM INVESTMENTS** |  |  |
| &nbsp;&nbsp;&nbsp;Non-controlled/non-affiliated investments | (8) | 61 |
| **Net change in unrealized appreciation/(depreciation) from investments** | (8) | 61 |
| **NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS** | $**1383** | $**1341** |
| NET INVESTMENT INCOME PER SHARE - BASIC AND DILUTED | $**0.23** | $**—** |
| NET CHANGE IN NET ASSETS RESULTING FROM OPERATIONS FROM PER SHARE - BASIC AND DILUTED | $**0.23** | $**—** |
| WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC AND DILUTED | **6025475** | **—** |

---

See accompanying notes to unaudited consolidated financial statements.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Statements of Changes in Net Assets**

**(In thousands, except share and per share data)**

**(Unaudited)**

**Three Months Ended March 31, 2026:**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Common Shares** | **Common Shares** | | | |
| | **Shares** | **Par Value** | **Paid In Capital**<br>**in excess of**<br>**Par Value** | **Distributable<br>Earnings /**<br>**(Accumulated**<br>**Deficit)** |<br>**Total**<br>**Net Assets** |
| **Balance as of December 31, 2025** | 6017855 | $— | $60896 | $703 | $61599 |
| &nbsp;&nbsp;&nbsp;Capital contributions | 22860 |  | 233 |  | 233 |
| &nbsp;&nbsp;&nbsp;Distributions |  |  |  | (1518) | (1518) |
| &nbsp;&nbsp;&nbsp;Net investment income |  |  |  | 1375 | 1375 |
| &nbsp;&nbsp;&nbsp;Net realized gain/(loss) on investments |  |  |  | 16 | 16 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation/(depreciation) on investments |  |  |  | (8) | (8) |
| **Balance as of March 31, 2026** | 6040715 |  | $61129 | $568 | $61697 |

---

**Three Months Ended March 31, 2025:**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Common Shares** | **Common Shares** | | | | |
| |<br>**Members'**<br>**Interest** | **Shares** | **Par Value** | |<br>**Paid In**<br>**Capital** | **Distributable<br>Earnings /**<br>**(Accumulated**<br>**Deficit)** |<br>**Total**<br>**Net Assets** |
| **Balance as of December 31, 2024** | $56305 |  | $— |  | $— | $— | $56305 |
| &nbsp;&nbsp;&nbsp;Capital contributions |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Capital distributions |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income | 1280 |  |  |  |  |  | 1280 |
| &nbsp;&nbsp;&nbsp;Net realized gain/(loss) on investments |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation/(depreciation) on investments | 61 |  |  |  |  |  | 61 |
| **Balance as of March 31, 2025** | $57646 |  | $— | $| $— | $— | $57646 |

---

See accompanying notes to unaudited consolidated financial statements.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Statements of Cash Flows**

**(In thousands)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31, 2026** | **Three Months Ended<br>March 31, 2025** |
| **Cash flows provided by/(used in) operating activities:** | | |
| &nbsp;&nbsp;Net increase/(decrease) in net assets resulting from operations | $1383 | $1341 |
| &nbsp;&nbsp;Adjustments to reconcile net increase/(decrease) in net assets resulting from operation to net cash provided by/(used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Net unrealized (appreciation)/depreciation from investments | 8 | (61) |
| &nbsp;&nbsp;&nbsp;Net realized (gain)/loss from investments | (16) |  |
| &nbsp;&nbsp;&nbsp;Accretion of original issue discounts and end of term payments on investments | (730) | (309) |
| &nbsp;&nbsp;&nbsp;Amortization of deferred debt financing costs | 136 | 107 |
| &nbsp;&nbsp;&nbsp;Purchases of investments, net of deferred fees | (14633) | (5979) |
| &nbsp;&nbsp;&nbsp;Interest received in-kind | (17) | (19) |
| &nbsp;&nbsp;&nbsp;Proceeds from the sale and paydowns of investments | 7162 | 2856 |
| &nbsp;&nbsp;**Change in operating assets and liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;(Increase)/Decrease in due from affiliates | 1240 |  |
| &nbsp;&nbsp;&nbsp;Increase/(Decrease) in interest receivable and other assets | (26) | (626) |
| &nbsp;&nbsp;&nbsp;Increase/(Decrease) in security deposits | (21) | 5 |
| &nbsp;&nbsp;&nbsp;Increase/(Decrease) in accrued expenses and other liabilities | 584 | 19 |
| &nbsp;&nbsp;&nbsp;Increase/(Decrease) in management fees payable, incentive fees payable, and interest payable | (49) | 606 |
| Net cash provided by/(used in) operating activities | (4979) | (2060) |
| **Cash flows provided by/(used in) financing activities** |  |  |
| &nbsp;&nbsp;Capital contributions | 233 |  |
| &nbsp;&nbsp;Capital distributions | (1518) |  |
| &nbsp;&nbsp;Borrowings under Credit Facility | 14500 | 1900 |
| &nbsp;&nbsp;Repayments under Credit Facility | (8200) | (1500) |
| &nbsp;&nbsp;Deferred credit facility costs paid | (26) |  |
| **Net cash provided by/(used in) financing activities** | 4989 | 400 |
| **Net increase/(decrease) in cash and cash equivalents** | 10 | (1660) |
| **Cash and cash equivalents at beginning of period** | 576 | 2239 |
| **Cash and cash equivalents at end of period** | $586 | $579 |
| **Supplemental and non-cash financing activities:** |  |  |
| Cash paid during the period for interest | $1574 | $322 |

---

See accompanying notes to unaudited consolidated financial statements.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States** | | | | | | | | |
| ***Artificial Intelligence & Automation*** | | | | | | | | |
| Applied Digital Corporation | Equipment Financing | June 28, 2024 | April 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | $54 | $54 | $55 |  |
|  | Equipment Financing | November 19, 2024 | April 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | $88 | $88 | $90 |  |
| &nbsp;&nbsp;Total Artificial Intelligence & Automation |  |  |  |  | $142 | $142 | $145 |  |
| Augmented Reality Concepts, Inc. | Secured Loan | November 19, 2024 | June 18, 2029 | Variable interest rate SOFR 3 Month Term + 7.3%; EOT 0.0% | $1230 | $1227 | $1222 | (6) |
| Cirrascale Cloud Services, LLC | Equipment Financing | November 19, 2024 | April 1, 2027 | Fixed interest rate 10.2%; EOT 5.0% | $429 | $492 | $491 |  |
|  | Equipment Financing | November 19, 2024 | September 1, 2026 | Fixed interest rate 12.7%; EOT 4.0% | $324 | $383 | $384 |  |
| Total Cirrascale Cloud Services, LLC |  |  |  |  | $753 | $875 | $875 |  |
| D-Wave Quantum Inc. | Equipment Financing | August 1, 2025 | September 1, 2028 | Fixed interest rate 10.8%; EOT 4.0% | $50 | $50 | $50 |  |
| Sortera Technologies, Inc. | Equipment Financing | February 11, 2025 | March 1, 2028 | Fixed interest rate 12.5%; EOT 4.0% | $977 | $977 | $990 | (6) |
| Swimlane, Inc. | Secured Loan | May 28, 2025 | June 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 2.3% | $3600 | $3554 | $3642 | (6) |
| Tquila Automation, Inc | Secured Loan | July 2, 2025 | August 1, 2030 | Variable interest rate Prime + 5.0% or Floor rate 12.3%; EOT 3.0% | $900 | $893 | $906 | (6) |
| Uniphore Technologies Inc. | Secured Loan | September 30, 2025 | October 1, 2030 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.0% | $4000 | $3918 | $3903 | (6) |
|  | Secured Loan | October 2, 2025 | October 1, 2030 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.0% | 1500 | 1473 | 1464 |  |
| &nbsp;&nbsp;Total Uniphore Technologies Inc. |  |  |  |  | $5500 | $5391 | $5367 |  |
| **Sub-Total: Artificial Intelligence & Automation (21.4%)\*** |  |  |  |  | $13152 | $13109 | $13197 |  |
| **<u>Biotechnology</u>** |  |  |  |  |  |  |  |  |
| Candel Therapeutics, Inc. | Secured Loan | October 14, 2025 | October 1, 2030 | Variable interest rate Prime + 3.0% or Floor rate 9.8%; EOT 4.3% | $1500 | $1458 | $1467 | (6) |
| Taysha Gene Therapies, Inc. | Secured Loan | August 7, 2025 | September 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 5.0% | $2000 | $2010 | $2058 | (6) |
| **Sub-Total: Biotechnology (5.7%)\*** |  |  |  |  | $3500 | $3468 | $3525 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| **<u>Connectivity</u>** | | | | | | | | |
| AST & Science, LLC | Equipment Financing | June 27, 2025 | July 1, 2030 | Fixed interest rate 12.4%; EOT 9.0% | $2267 | $2313 | $2349 |  |
|  | Equipment Financing | June 30, 2025 | July 1, 2030 | Fixed interest rate 12.5%; EOT 9.0% | 369 | 376 | 382 |  |
|  | Equipment Financing | September 26, 2025 | October 1, 2030 | Fixed interest rate 12.4%; EOT 9.0% | 826 | 835 | 847 |  |
|  | Equipment Financing | December 23, 2025 | January 1, 2031 | Fixed interest rate 12.4%; EOT 9.0% | 516 | 517 | 521 |  |
| &nbsp;&nbsp;Total AST & Science, LLC |  |  |  |  | $3978 | $4041 | $4099 |  |
| **Sub-Total: Connectivity (6.6%)\*** |  |  |  |  | $3978 | $4041 | $4099 |  |
| ***<u>Consumer Products & Services</u>*** |  |  |  |  |  |  |  |  |
| Bobbie Baby, Inc. | Equipment Financing | September 12, 2025 | October 1, 2028 | Fixed interest rate 11.6%; EOT 3.0% | $1792 | $1783 | $1814 |  |
| Ogee, Inc. | Secured Loan | November 25, 2024 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | $300 | $308 | $309 | (6) |
|  | Secured Loan | November 25, 2024 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 300 | 308 | 309 | (6) |
|  | Secured Loan | November 25, 2024 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 300 | 305 | 305 | (6) |
|  | Secured Loan | July 18, 2025 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 300 | 279 | 277 | (6) |
| &nbsp;&nbsp;Total Ogee, Inc. |  |  |  |  | $1200 | $1200 | $1200 |  |
| **Sub-Total: Consumer Products & Services (4.9%)\*** |  |  |  |  | $2992 | $2983 | $3014 |  |
| ***<u>Diagnostics & Tools</u>*** |  |  |  |  |  |  |  |  |
| Artera, Inc. | Secured Loan | March 13, 2026 | February 1, 2031 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 4.5% | $1350 | $1332 | $1332 | (6) |
| Rapid Micro Biosystems, Inc. | Secured Loan | August 8, 2025 | September 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 4.0% | $1800 | $1758 | $1783 | (6) |
| **Sub-Total: Diagnostics & Tools (2.9%)\*** |  |  |  |  | 3150 | 3090 | 3115 |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |  |
| Beam Technologies, Inc. | Secured Loan | November 19, 2024 | October 1, 2029 | Variable interest rate Prime + 2.8% or Floor rate 11.0%+PIK Fixed Interest Rate 1.5%; EOT 2.0% | $2272 | $2361 | $2283 | (6) (7) |
|  | Secured Loan | June 25, 2025 | October 1, 2029 | Variable interest rate Prime + 2.8% or Floor rate 11.0%+PIK Fixed Interest Rate 1.5%; EOT 2.0% | 182 | 186 | 183 | (6) (7) |
|  | Secured Loan | August 7, 2025 | December 31, 2029 | Fixed interest rate 0.0%; EOT 0.0% | 30 | 30 | 20 | (8) |
| &nbsp;&nbsp;Total Beam Technologies, Inc. |  |  |  |  | $2484 | $2577 | $2486 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| Centivo Corporation | Secured Loan | November 19, 2024 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | $508 | $506 | $515 | (6) (7) |
|  | Secured Loan | December 20, 2024 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 506 | 492 | 498 | (6) (7) |
|  | Secured Loan | February 3, 2025 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 505 | 493 | 499 | (6) (7) |
|  | Secured Loan | May 20, 2025 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 1008 | 981 | 995 | (6) (7) |
|  | Secured Loan | June 13, 2025 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 504 | 490 | 497 | (6) (7) |
| &nbsp;&nbsp;Total Centivo Corporation |  |  |  |  | $3031 | $2962 | $3004 |  |
| Cherry Technologies, Inc. | Secured Loan | June 28, 2024 | April 1, 2030 | Variable interest rate Prime + 2.5% or Floor rate 9.5%; EOT 2.0% | $265 | $276 | $273 | (6) |
|  | Secured Loan | July 31, 2024 | April 1, 2030 | Variable interest rate Prime + 2.5% or Floor rate 9.5%; EOT 2.0% | 265 | 276 | 273 | (6) |
| &nbsp;&nbsp;Total Cherry Technologies, Inc. |  |  |  |  | $530 | $552 | $546 |  |
| Tilt Finance, Inc (dba Empower Financial, Inc.) | Secured Loan | June 28, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | $378 | $388 | $385 | (6) |
|  | Secured Loan | June 28, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 98 | 98 | 99 | (6) |
|  | Secured Loan | June 28, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 147 | 147 | 148 | (6) |
|  | Secured Loan | June 28, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 152 | 150 | 150 | (6) |
|  | Secured Loan | June 28, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 505 | 515 | 522 | (6) |
| &nbsp;&nbsp;Total Tilt Finance, Inc (dba Empower Financial, Inc.) |  |  |  |  | $1280 | $1298 | $1304 |  |
| Gravie, Inc. | Secured Loan | November 19, 2024 | July 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 13.0%; EOT 2.5% | $1020 | $1032 | $1011 | (6) |
| Kard Financial, Inc. | Secured Loan | September 10, 2025 | October 1, 2030 | Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 2.0% | $980 | $958 | $986 | (6) |
| One Million Metrics (dba Kinetic) | Secured Loan | August 25, 2025 | September 1, 2030 | Variable interest rate Prime + 4.5% or Floor rate 12.0%; EOT 3.0% | $1050 | $1028 | $1062 | (6) |
| Lendflow, Inc. | Secured Loan | April 24, 2025 | May 1, 2030 | Variable interest rate Prime + 4.5% or Floor rate 12.0%; EOT 2.7% | $960 | $952 | $975 | (6) |
|  | Secured Loan | December 15, 2025 | May 1, 2030 | Variable interest rate Prime + 4.5% or Floor rate 12.0%; EOT 2.7% | 480 | 472 | 477 | (6) |
| Total Lendflow, Inc. |  |  |  |  | $1440 | $1424 | $1452 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| PatientFi, Inc. | Secured Loan | March 14, 2025 | April 1, 2030 | Variable interest rate Prime + 3.5% or Floor rate 10.5%; EOT 2.5% | $1800 | $1788 | $1761 | (6) |
|  | Secured Loan | December 16, 2025 | April 1, 2030 | Variable interest rate Prime + 3.5% or Floor rate 10.5%; EOT 2.5% | 1800 | 1760 | 1730 | (6) |
| &nbsp;&nbsp;Total PatientFi, Inc. |  |  |  |  | $3600 | $3548 | $3491 |  |
| Under Technologies, Inc. | Secured Loan | November 19, 2024 | June 1, 2029 | Variable interest rate Prime + 3.8% or Floor rate 12.0%; EOT 4.3% | $600 | $602 | $626 | (6) |
|  | Secured Loan | November 27, 2024 | June 1, 2029 | Variable interest rate Prime + 3.8% or Floor rate 12.0%; EOT 4.3% | 600 | 600 | 626 | (6) |
| &nbsp;&nbsp;Total Under Technologies, Inc. |  |  |  |  | $1200 | $1202 | $1252 |  |
| Wisetack, Inc. | Secured Loan | November 14, 2024 | December 1, 2029 | Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 2.5% | $900 | $896 | $918 | (6) |
|  | Secured Loan | December 9, 2025 | September 22, 2027 | Fixed interest rate 6.0%; EOT 0.0% | 30 | 30 | 31 | (6)(8) |
| &nbsp;&nbsp;Total Wisetack, Inc. |  |  |  |  | $930 | $926 | $949 |  |
| **Sub-Total: Finance and Insurance (28.5%)\*** |  |  |  |  | $17545 | $17507 | $17543 |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |  |
| DrinkPak, LLC | Equipment Financing | June 28, 2024 | September 1, 2026 | Fixed interest rate 12.9%; EOT 7.0% | $263 | $405 | $406 |  |
| **Sub-Total: Food and Agriculture Technologies (0.9%)\*** |  |  |  |  | $263 | $405 | $406 |  |
| ***<u>Energy & Resource Technology</u>*** |  |  |  |  |  |  |  |  |
| Commonwealth Fusion Systems, LLC | Equipment Financing | November 19, 2024 | July 1, 2030 | Fixed interest rate 13.2%; EOT 10.0% | $2858 | $3060 | $3084 |  |
|  | Equipment Financing | June 28, 2024 | July 1, 2030 | Fixed interest rate 13.0%; EOT 10.0% | 987 | 1095 | 1091 |  |
|  | Equipment Financing | January 14, 2025 | July 1, 2029 | Fixed interest rate 11.2%; EOT 6.0% | 150 | 155 | 157 |  |
|  | Equipment Financing | December 24, 2025 | December 1, 2030 | Fixed interest rate 11.4%; EOT 6.0% | 1226 | 1224 | 1232 |  |
| &nbsp;&nbsp;Total Commonwealth Fusion Systems, LLC |  |  |  |  | $5221 | $5534 | $5564 |  |
| Electric Hydrogen Co. | Equipment Financing | June 28, 2024 | January 1, 2029 | Fixed interest rate 12.6%; EOT 15.0% | $839 | $991 | $961 |  |
|  | Equipment Financing | November 19, 2024 | January 1, 2029 | Fixed interest rate 12.6%; EOT 15.0% | 689 | 786 | 774 |  |
|  | Equipment Financing | November 19, 2024 | October 1, 2028 | Fixed interest rate 12.5%; EOT 15.0% | 409 | 462 | 456 |  |
|  | Equipment Financing | November 14, 2024 | December 1, 2028 | Fixed interest rate 11.9%; EOT 15.0% | 99 | 110 | 109 |  |
|  | Equipment Financing | March 31, 2026 | April 1, 2030 | Fixed interest rate 12.2%; EOT 15.0% | 88 | 87 | 87 |  |
| &nbsp;&nbsp;Total Electric Hydrogen Co. |  |  |  |  | $2124 | $2436 | $2387 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| Form Energy, Inc. | Equipment Financing | November 19, 2024 | November 1, 2027 | Fixed interest rate 12.7%; EOT 3.0% | $1370 | $1405 | $1412 |  |
|  | Equipment Financing | December 12, 2024 | January 1, 2028 | Fixed interest rate 12.5%; EOT 3.0% | 376 | 382 | 384 |  |
| &nbsp;&nbsp;Total Form Energy, Inc. |  |  |  |  | $1746 | $1787 | $1796 |  |
| Torus Inc. | Equipment Financing | February 17, 2026 | August 1, 2029 | Fixed interest rate 11.9%; EOT 5.0% | $1813 | $1815 | $1815 |  |
| **Sub-Total: Energy & Resource Technology (16.7%)\*** |  |  |  |  | $10904 | $11572 | $11562 |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |  |
| B.Well Connected Health, Inc. | Secured Loan | April 10, 2025 | May 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 3.0% | $1800 | $1788 | $1831 | (6) |
|  | Secured Loan | October 29, 2025 | May 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 3.0% | 720 | 710 | 725 | (6) |
| &nbsp;&nbsp;Total B.Well Connected Health, Inc. |  |  |  |  | $2520 | $2498 | $2556 |  |
| Paytient Technologies, Inc. | Secured Loan | May 27, 2025 | June 1, 2030 | Variable interest rate Prime + 3.8% or Floor rate 10.8%; EOT 3.0% | $1250 | $1232 | $1249 | (6) |
|  | Secured Loan | October 2, 2025 | June 1, 2030 | Variable interest rate Prime + 3.8% or Floor rate 10.8%; EOT 3.0% | 1250 | 1248 | 1267 | (6) |
| &nbsp;&nbsp;Total Paytient Technologies, Inc. |  |  |  |  | $2500 | $2480 | $2516 |  |
| PurpleLab, Inc. | Secured Loan | September 24, 2025 | October 1, 2030 | Variable interest rate Prime + 4.5% or Floor rate 11.5%; EOT 2.0% | $3500 | $3438 | $3467 | (6) |
| **Sub-Total: Healthcare Technology (13.8%)\*** |  |  |  |  | $8520 | $8416 | $8539 |  |
| ***<u>Marketing, Media, and Entertainment</u>*** |  |  |  |  |  |  |  |  |
| Angel Studios, Inc. | Secured Loan | September 8, 2025 | October 1, 2030 | Variable interest rate Prime + 6.0% or Floor rate 13.5%; EOT 2.0% | $1600 | $1462 | $1491 | (6) |
|  | Secured Loan | February 17, 2026 | October 1, 2030 | Variable interest rate Prime + 6.0% or Floor rate 13.5%; EOT 2.0% | $800 | $781 | $781 | (6) |
| &nbsp;&nbsp;Total Angel Studios, Inc. |  |  |  |  | $2400 | $2243 | $2272 |  |
| Rarefied Atmosphere, Inc. | Secured Loan | May 6, 2025 | June 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 2.0% | $3163 | $3126 | $3205 | (6) |
|  | Secured Loan | January 29, 2026 | June 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 2.0% | $300 | $294 | $294 |  |
| &nbsp;&nbsp;Total Rarefied Atmosphere, Inc. |  |  |  |  | $3463 | $3420 | $3499 |  |
| Vox Media Holdings, Inc. | Secured Loan | June 28, 2024 | November 1, 2027 | Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5% | $1494 | $1508 | $1492 | (6) |
|  | Secured Loan | June 28, 2024 | January 1, 2028 | Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5% | 749 | 755 | 746 | (6) |
| &nbsp;&nbsp;Total Vox Media Holdings, Inc. |  |  |  |  | $2243 | $2263 | $2238 |  |
| **Sub-Total: Marketing, Media and Entertainment (11.2%)\*** |  |  |  |  | $8106 | $7926 | $8009 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| ***<u>Medical Devices</u>*** | | | | | | | | |
| Apiject Holdings, Inc. | Equipment Financing | November 19, 2024 | July 1, 2028 | Fixed interest rate 10.9%; EOT 7.5% | $853 | $949 | $848 |  |
|  | Equipment Financing | November 19, 2024 | October 1, 2028 | Fixed interest rate 11.3%; EOT 7.5% | 431 | 476 | 428 |  |
| &nbsp;&nbsp;Total Apiject Holdings, Inc. |  |  |  |  | $1284 | $1425 | $1276 |  |
| Cagent Vascular, Inc. | Secured Loan | January 24, 2025 | February 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.3%; EOT 3.0% | $1200 | $1218 | $1227 | (6) |
|  | Secured Loan | January 15, 2026 | February 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.3%; EOT 3.0% | $1200 | $1190 | $1190 | (6) |
| &nbsp;&nbsp;Total Cagent Vascular, Inc. |  |  |  |  | $2400 | $2408 | $2417 |  |
| Cala Health, Inc. | Secured Loan | February 24, 2026 | March 1, 2031 | Variable interest rate Prime + 4.5% or Floor rate 8.5%+PIK Fixed Interest Rate 1.5%; EOT 4.5% | $1040 | $1027 | $1027 | (6) |
| Elucent Medical, Inc. | Secured Loan | November 19, 2024 | November 30, 2029 | Variable interest rate Prime + 3.8% or Floor rate 11.3%; EOT 3.3% | $900 | $897 | $891 | (6) |
|  | Secured Loan | January 15, 2026 | November 30, 2029 | Variable interest rate Prime + 3.8% or Floor rate 11.3%; EOT 3.3% | $600 | $591 | $591 | (6) |
| &nbsp;&nbsp;Total Elucent Medical, Inc. |  |  |  |  | $1500 | $1488 | $1482 |  |
| Emboline, Inc. | Secured Loan | March 3, 2026 | April 1, 2031 | Variable interest rate Prime + 4.0% or Floor rate 10.5%; EOT 4.0% | $2100 | $2071 | $2071 | (6) |
| Lightforce Orthodontics, Inc. | Secured Loan | November 19, 2024 | August 6, 2029 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0% | $1800 | $1803 | $1781 | (6) |
|  | Secured Loan | November 19, 2024 | August 6, 2029 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0% | 300 | 300 | 297 | (6) |
| &nbsp;&nbsp;Total Lightforce Orthodontics, Inc. |  |  |  |  | $2100 | $2103 | $2078 |  |
| Monteris Medical US, Inc. | Secured Loan | March 3, 2026 | March 1, 2031 | Variable interest rate Prime + 4.3% or Floor rate 11.0%; EOT 4.0% | $2100 | $2050 | $2050 | (6) |
| Neuros Medical, Inc. | Secured Loan | December 11, 2025 | January 1, 2031 | Variable interest rate Prime + 3.8% or Floor rate 10.5%; EOT 4.0% | $1884 | $1888 | $1869 | (6) |
| Okami Medical, Inc. | Secured Loan | June 24, 2025 | July 1, 2030 | Variable interest rate Prime + 3.8% or Floor rate 10.5%; EOT 2.0% | $600 | $591 | $596 | (6) |
| Restor3d, Inc. | Secured Loan | November 19, 2024 | July 4, 2028 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.3% | $255 | $257 | $262 | (6) |
| Vital Connect, Inc. | Secured Loan | November 19, 2024 | July 3, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0% | $2100 | $2114 | $2172 | (6) |
|  | Secured Loan | March 21, 2025 | July 3, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0% | 600 | 601 | 618 | (6) |
|  | Secured Loan | December 17, 2025 | July 3, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0% | 600 | 596 | 602 | (6) |
| &nbsp;&nbsp;Total Vital Connect, Inc. |  |  |  |  | $3300 | $3311 | $3392 |  |
| **Sub-Total: Medical Devices (21.7%)\*** |  |  |  |  | $18563 | $18619 | $18520 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| ***<u>Other Healthcare Services</u>*** | | | | | | | | |
| Cellares Corporation | Secured Loan | November 19, 2024 | February 1, 2027 | Variable interest rate Prime + 3.3% or Floor rate 11.8%; EOT 4.0% | 3000 | 3117 | 3140 | (6) |
| LHV Newco LLC | Secured Loan | February 5, 2026 | February 1, 2031 | Variable interest rate Prime + 4.3% or Floor rate 12.8%; EOT 3.0% | $1600 | $1587 | $1587 | (6) |
| **Sub-Total: Other Healthcare Services (6.6%)\*** |  |  |  |  | $4600 | $4704 | $4727 |  |
| ***<u>Software as a Service ("SaaS")</u>*** |  |  |  |  |  |  |  |  |
| Eyelit Technologies, Inc. | Secured Loan | November 19, 2024 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 6.0%; EOT 0.0% | $500 | $493 | $493 | (6) (9) |
|  | Secured Loan | December 27, 2024 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 6.0%; EOT 0.0% | 880 | 867 | 867 | (6) (9) |
|  | Secured Loan | June 20, 2025 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 6.0%; EOT 0.0% | 100 | 98 | 99 | (6) (9) |
|  | Secured Loan | September 10, 2025 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 6.0%; EOT 0.0% | 250 | 246 | 245 | (6) (9) |
|  | Secured Loan | March 2, 2026 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 6.0%; EOT 0.0% | 120 | 118 | 118 | (6) (9) |
| &nbsp;&nbsp;Total Eyelit Technologies, Inc. |  |  |  |  | $1850 | $1822 | $1822 |  |
| Hometown Ticketing, Inc. | Secured Loan | November 25, 2024 | November 25, 2029 | Variable interest rate SOFR 3 Month Term + 7.7%; EOT 0.0% | $1570 | $1548 | $1556 | (6) |
| ServiceTrade, Inc. | Secured Loan | November 19, 2024 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | $1500 | $1482 | $1488 | (6) (9) |
|  | Secured Loan | May 2, 2025 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | 120 | 118 | 120 | (6) (9) |
|  | Secured Loan | June 3, 2025 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | 120 | 118 | 120 | (6) (9) |
|  | Secured Loan | September 22, 2025 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | 120 | 118 | 120 | (6) (9) |
|  | Secured Loan | January 22, 2026 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | 60 | 59 | 59 | (6) (9) |
|  | Secured Loan | February 17, 2026 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | 120 | 118 | 118 | (6) (9) |
|  | Secured Loan | March 9, 2026 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | 60 | 59 | 59 | (6) (9) |
| &nbsp;&nbsp;Total ServiceTrade, Inc. |  |  |  |  | $2100 | $2072 | $2084 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| Silk Technologies, Inc. | Secured Loan | November 19, 2024 | December 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.3%; EOT 1.5% | $1200 | $1185 | $1198 | (6) |
| SOCI, Inc. | Secured Loan | November 19, 2024 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0% | $2275 | $2245 | $2182 | (6) (9) |
|  | Secured Loan | December 30, 2024 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.8%; EOT 0.0% | 207 | 204 | 200 | (6) (9) |
|  | Secured Loan | April 23, 2025 | October 3, 2029 | Variable interest rate SOFR 6 Month Term + 7.8%; EOT 0.0% | 104 | 102 | 102 | (6) (9) |
|  | Secured Loan | August 5, 2025 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0% | 110 | 108 | 105 | (6) (9) |
| &nbsp;&nbsp;Total SOCI, Inc. |  |  |  |  | $2696 | $2659 | $2589 |  |
| Steno Agency, Inc. | Secured Loan | November 19, 2024 | July 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5% | $510 | $512 | $522 | (6) |
|  | Secured Loan | January 2, 2025 | July 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5% | 600 | 604 | 616 | (6) |
|  | Secured Loan | May 16, 2025 | July 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5% | 600 | 584 | 595 | (6) |
| &nbsp;&nbsp;Total Steno Agency |  |  |  |  | $1710 | $1700 | $1733 |  |
| Xytech Systems, LLC | Secured Loan | February 26, 2025 | February 26, 2030 | Variable interest rate SOFR 3 Month Term + 6.0%; EOT 0.0% | $2400 | $2400 | $2348 | (6) (9) |
|  | Secured Loan | July 2, 2025 | February 26, 2030 | Variable interest rate SOFR 3 Month Term + 6.0%; EOT 0.0% | 120 | 118 | 116 | (6) (9) |
|  | Secured Loan | March 3, 2026 | February 26, 2030 | Variable interest rate SOFR 3 Month Term + 6.0%; EOT 0.0% | 105 | 103 | 103 | (6) (9) |
| &nbsp;&nbsp;Total Xytech Systems, LLC |  |  |  |  | $2625 | $2621 | $2567 |  |
| **Sub-Total: Software as a Service ("SaaS") (21.3%)\*** |  |  |  |  | $13751 | $13607 | $13549 |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |
| Astranis Space Technologies Corp. | Equipment Financing | November 19, 2024 | October 1, 2027 | Fixed interest rate 12.6%; EOT 4.0% | 151 | 155 | 156 |  |
|  | Equipment Financing | August 25, 2025 | September 1, 2028 | Fixed interest rate 11.6%; EOT 4.0% | 165 | 167 | 169 |  |
|  | Equipment Financing | October 30, 2025 | November 1, 2028 | Fixed interest rate 11.7%; EOT 4.0% | 43 | 43 | 44 |  |
|  | Equipment Financing | March 30, 2026 | April 1, 2029 | Fixed interest rate 11.7%; EOT 4.0% | 85 | 84 | 84 |  |
|  | Secured Loan | August 25, 2025 | August 25, 2030 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 4.0% | 2000 | 1934 | 1990 | (6) |
| &nbsp;&nbsp;Total Astranis Space Technologies Corp. |  |  |  |  | 2444 | 2383 | 2443 |  |
| Hermeus Corporation | Equipment Financing | March 23, 2026 | October 1, 2029 | Fixed interest rate 11.3%; EOT 4.0% | 1372 | 1340 | 1340 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| Impulse Space, Inc. | Equipment Financing | November 19, 2024 | July 1, 2027 | Fixed interest rate 12.7%; EOT 3.0% | $154 | $162 | $163 |  |
|  | Equipment Financing | November 19, 2024 | October 1, 2027 | Fixed interest rate 12.5%; EOT 3.0% | 163 | 168 | 170 |  |
|  | Equipment Financing | December 27, 2024 | January 1, 2028 | Fixed interest rate 12.9%; EOT 3.0% | 168 | 170 | 175 |  |
|  | Equipment Financing | February 12, 2025 | March 1, 2028 | Fixed interest rate 12.6%; EOT 3.0% | 196 | 198 | 201 |  |
|  | Equipment Financing | June 25, 2025 | July 1, 2028 | Fixed interest rate 12.8%; EOT 3.0% | 248 | 248 | 252 |  |
|  | Equipment Financing | September 25, 2025 | October 1, 2028 | Fixed interest rate 12.8%; EOT 3.0% | 1217 | 1206 | 1223 |  |
| &nbsp;&nbsp;Total Impulse Space, Inc. |  |  |  |  | $2146 | $2152 | $2184 |  |
| Kymeta Corporation | Secured Loan | November 19, 2024 | August 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 3.0% | $600 | $592 | $612 | (6) |
|  | Secured Loan | June 11, 2025 | August 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 3.0% | 600 | 601 | 613 | (6) |
| &nbsp;&nbsp;Total Kymeta Corporation |  |  |  |  | $1200 | $1193 | $1225 |  |
| Slingshot Aerospace, Inc. | Secured Loan | November 19, 2024 | August 1, 2029 | Variable interest rate Prime + 5.5% or Floor rate 14.0%; EOT 3.0% | $1800 | $1799 | $1840 | (6) |
| **Sub-Total: Space Technology (13.4%)\*** |  |  |  |  | $8962 | $8867 | $9032 |  |
| ***<u>Transportation Technology</u>*** |  |  |  |  |  |  |  |  |
| EH Leasing Company, LLC | Equipment Financing | November 1, 2025 | November 1, 2029 | Fixed interest rate 14.4%; EOT 18.7% | $307 | $348 | $320 | (8) |
| **Sub-Total: Transportation Technology (0.5%)\*** |  |  |  |  | $307 | $348 | $320 |  |
| **Total Debt Securities - United States (180.7%)\*** |  |  |  |  | $118293 | $118662 | $119157 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - Canada** | | | | | | | | |
| ***<u>Space Technology</u>*** | | | | | | | | |
| Earthdaily Constellation Holdings, LP | Equipment Financing | June 10, 2025 | January 1, 2029 | Fixed interest rate 13.5%; EOT 7.0% | $2954 | $2975 | $2995 |  |
|  | Equipment Financing | August 28, 2025 | March 1, 2029 | Fixed interest rate 13.9%; EOT 7.0% | 411 | 409 | 413 |  |
| &nbsp;&nbsp;Total Earthdaily Constellation Holdings, LP |  |  |  |  | $3365 | $3384 | $3408 |  |
| **Sub-Total: Space Technology (5.9%)\*** |  |  |  |  | $3365 | $3384 | $3408 |  |
| **Total Debt Securities - Canada (5.9%)\*** |  |  |  |  | $3365 | $3384 | $3408 |  |
| **Debt Securities - Europe** |  |  |  |  |  |  |  |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |
| CMR Surgical Limited | Secured Loan | March 24, 2025 | April 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 4.0% | $1875 | $1892 | $1927 | (6) |
|  | Secured Loan | December 16, 2025 | April 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 4.0% | 750 | 738 | 758 | (6) |
| &nbsp;&nbsp;Total CMR Surgical Limited |  |  |  |  | $2625 | $2630 | $2685 |  |
| **Sub-Total: Medical Devices (4.3%)\*** |  |  |  |  | $2625 | $2630 | $2685 |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |
| Zandivio PLC | Secured Loan | November 19, 2024 | May 1, 2029 | Variable interest rate Prime + 5.3% or Floor rate 13.8%; EOT 2.5% | $1800 | $1789 | $1822 | (6) |
| **Sub-Total: Other Healthcare Services (2.9%)\*** |  |  |  |  | $1800 | $1789 | $1822 |  |
| **Total: Debt Securities - Europe (7.3%)\*** |  |  |  |  | $4425 | $4419 | $4507 |  |
| **Total Debt Securities (193.8%)\*** |  |  |  |  | $126083 | $126465 | $127072 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Warrant Investments - United States** | | | | | | | | | |
| ***<u>Artificial Intelligence & Automation</u>*** | | | | | | | | | |
| D-Wave Quantum Inc. | Warrant | August 1, 2025 | August 1, 2035 | Common Stock | 2588 | $16.05 | $35 | $30 |  |
| Sortera Technologies, Inc. | Warrant | February 11, 2025 | February 11, 2035 | Common Stock | 9995 | $5.23 | $69 | $73 |  |
| Swimlane, Inc. | Warrant | May 28, 2025 | May 28, 2037 | Preferred Series B | 687265 | $0.19 | $43 | $36 | (11) |
| Tquila Automation, Inc | Warrant | July 2, 2025 | July 2, 2037 | Common Stock | 4397 | $0.81 | $6 | $3 |  |
| Uniphore Technologies Inc. | Warrant | September 30, 2025 | September 30, 2035 | Common Stock | 92385 | $2.40 | $95 | $39 |  |
| **Sub-Total: Artificial Intelligence & Automation (0.3%)\*** |  |  |  |  |  |  | $248 | $181 |  |
| ***<u>Biotechnology</u>*** |  |  |  |  |  |  |  |  |  |
| Candel Therapeutics, Inc. | Warrant | October 14, 2025 | October 14, 2035 | Common Stock | 7639 | $5.89 | $41 | $36 |  |
| **Sub-Total: Biotechnology (0.1%)\*** |  |  |  |  |  |  | $41 | $36 |  |
| ***<u>Connectivity</u>*** |  |  |  |  |  |  |  |  |  |
| Tarana Wireless, Inc. | Warrant | November 19, 2024 | September 23, 2034 | Common Stock | 169859 | $0.51 | $56 | $37 |  |
| **Sub-Total: Connectivity (0.1%)\*** |  |  |  |  |  |  | $56 | $37 |  |
| ***<u>Consumer Products & Services</u>*** |  |  |  |  |  |  |  |  |  |
| Bobbie Baby, Inc. | Warrant | September 12, 2025 | September 12, 2035 | Common Stock | 15456 | $4.05 | $21 | $19 |  |
| Ogee, Inc. | Warrant | November 25, 2024 | February 14, 2033 | Preferred Series A-3 | 15553 | $0.68 | $8 | $30 | (11) |
|  | Warrant | November 25, 2024 | February 14, 2033 | Preferred Series A-3 | 15553 | $0.68 | 8 | 30 | (11) |
|  | Warrant | November 25, 2024 | August 1, 2034 | Preferred Series A-3 | 15553 | $0.68 | 8 | 30 | (11) |
|  | Warrant | July 18, 2025 | August 1, 2034 | Preferred Series A-3 | 15553 | $0.68 | 50 | 30 | (11) |
| &nbsp;&nbsp;Total Ogee, Inc. |  |  |  |  |  |  | $74 | $120 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Warrant Investments - United States, Continued** | | | | | | | | | |
| Whoop, Inc. | Warrant | June 28, 2024 | May 17, 2033 | Common Stock | 93745 | $0.43 | $76 | $517 |  |
| **Sub-Total: Consumer Products & Services (1.1%)\*** |  |  |  |  |  |  | $171 | $656 |  |
| ***<u>Diagnostics & Tools</u>*** |  |  |  |  |  |  |  |  |  |
| Artera, Inc. | Warrant | March 13, 2026 | March 13, 2036 | Class B Common Stock | 9903 | $4.77 | $5 | $5 |  |
| Rapid Micro Biosystems, Inc. | Warrant | August 8, 2025 | August 8, 2035 | Common Stock | 16119 | $3.35 | $44 | $28 |  |
| **Sub-Total: Diagnostics & Tools (0.1%)\*** |  |  |  |  |  |  | $49 | $33 |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |  |  |
| Beam Technologies, Inc. | Warrant | November 19, 2024 | August 30, 2034 | Common Stock | 3606 | $17.28 | $46 | $21 |  |
|  | Warrant | August 7, 2025 | August 7, 2032 | Preferred Series F Prime | 310 | $— | 11 | 11 | (11) |
| &nbsp;&nbsp;Total Beam Technologies, Inc. |  |  |  |  |  |  | $57 | $32 |  |
| Centivo Corporation | Warrant | November 19, 2024 | July 31, 2034 | Common Stock | 10744 | $0.76 | $9 | $11 |  |
|  | Warrant | December 20, 2024 | July 31, 2034 | Common Stock | 10744 | $0.76 | 25 | 11 |  |
|  | Warrant | February 3, 2025 | July 31, 2034 | Common Stock | 10744 | $0.76 | 22 | 11 |  |
|  | Warrant | May 20, 2025 | July 31, 2034 | Common Stock | 21488 | $0.76 | 39 | 22 |  |
|  | Warrant | June 13, 2025 | July 31, 2034 | Common Stock | 10744 | $0.76 | 19 | 11 |  |
| &nbsp;&nbsp;Total Centivo Corporation |  |  |  |  |  |  | $114 | $66 |  |
| Tilt Finance, Inc (dba Empower Financial, Inc.) | Warrant | June 28, 2024 | October 13, 2033 | Common Stock | 13503 | $1.43 | $51 | $115 |  |
| Gravie, Inc. | Warrant | November 19, 2024 | June 4, 2034 | Common Stock | 7903 | $2.68 | $16 | $1 |  |
| Kard Financial, Inc. | Warrant | September 10, 2025 | September 10, 2035 | Common Stock | 34331 | $1.36 | $41 | $45 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Warrant Investments - United States, Continued** | | | | | | | | | |
| One Million Metrics (dba Kinetic) | Warrant | August 25, 2025 | August 25, 2035 | Common Stock | 27490 | $0.51 | $22 | $19 |  |
| Lendflow, Inc. | Warrant | April 24, 2025 | April 24, 2035 | Common Stock | 40365 | $0.70 | $37 | $21 |  |
| PatientFi, Inc. | Warrant | March 14, 2025 | March 14, 2035 | Preferred Series B | 38521 | $3.10 | $60 | $107 | (11) |
| Under Technologies, Inc. | Warrant | November 19, 2024 | May 3, 2034 | Common Stock | 6173 | $2.90 | $17 | $14 |  |
| Wisetack, Inc. | Warrant | November 14, 2024 | November 14, 2034 | Common Stock | 8234 | $1.58 | $8 | $5 |  |
| **Sub-Total: Finance and Insurance (0.7%)\*** |  |  |  |  |  |  | $423 | $425 |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |  |  |
| DrinkPak, LLC | Warrant | June 28, 2024 | February 17, 2033 | Common Stock | 1608 | $18.89 | $69 | $35 |  |
| **Sub-Total: Food and Agriculture Technologies 0.1%)\*** |  |  |  |  |  |  | $69 | $35 |  |
| ***<u>Energy and Resource Technology</u>*** |  |  |  |  |  |  |  |  |  |
| Form Energy, Inc. | Warrant | November 19, 2024 | October 21, 2034 | Common Stock | 6338 | $8.03 | $59 | $10 |  |
| **Sub-Total: Energy and Resource Technology (0.0%)\*** |  |  |  |  |  |  | $59 | $10 |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |  |  |
| B.Well Connected Health, Inc. | Warrant | April 10, 2025 | April 10, 2035 | Common Stock | 20455 | $0.79 | $35 | $4 |  |
| Paytient Technologies, Inc. | Warrant | May 27, 2025 | May 27, 2035 | Common Stock | 9603 | $1.01 | $13 | $10 |  |
| PurpleLab, Inc. | Warrant | September 24, 2025 | September 24, 2035 | Common Stock | 1653 | $23.09 | $44 | $41 |  |
| **Sub-Total: Healthcare Technology (0.1%)\*** |  |  |  |  |  |  | $92 | $55 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(5)</sup> | | **Footnotes** |
| **Warrant Investments - United States, Continued** | | | | | | | | | | |
| ***<u>Marketing, Media, and Entertainment</u>*** | | | | | | | | | | |
| Angel Studios, Inc. | Warrant | September 8, 2025 | September 11, 2030 | Common Stock | 23402 | $7.29 | $153 | $21 |  |  |
|  | Warrant | February 17, 2026 | September 11, 2030 | Common Stock | 11702 | 7.29 | 12 | 11 |  |  |
| &nbsp;&nbsp;Total Angel Studios, Inc. |  |  |  |  |  |  | $165 | $32 |  |  |
| Rarefied Atmosphere, Inc. | Warrant | May 6, 2025 | May 6, 2037 | Common Stock | 13218 | $7.35 | $43 | $41 |  |  |
| Vox Media Holdings, Inc. | Warrant | June 1, 2025 | June 25, 2035 | Class A Common Stock | 225010 | $0.37 | $66 | $50 |  |  |
| **Sub-Total: Marketing, Media and Entertainment (0.2%)\*** |  |  |  |  |  |  | $274 | $123 |  |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |  |  |
| Apiject Holdings, Inc. | Warrant | November 19, 2024 | June 24, 2034 | Common Stock | 63068 | $0.01 | $35 | $2 |  |  |
| Cala Health, Inc. | Warrant | February 24, 2026 | February 24, 2036 | Preferred Series C-1 | 63254 | $0.33 | $5 | $5 |  | (11) |
| Elucent Medical, Inc. | Warrant | November 19, 2024 | October 31, 2034 | Preferred Series C-2 | 120603 | $0.30 | $15 | $10 |  | (11) |
| Emboline, Inc. | Warrant | March 3, 2026 | March 3, 2036 | Series D Preferred Stock | 21396 | $3.93 | $9 | $9 |  | (11) |
| Lightforce Orthodontics, Inc. | Warrant | November 19, 2024 | August 6, 2034 | Preferred Series-D | 666 | $18.01 | $2 | $— |  | (11) |
|  | Warrant | December 1, 2024 | August 6, 2034 | Preferred Series-D | 3997 | $18.01 | 14 | 2 |  | (11) |
| &nbsp;&nbsp;Total Lightforce Orthodontics, Inc. |  |  |  |  |  |  | $16 | $2 | 2000 |  |
| Monteris Medical US, Inc. | Warrant | March 3, 2026 | March 3, 2036 | Series E Convertible Preferred Stock | 402813 | $0.23 | $32 | $32 |  | (11) |
| Okami Medical, Inc. | Warrant | June 24, 2025 | June 24, 2035 | Preferred Series F-1 | 5254 | $2.86 | $6 | $6 |  | (11) |
| Restor3d, Inc. | Warrant | November 19, 2024 | June 4, 2034 | Preferred Series A | 6108 | $5.01 | $5 | $1 |  | (11) |
| **Sub-Total: Medical Devices (0.1%)\*** |  |  |  |  |  |  | $123 | $67 |  |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | | **Fair Value** <sup>(5)</sup> | | **Footnotes** |
| **Warrant Investments - United States, Continued** | | | | | | | | | | | |
| ***<u>Other Healthcare Services</u>*** | | | | | | | | | | | |
| Cellares Corporation | Warrant | November 19, 2024 | August 2, 2034 | Common Stock | 15566 | $4.77 | $54 |  | $79 |  |  |
| Upward Health, Inc. | Warrant | November 19, 2024 | August 6, 2034 | Class A Common Stock | 64948 | $0.28 | $21 |  | $54 |  |  |
| **Sub-Total: Other Healthcare Services (0.2%)\*** |  |  |  |  |  |  | $75 |  | $133 |  |  |
| ***<u>Software as a Service ("SaaS")</u>*** |  |  |  |  |  |  |  |  |  |  |  |
| Silk Technologies, Inc. | Warrant | November 19, 2024 | November 4, 2034 | Common Stock | 15167 | $1.98 | $32 |  | $24 |  |  |
| Steno Agency, Inc. | Warrant | November 19, 2024 | June 21, 2034 | Common Stock | 7612 | $1.98 | $18 |  | $7 |  |  |
|  | Warrant | May 16, 2025 | June 21, 2034 | Common Stock | 8955 | $1.98 | 27 |  | 8 |  |  |
| &nbsp;&nbsp;Total Steno Agency, Inc. |  |  |  |  |  |  | $45 |  | $15 |  |  |
| **Sub-Total: Software as a Service ("SaaS") (0.1%)\*** |  |  |  |  |  |  | $77 | $— | $39 |  |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |  |  |  |
| Astranis Space Technologies Corp. | Warrant | June 28, 2024 | April 13, 2033 | Common Stock | 11203 | $7.89 | $39 |  | $158 |  |  |
|  | Warrant | November 19, 2024 | September 27, 2034 | Common Stock | 14930 | $2.27 | 66 |  | 230 |  |  |
|  | Warrant | June 26, 2025 | June 26, 2035 | Common Stock | 2751 | $0.01 | 13 |  | 44 |  |  |
|  | Warrant | June 26, 2025 | June 26, 2035 | Common Stock | 1765 | $0.01 | 9 |  | 28 |  |  |
|  | Warrant | August 25, 2025 | August 25, 2035 | Common Stock | 18319 | $2.33 | 70 |  | 282 |  |  |
| &nbsp;&nbsp;Total Astranis Space Technologies Corp. |  |  |  |  |  |  | $197 |  | $742 | 742000 |  |
| Hermeus Corporation | Warrant | June 28, 2024 | August 9, 2032 | Common Stock | 9338 | $6.24 | $21 |  | $113 |  |  |
|  | Warrant | March 23, 2026 | March 20, 2036 | Common Stock | 3198 | $8.83 | $35 |  | $35 |  |  |
| &nbsp;&nbsp;Total Hermeus Corporation |  |  |  |  |  |  | $56 |  | $148 |  |  |
| Impulse Space, Inc. | Warrant | November 19, 2024 | June 18, 2034 | Common Stock | 13944 | $1.91 | $248 |  | $618 |  |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Warrant Investments - United States, Continued** | | | | | | | | | | |
| Kymeta Corporation | Warrant | November 19, 2024 |  | July 3, 2034 | Common Stock | 303449 | $0.11 | $22 | $12 |  |
| Slingshot Aerospace, Inc. | Warrant | November 19, 2024 |  | July 12, 2036 | Common Stock | 24943 | $0.46 | $30 | $35 |  |
| **Sub-Total: Space Technology (2.5%)\*** |  |  |  |  |  |  |  | $553 | $1555 |  |
| **Total: Warrant Investments - United States (5.5%)\*** |  |  |  |  |  |  |  | $2310 | $3006 |  |
| **Warrant Investments- Canada** |  |  |  |  |  |  |  |  |  |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |  |  |
| Earthdaily Constellation Holdings, LP | Warrant | June 10, 2025 |  | June 10, 2035 | Class B Common Stock | 282171 | $0.81 | $161 | $127 |  |
| **Sub-Total: Space Technology (0.2%)\*** |  |  |  |  |  |  |  |  |  |  |
| **Total: Warrants Investments- Canada (0.2%)\*** |  |  |  |  |  |  |  | $161 | $127 |  |
| **Warrant Investments- Europe** |  |  |  |  |  |  |  |  |  |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |  |  |
| CMR Surgical Limited | Warrant | March 24, 2025 |  | March 24, 2030 | Ordinary Stock | 672 | 0.01 | $16 | $29 |  |
| **Sub-Total: Medical Devices (0.0%)\*** |  |  | April 24, 1901 |  |  |  |  | $16 | $29 |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |  |  |
| Zandivio PLC | Warrant | November 19, 2024 |  | October 29, 2034 | Common Stock | 8428 | 0.01 | $49 | $26 |  |
| **Sub-Total: Other Healthcare Services (0.0%)\*** |  |  | January 27, 1923 |  |  |  |  | $49 | $26 |  |
| **Total: Warrant Investments- Europe (0.1%)\*** |  |  |  |  |  |  |  | $65 | $55 |  |
| **Total Warrant Investments (5.8%)\*** |  |  |  |  |  |  |  | $2536 | $3567 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | **Shares/Principal** | **Series** | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Equity Investments- United States** | | | | | | | |
| ***<u>Connectivity</u>*** | | | | | | | |
| Tarana Wireless, Inc. | Equity | 10/9/2025 | 28053 | Preferred Series 8 | $30 | $48 | 11 |
| **Sub-Total: Connectivity (0.1%)\*** |  |  |  |  | $30 | $48 |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |
| Centivo Corporation | Equity | 12/20/2024 | 17119 | Preferred Series B-1 | $50 | $41 | 11 |
| **Sub-Total: Finance and Insurance (0.1%)\*** |  |  |  |  | $50 | $41 |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |
| Athletic Brewing Company, LLC | Equity | 8/1/2024 | 73 | Class B Units | $17 | $15 | 11 |
| **Sub-Total: Food and Agriculture Technologies (0.0%)\*** |  |  |  |  | $17 | $15 |  |
| ***<u>Energy and Resource Technology</u>*** |  |  |  |  |  |  |  |
| Crusoe Energy Systems LLC | Equity | 11/6/2024 | 1713 | Preferred Series D-1 | $50 | $91 | 11 |
| **Sub-Total: Energy and Resource Technology (0.1%)\*** |  |  |  |  | $50 | $91 |  |
| ***<u>Software as a Service ("SaaS")</u>*** |  |  |  |  |  |  |  |
| Silk Technologies, Inc. | Equity | 12/1/2025 | 30000 | SAFE Note | $30 | $30 |  |
| **Sub-Total: Software as a Service ("SaaS") (0.0%)\*** |  |  |  |  | $30 | $30 |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |
| Impulse Space, Inc. | Equity | 3/4/2025 | 7151 | Preferred Series B | $98 | $342 | 11 |
|  | Equity | 5/9/2025 | 2616 | Preferred Series C | 100 | 147 | 11 |
| Total Impulse Space Inc. |  |  |  |  | $198 | $489 |  |
| **Sub-Total: Space Technology (0.8%)\*** |  |  |  |  | $198 | $489 |  |
| **Total: Equity Investments- United States (1.2%)\*** |  |  |  |  | $375 | $714 |  |
| **Total Investments in Securities (212.9%)\*** |  |  |  |  | $129376 | $131353 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**March 31, 2026**

**(In thousands, except share and per share data)**

**(Unaudited)**

\* Represents % of Net Asset.

(1)All portfolio companies are located in North America or Europe. As of March 31, 2026, the Fund had three foreign domiciled portfolio companies, two of which are based in Europe and one of which is based in Canada. In total, foreign domiciled portfolio investment represented 13.12% of total net assets based on fair value.

(2)All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted.

(3)Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term ("EOT") payment, or additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. The EOT payment is amortized and recognized as non-cash income over the term of the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Fund's current debt securities.

(4)Principal is net of repayments, if any, as per the terms of the debt instrument's contract.

(5)All investments were valued at fair value using Level 3 inputs. Fair value is determined in good faith by Eagle Point Credit Management LLC, as the Fund's "valuation designee," in accordance with Rule 2a-5 under the Investment Company Act of 1940.

(6)The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. As of March 31, 2026, the U.S. Prime Rate ("Prime") was 6.75%, the Secured Overnight Financing Rate ("SOFR") 30 Day Forward Rate was 3.66%, and the SOFR 3-Month Term Rate was 3.68%.

(7)Interest on this loan includes a payment-in-kind ("PIK") provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is recorded on an accrual basis to the extent such amounts are expected to be collected.

(8)Investment is not pledged as collateral supporting amounts outstanding under the Fund's credit facility with KeyBank, National Association (the "KeyBank Credit Facility"). See "Note 5 – Borrowings" for more information.

(9)Investment has an unfunded commitment as of March 31, 2026 (see "Note 6 – Commitments and Contingencies"). The fair value of the investment includes the impact of the fair value of any unfunded commitments.

(10)Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications.

(11)Preferred stock represents investments through which the Fund will have preference in liquidation rights and do not contain any cumulative preferred dividends.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States** | | | | | | | | |
| ***Artificial Intelligence & Automation*** | | | | | | | | |
| Applied Digital Corporation | Equipment Financing | June 28, 2024 | March 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | $320 | $320 | $326 |  |
|  | Equipment Financing | June 28, 2024 | April 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | $213 | $213 | $217 |  |
|  | Equipment Financing | November 19, 2024 | April 1, 2026 | Fixed interest rate 19.0%; EOT 0.0% | $345 | $346 | $351 |  |
| &nbsp;&nbsp;Total Artificial Intelligence & Automation |  |  |  |  | $878 | $879 | $894 |  |
| Augmented Reality Concepts, Inc. | Secured Loan | November 19, 2024 | June 18, 2029 | Variable interest rate SOFR 3 Month Term + 7.3%; EOT 0.0% | $1230 | $1227 | $1235 | (6) |
| Cirrascale Cloud Services, LLC | Equipment Financing | November 19, 2024 | April 1, 2027 | Fixed interest rate 10.2%; EOT 5.0% | $605 | $661 | $663 |  |
|  | Equipment Financing | November 19, 2024 | September 1, 2026 | Fixed interest rate 12.7%; EOT 4.0% | $510 | $567 | $568 |  |
| Total Cirrascale Cloud Services, LLC |  |  |  |  | $1115 | $1228 | $1231 |  |
| D-Wave Quantum Inc. | Equipment Financing | August 1, 2025 | September 1, 2028 | Fixed interest rate 10.8%; EOT 4.0% | $54 | $53 | $54 |  |
| Sortera Technologies, Inc. | Equipment Financing | February 11, 2025 | March 1, 2028 | Fixed interest rate 12.5%; EOT 4.0% | $1088 | $1074 | $1085 | (6) |
| Swimlane, Inc. | Secured Loan | May 28, 2025 | June 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 2.3% | $3600 | $3544 | $3639 | (6) |
| Tquila Automation, Inc | Secured Loan | July 2, 2025 | August 1, 2030 | Variable interest rate Prime + 5.0% or Floor rate 12.3%; EOT 3.0% | $900 | $891 | $904 |  |
| Uniphore Technologies Inc. | Secured Loan | September 30, 2025 | October 1, 2030 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.0% | $4000 | $3904 | $3975 |  |
|  | Secured Loan | October 2, 2025 | October 1, 2030 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.0% | 1500 | 1468 | 1468 |  |
| &nbsp;&nbsp;Total Uniphore Technologies Inc. |  |  |  |  | $5500 | $5372 | $5443 |  |
| **Sub-Total: Artificial Intelligence & Automation (23.5%)\*** |  |  |  |  | $14365 | $14268 | $14485 |  |
| **<u>Biotechnology</u>** |  |  |  |  |  |  |  |  |
| Candel Therapeutics, Inc. | Secured Loan | October 14, 2025 | October 1, 2030 | Variable interest rate Prime + 3.0% or Floor rate 9.8%; EOT 4.3% | $1500 | $1451 | $1451 |  |
| Taysha Gene Therapies, Inc. | Secured Loan | August 7, 2025 | September 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 5.0% | $2000 | $2005 | $2055 | (6) |
| **Sub-Total: Biotechnology (5.7%)\*** |  |  |  |  | $3500 | $3456 | $3506 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| **<u>Connectivity</u>** | | | | | | | | |
| AST & Science, LLC | Equipment Financing | June 27, 2025 | July 1, 2030 | Fixed interest rate 12.4%; EOT 9.0% | $2367 | $2394 | $2439 |  |
|  | Equipment Financing | June 30, 2025 | July 1, 2030 | Fixed interest rate 12.5%; EOT 9.0% | 385 | 389 | 397 |  |
|  | Equipment Financing | September 26, 2025 | October 1, 2030 | Fixed interest rate 12.4%; EOT 9.0% | 860 | 861 | 876 |  |
|  | Equipment Financing | December 23, 2025 | January 1, 2031 | Fixed interest rate 12.4%; EOT 9.0% | 540 | 536 | 536 |  |
| &nbsp;&nbsp;Total AST & Science, LLC |  |  |  |  | $4152 | $4180 | $4248 |  |
| Tarana Wireless, Inc. | Secured Loan | November 19, 2024 | October 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 12.5%; EOT 4.0% | $1200 | $1172 | $1176 | (6) |
| **Sub-Total: Connectivity (8.8%)\*** |  |  |  |  | $5352 | $5352 | $5424 |  |
| ***<u>Consumer Products & Services</u>*** |  |  |  |  |  |  |  |  |
| Bobbie Baby, Inc. | Equipment Financing | September 12, 2025 | October 1, 2028 | Fixed interest rate 11.6%; EOT 3.0% | $1944 | $1922 | $1957 |  |
| Ogee, Inc. | Secured Loan | November 25, 2024 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | $300 | $307 | $307 | (6) |
|  | Secured Loan | November 25, 2024 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 300 | 308 | 308 | (6) |
|  | Secured Loan | November 25, 2024 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 300 | 304 | 303 | (6) |
|  | Secured Loan | July 18, 2025 | March 1, 2027 | Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8% | 300 | 268 | 266 | (6) |
| &nbsp;&nbsp;Total Ogee, Inc. |  |  |  |  | $1200 | $1187 | $1184 |  |
| **Sub-Total: Consumer Products & Services (5.1%)\*** |  |  |  |  | $3144 | $3109 | $3141 |  |
| ***<u>Diagnostics & Tools</u>*** |  |  |  |  |  |  |  |  |
| Rapid Micro Biosystems, Inc. | Secured Loan | August 8, 2025 | September 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 4.0% | $1800 | $1751 | $1777 |  |
| **Sub-Total: Diagnostics & Tools (2.9%)\*** |  |  |  |  | 1800 | 1751 | 1777 |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |  |
| Beam Technologies, Inc. | Secured Loan | November 19, 2024 | October 1, 2029 | Variable interest rate Prime + 2.8% or Floor rate 11.0%+PIK Fixed Interest Rate 1.5%; EOT 2.0% | $2264 | $2358 | $2320 | (6) (7) |
|  | Secured Loan | June 25, 2025 | October 1, 2029 | Variable interest rate Prime + 2.8% or Floor rate 11.0%+PIK Fixed Interest Rate 1.5%; EOT 2.0% | 181 | 185 | 186 | (6) (7) |
|  | Secured Loan | August 7, 2025 | December 31, 2029 | Fixed interest rate 0.0%; EOT 0.0% | 30 | 30 | 30 | (8) |
| &nbsp;&nbsp;Total Beam Technologies, Inc. |  |  |  |  | $2475 | $2573 | $2536 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| Centivo Corporation | Secured Loan | November 19, 2024 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | $507 | $504 | $513 | (6) (7) |
|  | Secured Loan | December 20, 2024 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 505 | 488 | 495 | (6) (7) |
|  | Secured Loan | February 3, 2025 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 504 | 489 | 496 | (6) (7) |
|  | Secured Loan | May 20, 2025 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 1005 | 973 | 988 | (6) (7) |
|  | Secured Loan | June 13, 2025 | August 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0% | 502 | 486 | 493 | (6) (7) |
| &nbsp;&nbsp;Total Centivo Corporation |  |  |  |  | $3023 | $2940 | $2985 |  |
| Cherry Technologies, Inc. | Secured Loan | June 28, 2024 | April 1, 2030 | Variable interest rate Prime + 2.5% or Floor rate 9.5%; EOT 2.0% | $265 | $276 | $273 | (6) |
|  | Secured Loan | July 31, 2024 | April 1, 2030 | Variable interest rate Prime + 2.5% or Floor rate 9.5%; EOT 2.0% | 265 | 276 | 272 | (6) |
| &nbsp;&nbsp;Total Cherry Technologies, Inc. |  |  |  |  | $530 | $552 | $545 |  |
| Tilt Finance, Inc (dba Empower Financial, Inc.) | Secured Loan | June 28, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | $378 | $388 | $384 | (6) |
|  | Secured Loan | June 28, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 98 | 97 | 98 | (6) |
|  | Secured Loan | June 28, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT3.8% | 147 | 147 | 147 | (6) |
|  | Secured Loan | June 28, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 152 | 149 | 149 | (6) |
|  | Secured Loan | June 28, 2024 | May 1, 2028 | Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8% | 505 | 514 | 522 | (6) |
| &nbsp;&nbsp;Total Tilt Finance, Inc (dba Empower Financial, Inc.) |  |  |  |  | $1280 | $1295 | $1300 |  |
| Gravie, Inc. | Secured Loan | November 19, 2024 | July 1, 2029 | Variable interest rate Prime + 4.5% or Floor rate 13.0%; EOT 2.5% | $1020 | $1030 | $1007 | (6) |
| Kard Financial, Inc. | Secured Loan | September 10, 2025 | October 1, 2030 | Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 2.0% | $980 | $955 | $984 | (6) |
| One Million Metrics (dba Kinetic) | Secured Loan | August 25, 2025 | September 1, 2030 | Variable interest rate Prime + 4.5% or Floor rate 12.0%; EOT 3.0% | $1050 | $1024 | $1053 | (6) |
| Lendflow, Inc. | Secured Loan | April 24, 2025 | May 1, 2030 | Variable interest rate Prime + 4.5% or Floor rate 12.0%; EOT 2.7% | $960 | $949 | $974 | (6) |
|  | Secured Loan | December 15, 2025 | May 1, 2030 | Variable interest rate Prime + 4.5% or Floor rate 12.0%; EOT 2.7% | 480 | 471 | 471 | (6) |
| Total Lendflow, Inc. |  |  |  |  | $1440 | $1420 | $1445 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| PatientFi, Inc. | Secured Loan | March 14, 2025 | April 1, 2030 | Variable interest rate Prime + 3.5% or Floor rate 10.5%; EOT 2.5% | $1800 | $1783 | $1797 | (6) |
|  | Secured Loan | December 16, 2025 | April 1, 2030 | Variable interest rate Prime + 3.5% or Floor rate 10.5%; EOT 2.5% | 1800 | 1753 | 1753 | (6) |
| &nbsp;&nbsp;Total PatientFi, Inc. |  |  |  |  | $3600 | $3536 | $3550 |  |
| Under Technologies, Inc. | Secured Loan | November 19, 2024 | June 1, 2029 | Variable interest rate Prime + 3.8% or Floor rate 12.0%; EOT 4.3% | $600 | $599 | $615 | (6) |
|  | Secured Loan | November 27, 2024 | June 1, 2029 | Variable interest rate Prime + 3.8% or Floor rate 12.0%; EOT 4.3% | 600 | 598 | 607 | (6) |
| &nbsp;&nbsp;Total Under Technologies, Inc. |  |  |  |  | $1200 | $1197 | $1222 |  |
| Wisetack, Inc. | Secured Loan | November 14, 2024 | December 1, 2029 | Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 2.5% | $900 | $894 | $917 | (6) |
|  | Secured Loan | December 9, 2025 | September 22, 2027 | Fixed interest rate 6.0%; EOT 0.0% | 30 | 30 | 30 | (6)(8) |
| &nbsp;&nbsp;Total Wisetack, Inc. |  |  |  |  | $930 | $924 | $947 |  |
| **Sub-Total: Finance and Insurance (28.5%)\*** |  |  |  |  | $17528 | $17446 | $17574 |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |  |
| DrinkPak, LLC | Equipment Financing | June 28, 2024 | September 1, 2026 | Fixed interest rate 12.9%; EOT 7.0% | $415 | $548 | $554 |  |
| **Sub-Total: Food and Agriculture Technologies (0.9%)\*** |  |  |  |  | $415 | $548 | $554 |  |
| ***<u>Green Technology</u>*** |  |  |  |  |  |  |  |  |
| Commonwealth Fusion Systems, LLC | Equipment Financing | November 19, 2024 | July 1, 2030 | Fixed interest rate 13.2%; EOT 10.0% | $2981 | $3167 | $3200 |  |
|  | Equipment Financing | June 28, 2024 | July 1, 2030 | Fixed interest rate 13.0%; EOT 10.0% | 1030 | 1135 | 1132 |  |
|  | Equipment Financing | January 14, 2025 | July 1, 2029 | Fixed interest rate 11.2%; EOT 6.0% | 161 | 165 | 167 |  |
|  | Equipment Financing | December 24, 2025 | December 1, 2030 | Fixed interest rate 11.4%; EOT 6.0% | 1300 | 1288 | 1288 |  |
| &nbsp;&nbsp;Total Commonwealth Fusion Systems, LLC |  |  |  |  | $5472 | $5755 | $5787 |  |
| Electric Hydrogen Co. | Equipment Financing | June 28, 2024 | January 1, 2029 | Fixed interest rate 12.6%; EOT 15.0% | $902 | $1046 | $1016 |  |
|  | Equipment Financing | November 19, 2024 | January 1, 2029 | Fixed interest rate 12.6%; EOT 15.0% | 740 | 828 | 818 |  |
|  | Equipment Financing | November 19, 2024 | October 1, 2028 | Fixed interest rate 12.5%; EOT 15.0% | 444 | 489 | 485 |  |
|  | Equipment Financing | November 14, 2024 | December 1, 2028 | Fixed interest rate 11.9%; EOT 15.0% | 107 | 116 | 115 |  |
| &nbsp;&nbsp;Total Electric Hydrogen Co. |  |  |  |  | $2193 | $2479 | $2434 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| Form Energy, Inc. | Equipment Financing | November 19, 2024 | November 1, 2027 | Fixed interest rate 12.7%; EOT 3.0% | $1563 | $1585 | $1608 |  |
|  | Equipment Financing | December 12, 2024 | January 1, 2028 | Fixed interest rate 12.5%; EOT 3.0% | 423 | 426 | 432 |  |
| &nbsp;&nbsp;Total Form Energy, Inc. |  |  |  |  | $1986 | $2011 | $2040 |  |
| **Sub-Total: Green Technology (16.7%)\*** |  |  |  |  | $9651 | $10245 | $10261 |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |  |
| B.Well Connected Health, Inc. | Secured Loan | April 10, 2025 | May 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 3.0% | $1800 | $1783 | $1829 | (6) |
|  | Secured Loan | October 29, 2025 | May 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 3.0% | 720 | 708 | 708 | (6) |
| &nbsp;&nbsp;Total B.Well Connected Health, Inc. |  |  |  |  | $2520 | $2491 | $2537 |  |
| Paytient Technologies, Inc. | Secured Loan | May 27, 2025 | June 1, 2030 | Variable interest rate Prime + 3.8% or Floor rate 10.8%; EOT 3.0% | $1250 | $1228 | $1246 | (6) |
|  | Secured Loan | October 2, 2025 | June 1, 2030 | Variable interest rate Prime + 3.8% or Floor rate 10.8%; EOT 3.0% | 1250 | 1246 | 1246 | (6) |
| &nbsp;&nbsp;Total Paytient Technologies, Inc. |  |  |  |  | $2500 | $2474 | $2492 |  |
| PurpleLab, Inc. | Secured Loan | September 24, 2025 | October 1, 2030 | Variable interest rate Prime + 4.5% or Floor rate 11.5%; EOT 2.0% | $3500 | $3430 | $3461 | (6) |
| **Sub-Total: Healthcare Technology (13.8%)\*** |  |  |  |  | $8520 | $8395 | $8490 |  |
| ***<u>Marketing, Media, and Entertainment</u>*** |  |  |  |  |  |  |  |  |
| Angel Studios, Inc. | Secured Loan | September 8, 2025 | October 1, 2030 | Variable interest rate Prime + 6.0% or Floor rate 13.5%; EOT 2.0% | $1600 | $1449 | $1481 | (6) |
| Rarefied Atmosphere, Inc. | Secured Loan | May 6, 2025 | June 1, 2030 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 2.0% | $3163 | $3119 | $3202 | (6) |
| Vox Media Holdings, Inc. | Secured Loan | June 28, 2024 | November 1, 2027 | Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5% | $1494 | $1503 | $1479 | (6) |
|  | Secured Loan | June 28, 2024 | January 1, 2028 | Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5% | 749 | 753 | 740 | (6) |
| &nbsp;&nbsp;Total Vox Media Holdings, Inc. |  |  |  |  | $2243 | $2256 | $2219 |  |
| **Sub-Total: Marketing, Media and Entertainment (11.2%)\*** |  |  |  |  | $7006 | $6824 | $6902 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| ***<u>Medical Devices</u>*** | | | | | | | | |
| Apiject Holdings, Inc. | Equipment Financing | November 19, 2024 | July 1, 2028 | Fixed interest rate 10.9%; EOT 7.5% | $880 | $976 | $894 |  |
|  | Equipment Financing | November 19, 2024 | October 1, 2028 | Fixed interest rate 11.1%; EOT 7.5% | 447 | 492 | 455 |  |
| &nbsp;&nbsp;Total Apiject Holdings, Inc. |  |  |  |  | $1327 | $1468 | $1349 |  |
| Cagent Vascular, Inc. | Secured Loan | January 24, 2025 | February 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.3%; EOT 3.0% | $1200 | $1217 | $1226 | (6) |
| Elucent Medical, Inc. | Secured Loan | November 19, 2024 | November 30, 2029 | Variable interest rate Prime + 3.8% or Floor rate 11.3%; EOT 3.3% | $900 | $894 | $887 | (6) |
| Lightforce Orthodontics, Inc. | Secured Loan | November 19, 2024 | August 6, 2029 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0% | $1800 | $1798 | $1845 | (6) |
|  | Secured Loan | November 19, 2024 | August 6, 2029 | Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0% | 300 | 300 | 307 | (6) |
| &nbsp;&nbsp;Total Lightforce Orthodontics, Inc. |  |  |  |  | $2100 | $2098 | $2152 |  |
| Nalu Medical, Inc | Secured Loan | July 3, 2025 | August 1, 2030 | Variable interest rate Prime + 3.0% or Floor rate 10.0%; EOT 4.0% | $1575 | $1562 | $1588 | (6) |
| Neuros Medical, Inc. | Secured Loan | December 11, 2025 | January 1, 2031 | Variable interest rate Prime + 3.8% or Floor rate 10.5%; EOT 4.0% | $1884 | $1885 | $1896 | (6) |
| Okami Medical, Inc. | Secured Loan | June 24, 2025 | July 1, 2030 | Variable interest rate Prime + 3.8% or Floor rate 10.5%; EOT 2.0% | $600 | $590 | $595 | (6) |
| Restor3d, Inc. | Secured Loan | November 19, 2024 | July 4, 2028 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.3% | $255 | $257 | $262 | (6) |
| Vital Connect, Inc. | Secured Loan | November 19, 2024 | July 3, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0% | $2100 | $2110 | $2170 | (6) |
|  | Secured Loan | March 21, 2025 | July 3, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0% | 600 | 600 | 617 | (6) |
|  | Secured Loan | December 17, 2025 | July 3, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0% | 600 | 594 | 594 | (6) |
| &nbsp;&nbsp;Total Vital Connect, Inc. |  |  |  |  | $3300 | $3304 | $3381 |  |
| **Sub-Total: Medical Devices (21.7%)\*** |  |  |  |  | $13141 | $13275 | $13336 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| ***<u>Other Healthcare Services</u>*** | | | | | | | | |
| Cellares Corporation | Equipment Financing | November 19, 2024 | September 1, 2029 | Fixed interest rate 12.0%; EOT 4.5% | $237 | $242 | $245 |  |
|  | Equipment Financing | January 10, 2025 | February 1, 2030 | Fixed interest rate 12.2%; EOT 4.5% | 159 | 161 | 161 |  |
|  | Equipment Financing | January 29, 2025 | February 1, 2030 | Fixed interest rate 12.5%; EOT 4.5% | 97 | 98 | 98 |  |
|  | Secured Loan | November 19, 2024 | February 1, 2027 | Variable interest rate Prime + 3.3% or Floor rate 11.8%; EOT 4.0% | 3000 | 3037 | 3082 | (6) |
| &nbsp;&nbsp;Total Cellares Corporation |  |  |  |  | $3493 | $3538 | $3586 |  |
| Upward Health, Inc. | Secured Loan | November 19, 2024 | September 1, 2029 | Variable interest rate Prime + 4.3% or Floor rate 12.8%; EOT 3.0% | $500 | $494 | $509 | (6) |
| **Sub-Total: Other Healthcare Services (6.6%)\*** |  |  |  |  | $3993 | $4032 | $4095 |  |
| ***<u>Software as a Service ("SaaS")</u>*** |  |  |  |  |  |  |  |  |
| Eyelit Technologies, Inc. | Secured Loan | November 19, 2024 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0% | $500 | $492 | $491 | (6) (9) |
|  | Secured Loan | December 27, 2024 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0% | 880 | 866 | 864 | (6) (9) |
|  | Secured Loan | June 20, 2025 | November 4, 2029 | Variable interest rate SOFR 1 Month Term +5.8%; EOT 0.0% | 100 | 98 | 99 | (6) (9) |
|  | Secured Loan | September 10, 2025 | November 4, 2029 | Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0% | 250 | 245 | 244 | (6) (9) |
| &nbsp;&nbsp;Total Eyelit Technologies, Inc. |  |  |  |  | $1730 | $1701 | $1698 |  |
| Hometown Ticketing, Inc. | Secured Loan | November 25, 2024 | November 25, 2029 | Variable interest rate SOFR 3 Month Term + 7.7%; EOT 0.0% | $1574 | $1551 | $1580 | (6) |
| ServiceTrade, Inc. | Secured Loan | November 19, 2024 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | $1500 | $1481 | $1494 | (6) (9) |
|  | Secured Loan | May 2, 2025 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | 120 | 118 | 120 | (6) (9) |
|  | Secured Loan | June 3, 2025 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | 120 | 118 | 120 | (6) (9) |
|  | Secured Loan | September 22, 2025 | August 15, 2029 | Variable interest rate SOFR 3 Month Term + 5.3%; EOT 0.0% | 120 | 118 | 120 | (6) (9) |
| &nbsp;&nbsp;Total ServiceTrade, Inc. |  |  |  |  | $1860 | $1835 | $1854 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| Silk Technologies, Inc. | Secured Loan | November 19, 2024 | December 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 11.3%; EOT 1.5% | $1200 | $1182 | $1195 | (6) |
| SOCI, Inc. | Secured Loan | November 19, 2024 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0% | $2281 | $2244 | $2203 | (6) (9) |
|  | Secured Loan | December 30, 2024 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.8%; EOT 0.0% | 208 | 204 | 201 | (6) (9) |
|  | Secured Loan | April 23, 2025 | October 3, 2029 | Variable interest rate SOFR 6 Month Term + 7.8%; EOT 0.0% | 104 | 102 | 103 | (6) (9) |
|  | Secured Loan | August 5, 2025 | October 3, 2029 | Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0% | 110 | 108 | 108 | (6) (9) |
| &nbsp;&nbsp;Total SOCI, Inc. |  |  |  |  | $2703 | $2658 | $2615 |  |
| Steno Agency, Inc. | Secured Loan | November 19, 2024 | July 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5% | $510 | $511 | $522 | (6) |
|  | Secured Loan | January 2, 2025 | July 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5% | 600 | 603 | 616 | (6) |
|  | Secured Loan | May 16, 2025 | July 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5% | 600 | 580 | 592 | (6) |
| &nbsp;&nbsp;Total Steno Agency |  |  |  |  | $1710 | $1694 | $1730 |  |
| Xytech Systems, LLC | Secured Loan | February 26, 2025 | February 26, 2030 | Variable interest rate SOFR 3 Month Term + 6.0%; EOT 0.0% | $2400 | $2400 | $2357 | (6) (9) |
|  | Secured Loan | July 2, 2025 | February 26, 2030 | Variable interest rate SOFR 3 Month Term + 6.0%; EOT 0.0% | 120 | 118 | 116 | (6) (9) |
| &nbsp;&nbsp;Total Xytech Systems, LLC |  |  |  |  | $2520 | $2518 | $2473 |  |
| **Sub-Total: Software as a Service ("SaaS") (21.3%)\*** |  |  |  |  | $13297 | $13139 | $13145 |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |
| Astranis Space Technologies Corp. | Equipment Financing | June 28, 2024 | May 1, 2027 | Fixed interest rate 12.1%; EOT 6.5% | 184 | 231 | 197 |  |
|  | Equipment Financing | November 19, 2024 | October 1, 2028 | Fixed interest rate 13.8%; EOT 6.5% | 225 | 243 | 242 |  |
|  | Equipment Financing | November 19, 2024 | October 1, 2027 | Fixed interest rate 12.6%; EOT 4.0% | 173 | 175 | 176 |  |
|  | Equipment Financing | August 25, 2025 | September 1, 2028 | Fixed interest rate 11.6%; EOT 4.0% | 180 | 180 | 183 |  |
|  | Equipment Financing | October 30, 2025 | November 1, 2028 | Fixed interest rate 11.7%; EOT 4.0% | 46 | 46 | 46 |  |
|  | Secured Loan | August 25, 2025 | August 25, 2030 | Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 4.0% | 2000 | 1925 | 1984 | (6) |
| &nbsp;&nbsp;Total Astranis Space Technologies Corp. |  |  |  |  | 2808 | 2800 | 2828 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - United States, Continued** | | | | | | | | |
| Impulse Space, Inc. | Equipment Financing | November 19, 2024 | July 1, 2027 | Fixed interest rate 12.7%; EOT 3.0% | $182 | $189 | $190 |  |
|  | Equipment Financing | November 19, 2024 | October 1, 2027 | Fixed interest rate 12.5%; EOT 3.0% | 187 | 191 | 194 |  |
|  | Equipment Financing | December 27, 2024 | January 1, 2028 | Fixed interest rate 12.9%; EOT 3.0% | 189 | 189 | 195 |  |
|  | Equipment Financing | February 12, 2025 | March 1, 2028 | Fixed interest rate 12.6%; EOT 3.0% | 218 | 219 | 222 |  |
|  | Equipment Financing | June 25, 2025 | July 1, 2028 | Fixed interest rate 12.8%; EOT 3.0% | 272 | 269 | 274 |  |
|  | Equipment Financing | September 25, 2025 | October 1, 2028 | Fixed interest rate 12.8%; EOT 3.0% | 1319 | 1298 | 1318 |  |
| &nbsp;&nbsp;Total Impulse Space, Inc. |  |  |  |  | $2367 | $2355 | $2393 |  |
| Kymeta Corporation | Secured Loan | November 19, 2024 | August 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 3.0% | $600 | $589 | $608 | (6) |
|  | Secured Loan | June 11, 2025 | August 1, 2029 | Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 3.0% | 600 | 599 | 610 | (6) |
| &nbsp;&nbsp;Total Kymeta Corporation |  |  |  |  | $1200 | $1188 | $1218 |  |
| Slingshot Aerospace, Inc. | Secured Loan | November 19, 2024 | August 1, 2029 | Variable interest rate Prime + 5.5% or Floor rate 14.0%; EOT 3.0% | $1800 | $1793 | $1837 | (6) |
| **Sub-Total: Space Technology (13.4%)\*** |  |  |  |  | $8175 | $8136 | $8276 |  |
| ***<u>Transportation Technology</u>*** |  |  |  |  |  |  |  |  |
| EH Leasing Company, LLC | Equipment Financing | November 1, 2025 | November 1, 2029 | Fixed interest rate 14.4%; EOT 18.7% | $318 | $357 | $328 | (8) |
| **Sub-Total: Transportation Technology (0.5%)\*** |  |  |  |  | $318 | $357 | $328 |  |
| **Total Debt Securities - United States (180.7%)\*** |  |  |  |  | $110205 | $110333 | $111294 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)</sup> | **Investment Date** <sup>(10)</sup> | **Maturity Date** | **Interest Rate** <sup>(3)</sup> | **Principal Amount** <sup>(4)</sup> | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Debt Securities - Canada** | | | | | | | | |
| ***<u>Space Technology</u>*** | | | | | | | | |
| Earthdaily Constellation Holdings, LP | Equipment Financing | June 10, 2025 | January 1, 2029 | Fixed interest rate 13.5%; EOT 7.0% | $3173 | $3154 | $3185 |  |
|  | Equipment Financing | August 28, 2025 | March 1, 2029 | Fixed interest rate 13.9%; EOT 7.0% | 439 | 432 | 437 |  |
| &nbsp;&nbsp;Total Earthdaily Constellation Holdings, LP |  |  |  |  | $3612 | $3586 | $3622 |  |
| **Sub-Total: Space Technology (5.9%)\*** |  |  |  |  | $3612 | $3586 | $3622 |  |
| **Total Debt Securities - Canada (5.9%)\*** |  |  |  |  | $3612 | $3586 | $3622 |  |
| **Debt Securities - Europe** |  |  |  |  |  |  |  |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |
| CMR Surgical Limited | Secured Loan | March 24, 2025 | April 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 4.0% | $1875 | $1887 | $1925 | (6) |
|  | Secured Loan | December 16, 2025 | April 1, 2030 | Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 4.0% | 750 | 735 | 735 | (6) |
| &nbsp;&nbsp;Total CMR Surgical Limited |  |  |  |  | $2625 | $2622 | $2660 |  |
| **Sub-Total: Medical Devices (4.3%)\*** |  |  |  |  | $2625 | $2622 | $2660 |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |
| Zandivio PLC | Secured Loan | November 19, 2024 | May 1, 2029 | Variable interest rate Prime + 5.3% or Floor rate 13.8%; EOT 2.5% | $1800 | $1782 | $1817 | (6) |
| **Sub-Total: Other Healthcare Services (2.9%)\*** |  |  |  |  | $1800 | $1782 | $1817 |  |
| **Total: Debt Securities - Europe (7.3%)\*** |  |  |  |  | $4425 | $4404 | $4477 |  |
| **Total Debt Securities (193.8%)\*** |  |  |  |  | $118242 | $118323 | $119393 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | Expiration Date | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Warrant Investments - United States** |  |  |  |  |  |  |  |  |  |
| ***<u>Artificial Intelligence & Automation</u>*** |  |  |  |  |  |  |  |  |  |
| D-Wave Quantum Inc. | Warrant | August 1, 2025 | August 1, 2035 | Common Stock | 2588 | $16.05 | $35 | $58 |  |
| Sortera Technologies, Inc. | Warrant | February 11, 2025 | February 11, 2035 | Common Stock | 9995 | $5.23 | $69 | $66 |  |
| Swimlane, Inc. | Warrant | May 28, 2025 | May 28, 2037 | Preferred Series B | 687265 | $0.19 | $43 | $46 | (11) |
| Tquila Automation, Inc | Warrant | July 2, 2025 | July 2, 2037 | Common Stock | 4397 | $0.81 | $6 | $5 |  |
| Uniphore Technologies Inc. | Warrant | September 30, 2025 | September 30, 2035 | Common Stock | 92385 | $2.40 | $95 | $72 |  |
| **Sub-Total: Artificial Intelligence & Automation (0.4%)\*** |  |  |  |  |  |  | $248 | $247 |  |
| ***<u>Biotechnology</u>*** |  |  |  |  |  |  |  |  |  |
| Candel Therapeutics, Inc. | Warrant | October 14, 2025 | October 14, 2035 | Common Stock | 7639 | $5.89 | $41 | $42 |  |
| **Sub-Total: Biotechnology (0.1%)\*** |  |  |  |  |  |  | $41 | $42 |  |
| ***<u>Connectivity</u>*** |  |  |  |  |  |  |  |  |  |
| Tarana Wireless, Inc. | Warrant | November 19, 2024 | September 23, 2034 | Common Stock | 169859 | $0.51 | $56 | $35 |  |
| **Sub-Total: Connectivity (0.1%)\*** |  |  |  |  |  |  | $56 | $35 |  |
| ***<u>Consumer Products & Services</u>*** |  |  |  |  |  |  |  |  |  |
| Bobbie Baby, Inc. | Warrant | September 12, 2025 | September 12, 2035 | Common Stock | 15456 | $4.05 | $21 | $22 |  |
| Ogee, Inc. | Warrant | November 25, 2024 | February 14, 2033 | Preferred Series A-3 | 15553 | $0.68 | $8 | $42 | (11) |
|  |  | November 25, 2024 | February 14, 2033 | Preferred Series A-3 | 15553 | $0.68 | 8 | 42 | (11) |
|  |  | November 25, 2024 | August 1, 2034 | Preferred Series A-3 | 15553 | $0.68 | 8 | 42 | (11) |
|  |  | July 18, 2025 | August 1, 2034 | Preferred Series A-3 | 15553 | $0.68 | 50 | 42 | (11) |
| &nbsp;&nbsp;Total Ogee, Inc. |  |  |  |  |  |  | $74 | $168 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Warrant Investments - United States, Continued** | | | | | | | | | |
| Whoop, Inc. | Warrant | June 28, 2024 | May 17, 2033 | Common Stock | 93745 | $0.43 | $76 | $181 |  |
| **Sub-Total: Consumer Products & Services (0.6%)\*** |  |  |  |  |  |  | $171 | $371 |  |
| ***<u>Diagnostics & Tools</u>*** |  |  |  |  |  |  |  |  |  |
| Rapid Micro Biosystems, Inc. | Warrant | August 8, 2025 | August 8, 2035 | Common Stock | 16119 | $3.35 | $44 | $37 |  |
| **Sub-Total: Diagnostics & Tools (0.1%)\*** |  |  |  |  |  |  | $44 | $37 |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |  |  |
| Beam Technologies, Inc. | Warrant | November 19, 2024 | August 30, 2034 | Common Stock | 3606 | $17.28 | $46 | $36 |  |
|  |  | August 7, 2025 | August 7, 2032 | Preferred Series F Prime | 310 | $— | 11 | 12 | (11) |
| &nbsp;&nbsp;Total Beam Technologies, Inc. |  |  |  |  |  |  | $57 | $48 |  |
| Centivo Corporation | Warrant | November 19, 2024 | July 31, 2034 | Common Stock | 10744 | $0.76 | $9 | $13 |  |
|  |  | December 20, 2024 | July 31, 2034 | Common Stock | 10744 | $0.76 | 25 | 13 |  |
|  |  | February 3, 2025 | July 31, 2034 | Common Stock | 10744 | $0.76 | 22 | 13 |  |
|  |  | May 20, 2025 | July 31, 2034 | Common Stock | 21488 | $0.76 | 39 | 25 |  |
|  |  | June 13, 2025 | July 31, 2034 | Common Stock | 10744 | $0.76 | 19 | 13 |  |
| &nbsp;&nbsp;Total Centivo Corporation |  |  |  |  |  |  | $114 | $77 |  |
| Tilt Finance, Inc (dba Empower Financial, Inc.) | Warrant | June 28, 2024 | October 13, 2033 | Common Stock | 13503 | $1.43 | $51 | $116 |  |
| Gravie, Inc. | Warrant | November 19, 2024 | June 4, 2034 | Common Stock | 7903 | $2.68 | $16 | $1 |  |
| Kard Financial, Inc. | Warrant | September 10, 2025 | September 10, 2035 | Common Stock | 34331 | $1.36 | $41 | $40 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Warrant Investments - United States, Continued** | | | | | | | | | |
| One Million Metrics (dba Kinetic) | Warrant | August 25, 2025 | August 25, 2035 | Common Stock | 27490 | $0.51 | $22 | $22 |  |
| Lendflow, Inc. | Warrant | April 24, 2025 | April 24, 2035 | Common Stock | 40365 | $0.70 | $37 | $41 |  |
| PatientFi, Inc. | Warrant | March 14, 2025 | March 14, 2035 | Preferred Series B | 38521 | $3.10 | $60 | $54 | (11) |
| Under Technologies, Inc. | Warrant | November 19, 2024 | May 3, 2034 | Common Stock | 6173 | $2.90 | $17 | $18 |  |
| Wisetack, Inc. | Warrant | November 14, 2024 | November 14, 2034 | Common Stock | 8234 | $1.58 | $8 | $9 |  |
| **Sub-Total: Finance and Insurance (0.7%)\*** |  |  |  |  |  |  | $423 | $426 |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |  |  |
| DrinkPak, LLC | Warrant | June 28, 2024 | February 17, 2033 | Common Stock | 1608 | $18.89 | $69 | $32 |  |
| **Sub-Total: Food and Agriculture Technologies (0.1%)\*** |  |  |  |  |  |  | $69 | $32 |  |
| ***<u>Green Technology</u>*** |  |  |  |  |  |  |  |  |  |
| Form Energy, Inc. | Warrant | November 19, 2024 | October 21, 2034 | Common Stock | 6338 | $8.03 | $59 | $44 |  |
| **Sub-Total: Green Technology (0.1%)\*** |  |  |  |  |  |  | $59 | $44 |  |
| ***<u>Healthcare Technology</u>*** |  |  |  |  |  |  |  |  |  |
| B.Well Connected Health, Inc. | Warrant | April 10, 2025 | April 10, 2035 | Common Stock | 20455 | $0.79 | $35 | $21 |  |
| Paytient Technologies, Inc. | Warrant | May 27, 2025 | May 27, 2035 | Common Stock | 9603 | $1.01 | $13 | $15 |  |
| PurpleLab, Inc. | Warrant | September 24, 2025 | September 24, 2035 | Common Stock | 1653 | $23.09 | $44 | $46 |  |
| **Sub-Total: Healthcare Technology (0.1%)\*** |  |  |  |  |  |  | $92 | $82 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Warrant Investments - United States, Continued** | | | | | | | | | |
| ***<u>Marketing, Media, and Entertainment</u>*** | | | | | | | | | |
| Angel Studios, Inc. | Warrant | September 8, 2025 | September 11, 2030 | Common Stock | 23402 | $7.29 | $152 | $47 |  |
| Rarefied Atmosphere, Inc. | Warrant | May 6, 2025 | May 6, 2037 | Common Stock | 13218 | $7.35 | $43 | $50 |  |
| Vox Media Holdings, Inc. | Warrant | June 1, 2025 | June 25, 2035 | Class A Common Stock | 225010 | $0.37 | $66 | $53 |  |
| **Sub-Total: Marketing, Media and Entertainment (0.2%)\*** |  |  |  |  |  |  | $261 | $150 |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |  |
| Apiject Holdings, Inc. | Warrant | November 19, 2024 | June 24, 2034 | Common Stock | 63068 | $0.01 | $35 | $9 |  |
| Elucent Medical, Inc. | Warrant | November 19, 2024 | October 31, 2034 | Preferred Series C-2 | 120603 | $0.30 | $11 | $7 | (11) |
| Lightforce Orthodontics, Inc. | Warrant | November 19, 2024 | August 6, 2034 | Preferred Series-D | 666 | $18.01 | $2 | $1 | (11) |
|  |  | December 1, 2024 | August 6, 2034 | Preferred Series-D | 3997 | $18.01 | 14 | 3 | (11) |
| &nbsp;&nbsp;Total Lightforce Orthodontics, Inc. |  |  |  |  |  |  | $16 | $4 |  |
| Nalu Medical, Inc | Warrant | July 3, 2025 | July 3, 2035 | Preferred Series E | 7313 | $4.85 | $12 | $27 | (11) |
| Okami Medical, Inc. | Warrant | June 24, 2025 | June 24, 2035 | Preferred Series F-1 | 5254 | $2.86 | $6 | $5 | (11) |
| Restor3d, Inc. | Warrant | November 19, 2024 | June 4, 2034 | Preferred Series A | 6108 | $5.01 | $5 | $11 | (11) |
| **Sub-Total: Medical Devices (0.1%)\*** |  |  |  |  |  |  | $85 | $63 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Warrant Investments - United States, Continued** | | | | | | | | | | |
| ***<u>Other Healthcare Services</u>*** | | | | | | | | | | |
| Cellares Corporation | Warrant | November 19, 2024 | August 2, 2034 | Common Stock | 15566 | $4.77 | $54 |  | $78 |  |
| Upward Health, Inc. | Warrant | November 19, 2024 | August 6, 2034 | Class A Common Stock | 64948 | $0.28 | $21 |  | $64 |  |
| **Sub-Total: Other Healthcare Services (0.2%)\*** |  |  |  |  |  |  | $75 |  | $142 |  |
| ***<u>Software as a Service ("SaaS")</u>*** |  |  |  |  |  |  |  |  |  |  |
| Silk Technologies, Inc. | Warrant | November 19, 2024 | November 4, 2034 | Common Stock | 15167 | $1.98 | $32 |  | $26 |  |
| Steno Agency, Inc. | Warrant | November 19, 2024 | June 21, 2034 | Common Stock | 7612 | $1.98 | $18 |  | $25 |  |
|  |  | May 16, 2025 | June 21, 2034 | Common Stock | 8955 | $1.98 | 27 |  | 30 |  |
| &nbsp;&nbsp;Total Steno Agency, Inc. |  |  |  |  |  |  | $45 |  | $55 |  |
| **Sub-Total: Software as a Service ("SaaS") (0.1%)\*** |  |  |  |  |  |  | $77 | $— | $81 |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |  |  |
| Astranis Space Technologies Corp. | Warrant | June 28, 2024 | April 13, 2033 | Common Stock | 11203 | $7.89 | $39 |  | $146 |  |
|  |  | November 19, 2024 | September 27, 2034 | Common Stock | 14930 | $2.27 | 66 |  | 235 |  |
|  |  | June 26, 2025 | June 26, 2035 | Common Stock | 2751 | $0.01 | 13 |  | 47 |  |
|  |  | June 26, 2025 | June 26, 2035 | Common Stock | 1765 | $0.01 | 9 |  | 30 |  |
|  |  | August 25, 2025 | August 25, 2035 | Common Stock | 18319 | $2.33 | 70 |  | 288 |  |
| &nbsp;&nbsp;Total Astranis Space Technologies Corp. |  |  |  |  |  |  | $197 |  | $746 |  |
| Hermeus Corporation | Warrant | June 28, 2024 | August 9, 2032 | Common Stock | 9338 | $6.24 | $21 |  | $110 |  |
| Impulse Space, Inc. | Warrant | November 19, 2024 | June 18, 2034 | Common Stock | 13944 | $1.91 | $248 |  | $345 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | | **Expiration Date** | **Series** | **Shares** | **Strike Price** | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Warrant Investments - United States, Continued** | | | | | | | | | | |
| Kymeta Corporation | Warrant | November 19, 2024 |  | July 3, 2034 | Common Stock | 303449 | $0.11 | $22 | $15 |  |
| Slingshot Aerospace, Inc. | Warrant | November 19, 2024 |  | July 12, 2036 | Common Stock | 24943 | $0.46 | $30 | $38 |  |
| **Sub-Total: Space Technology (2.0%)\*** |  |  |  |  |  |  |  | $518 | $1254 |  |
| **Total: Warrant Investments - United States (4.9%)\*** |  |  |  |  |  |  |  | $2219 | $3006 |  |
| **Warrant Investments- Canada** |  |  |  |  |  |  |  |  |  |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |  |  |  |
| Earthdaily Constellation Holdings, LP | Warrant | June 10, 2025 |  | June 10, 2035 | Class B Common Stock | 282171 | $0.81 | $161 | $145 |  |
| **Sub-Total: Space Technology (0.2%)\*** |  |  |  |  |  |  |  |  |  |  |
| **Total: Warrants Investments- Canada (0.2%)\*** |  |  |  |  |  |  |  | $161 | $145 |  |
| **Warrant Investments- Europe** |  |  |  |  |  |  |  |  |  |  |
| ***<u>Medical Devices</u>*** |  |  |  |  |  |  |  |  |  |  |
| CMR Surgical Limited | Warrant | March 24, 2025 |  | March 24, 2030 | Ordinary Stock | 672 | 0.01 | $16 | $29 |  |
| **Sub-Total: Medical Devices (0.0%)\*** |  |  | April 24, 1901 |  |  |  |  | $16 | $29 |  |
| ***<u>Other Healthcare Services</u>*** |  |  |  |  |  |  |  |  |  |  |
| Zandivio PLC | Warrant | November 19, 2024 |  | October 29, 2034 | Common Stock | 8428 | 0.01 | $49 | $34 |  |
| **Sub-Total: Other Healthcare Services (0.1%)\*** |  |  | January 27, 1923 |  |  |  |  | $49 | $34 |  |
| **Total: Warrant Investments- Europe (0.1%)\*** |  |  |  |  |  |  |  | $65 | $63 |  |
| **Total Warrant Investments (5.2%)\*** |  |  |  |  |  |  |  | $2445 | $3214 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Company** <sup>(1)</sup> | **Type of Investment** <sup>(2)(8)</sup> | **Investment Date** <sup>(10)</sup> | **Shares/Principal** | **Series** | **Cost** | **Fair Value** <sup>(5)</sup> | **Footnotes** |
| **Equity Investments- United States** | | | | | | | |
| ***<u>Connectivity</u>*** | | | | | | | |
| Tarana Wireless, Inc. | Equity | 10/9/2025 | 28053 | Preferred Series 8 | $30 | $52 | 11 |
| **Sub-Total: Connectivity (0.1%)\*** |  |  |  |  | $30 | $52 |  |
| ***<u>Finance and Insurance</u>*** |  |  |  |  |  |  |  |
| Centivo Corporation | Equity | 12/20/2024 | 17119 | Preferred Series B-1 | $50 | $45 | 11 |
| **Sub-Total: Finance and Insurance (0.1%)\*** |  |  |  |  | $50 | $45 |  |
| ***<u>Food and Agriculture Technologies</u>*** |  |  |  |  |  |  |  |
| Athletic Brewing Company, LLC | Equity | 8/1/2024 | 73 | Class B Units | $17 | $15 | 11 |
| **Sub-Total: Food and Agriculture Technologies (0.0%)\*** |  |  |  |  | $17 | $15 |  |
| ***<u>Green Technology</u>*** |  |  |  |  |  |  |  |
| Crusoe Energy Systems LLC | Equity | 11/6/2024 | 1713 | Preferred Series D-1 | $50 | $75 | 11 |
| **Sub-Total: Green Technology (0.1%)\*** |  |  |  |  | $50 | $75 |  |
| ***<u>Software as a Service ("SaaS")</u>*** |  |  |  |  |  |  |  |
| Silk Technologies, Inc. | Equity | 12/1/2025 | 30000 | SAFE Note | $30 | $30 |  |
| **Sub-Total: Software as a Service ("SaaS") (0.0%)\*** |  |  |  |  | $30 | $30 |  |
| ***<u>Space Technology</u>*** |  |  |  |  |  |  |  |
| Impulse Space, Inc. | Equity | 3/4/2025 | 7151 | Preferred Series B | $98 | $206 | 11 |
|  | Equity | 5/9/2025 | 2616 | Preferred Series C | 99 | 97 | 11 |
| Total Impulse Space Inc. |  |  |  |  | $197 | $303 |  |
| **Sub-Total: Space Technology (0.5%)\*** |  |  |  |  | $197 | $303 |  |
| **Total: Equity Investments- United States (0.8%)\*** |  |  |  |  | $374 | $520 |  |
| **Total Investments in Securities (199.9%)\*** |  |  |  |  | $121142 | $123127 |  |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**Consolidated Schedule of Investments**

**December 31, 2025**

**(In thousands, except share and per share data)**

\* Represents % of Net Asset.

(1)All portfolio companies are located in North America or Europe. As of December 31, 2025, the Fund had three foreign domiciled portfolio companies, two of which are based in Europe and one of which is based in Canada. In total, foreign domiciled portfolio investment represented 13.4% of total net assets based on fair value.

(2)All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted.

(3)Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term ("EOT") payment, or additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair value, generally subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the term of the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Fund's current debt securities.

(4)Principal is net of repayments, if any, as per the terms of the debt instrument's contract.

(5)All investments were valued at fair value using Level 3 inputs. Fair value is determined in good faith by Eagle Point Credit Management LLC, as the Fund's "valuation designee," in accordance with Rule 2a-5 under the Investment Company Act of 1940.

(6)The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. As of December 31, 2025, the U.S. Prime Rate ("Prime") was 6.75%, the Secured Overnight Financing Rate ("SOFR") 30 Day Forward Rate was 3.69%, and the SOFR 3-Month Term Rate was 3.65%.

(7)Interest on this loan includes a payment-in-kind ("PIK") provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is recorded on an accrual basis to the extent such amounts are expected to be collected.

(8)Investment is not pledged as collateral supporting amounts outstanding under the Fund's credit facility with KeyBank, National Association (the "KeyBank Credit Facility"). See "Note 5 – Borrowings" for more information.

(9)Investment has an unfunded commitment as of December 31, 2025 (see "Note 6 – Commitments and Contingencies"). The fair value of the investment includes the impact of the fair value of any unfunded commitments.

(10)Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications.

(11)Preferred stock represents investments through which the Fund will have preference in liquidation rights and do not contain any cumulative preferred dividends.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**Note 1. Organization** 

Eagle Point Trinity Senior Secured Lending Company ("EPT" or the "Fund") is a Delaware statutory trust that is a "perpetual-life," externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company ("BDC") under the Investment Company Act of 1940, as amended (the "1940 Act"). The Fund intends to elect to be treated, and to qualify annually, as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"), for U.S. federal income tax purposes.

The Fund's investment objective is to generate current income and, to a lesser extent, capital appreciation. The Fund seeks to achieve its investment objective by making investments consisting primarily of senior secured term loans, equipment financings and to a lesser extent, asset-based lending, working capital loans, equity and equity-related investments.

The Fund was initially formed on May 3, 2024 as a Delaware limited liability company named EPT 16 LLC and commenced operations on June 28, 2024 as a private fund in reliance on an exemption from the definition of "investment company" under Section 3(c)(7) of the 1940 Act. On August 28, 2025, the Fund converted into a Delaware statutory trust named Eagle Point Trinity Senior Secured Lending Company and elected to be regulated as a BDC (the "Conversion").

The Fund's investment activities are managed by Eagle Point Credit Management LLC (the "Adviser") and Trinity Capital Adviser LLC (the "Sub-Adviser"), a wholly owned subsidiary of Trinity Capital Inc., and supervised by the Fund's Board of Trustees (the "Board" or "Board of Trustees"), a majority of whom are independent as required by the 1940 Act. The Adviser's affiliate, Eagle Point Administration LLC (the "Administrator") provides certain ongoing administrative services necessary for the Fund's operations. See "Note 11 – Related Party Transactions" for additional information.

The Fund holds certain assets through its wholly-owned subsidiary, EPT SPV 16 SUB (US) LLC (the "SPV"), to secure the KeyBank Credit Facility (as discussed and defined in "Note 5 – Borrowings"). EPT and the SPV are collectively referred to herein as the "Fund."

**Note 2. Summary of Significant Accounting Policies**

***Basis of Presentation***

The Fund's interim consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Articles 6, 10 and 12 of Regulation S-X. Accordingly, certain disclosures accompanying annual financial statements prepared in accordance with U.S. GAAP are omitted. In the opinion of management, the unaudited financial results included herein contain all adjustments, consisting solely of normal accruals, considered necessary for the fair statement of the results for the interim period included herein. The current period's consolidated results of operations are not necessarily indicative of results that may be achieved for the year. The interim consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto included in the Fund's Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission ("SEC") on March 31, 2026.

The Fund is an investment company and follows the accounting and reporting guidance applicable to investment companies in the Financial Accounting Standards Board ("FASB") Accounting Standards Codification, as amended, ("ASC") Topic 946, *Financial Services - Investment Companies* ("ASC 946"). Items included in the

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

consolidated financial statements are measured and presented in U.S. dollars. Under U.S. GAAP for investment companies, investments are recorded at their estimated fair value, and the carrying value for all other assets and liabilities approximates their fair value.

***Principles of Consolidation***

As permitted under Regulation S-X and consistent with the guidance in ASC 946-810-45-3, *Financial Services - Investment Companies - Consolidation - Other Presentation Matters*, the Fund generally does not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Fund. Accordingly, the Fund consolidates the results of its wholly owned subsidiary, the SPV, in the Fund's consolidated financial statements. All intercompany accounts and transactions have been eliminated in consolidation. The SPV is the borrower under the Fund's KeyBank Credit Facility as discussed in "*Note 5 – Borrowings*."

***Use of Estimates***

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the applicable reporting date. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ materially from these estimates.

***Investment Transactions***

Loan originations are recorded on the date of the legally binding commitment. Realized gains or losses are recorded using the specific identification method as the difference between the net proceeds received, excluding prepayment fees, if any, and the amortized cost basis of the investment without regard to unrealized gains or losses previously recognized, and include investments written off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment fair values as of the last business day of the reporting period and also includes the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.

***Valuation of Investments***

The most significant estimate inherent in the preparation of the Fund's consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded.

The Fund's investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, *Fair Value Measurements and Disclosures* ("ASC 820"). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Fund to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact.

The SEC adopted Rule 2a-5 under the 1940 Act ("Rule 2a-5"), which establishes a framework for determining fair value in good faith for purposes of the 1940 Act. As adopted, Rule 2a-5 permits boards of directors to designate certain parties to perform fair value determinations, subject to board oversight and certain other conditions. The SEC also adopted Rule 31a-4 under the 1940 Act ("Rule 31a-4"), which provides the recordkeeping requirements associated with fair value determinations. Pursuant to Rule 2a-5, the Board of Trustees has designated the Adviser to serve as the "valuation designee" to perform fair value determinations in respect of the Fund's portfolio investments that do not have readily available market quotations. Accordingly, fair valuations are ultimately determined by the Adviser in accordance with its valuation policies and procedures. The Adviser's valuation process will be conducted

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

monthly (or more frequently, as appropriate) or as otherwise determined by the Adviser. The Adviser may either engage independent valuation firms on a discretionary basis or receive (on a non-reliance basis) the Sub-Adviser valuations and the reports of independent valuation firms engaged by the Sub-Adviser and its affiliates (as discussed below). The Board of Trustees oversees the valuation designee and the process that it uses to determine the fair value of the Fund's assets. In this regard, the Board of Trustees receives periodic and, as applicable, prompt reporting regarding certain material valuation matters, as required by Rule 2a-5 under the 1940 Act.

Independent valuation firms have been engaged to provide valuation assistance with respect to the Fund's investments on a discretionary basis. Specifically, an independent valuation firm assists in valuing a subset of the Fund's portfolio investments on a quarterly basis. The Sub-Adviser assists in selecting these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The guidance establishes three levels of the fair value hierarchy as follows:

Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Fund has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).

Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.

Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management's own assumptions about the assumptions a market participant would use in pricing the investment.

Given the nature of lending to venture capital-backed growth-stage companies, 100% of the Fund's investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanged. The Fund uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis, and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Fund's investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

*Debt Securities*

The debt securities identified on the Consolidated Schedule of Investments are secured loans and equipment financings made to growth-stage companies. For portfolio investments in debt securities for which third-party quotes or other independent pricing are not available, fair value is generally estimated based on the assumptions that hypothetical market participants would use to value the investment in a current hypothetical sale using an income approach.

In applying the income approach to determine the fair value of debt securities, the assessment of fair value is based on projections of the discounted future free cash flows that the security will likely generate, including analyzing the discounted cash flows of interest and principal amounts for the security, as set forth in the associated

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

loan and equipment financing agreements, as well as market yields and the financial position and credit risk of the portfolio company (the "Hypothetical Market Yield Method"). The discount rate applied to the future cash flows of the security is based on the calibrated yield implied by the terms of the Fund's investment adjusted for changes in market yields and performance of the subject company. The estimate of the expected repayment date of the Fund's loans and equipment financings securities is either the maturity date of the instrument or the anticipated pre-payment date, depending on the facts and circumstances. The Hypothetical Market Yield Method also considers changes in leverage levels, credit quality, portfolio company performance, market yield movements, and other factors. If there is deterioration in credit quality or if a security is in workout status, other factors may be considered in determining the fair value of the security, including, but not limited to, the value attributable to the security from the enterprise value of the portfolio company or the proceeds that would most likely be received in a liquidation analysis.

*Equity Securities and Warrants*

Often the Fund is issued warrants by issuers as yield enhancements. These warrants are recorded as assets at estimated fair value on the grant date. The cost basis of the warrants or other equity securities received is determined based upon their respective fair values on the date of receipt in proportion to the total fair value of the debt and warrants or other equity securities received. Depending on the facts and circumstances, a combination of one or several forms of the market approach and contingent claim analyses (a form of option analysis) may be utilized to estimate the fair value of the securities as of the measurement date and determine the cost basis using a relative fair value methodology. In applying the market approach, the enterprise value of a portfolio company is estimated utilizing customary pricing multiples, based on the development stage of the underlying issuers, or other appropriate valuation methods, such as considering recent transactions in the equity securities of the portfolio company or third-party valuations that are assessed to be indicative of fair value of the respective portfolio company. If appropriate, based on the facts and circumstances, the enterprise value to the equity securities may be allocated utilizing a contingent claim analysis and/or other waterfall calculation by which the enterprise value is allocated across the portfolio company's securities in order of their preference relative to one another.

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Fund's financial instruments, consisting of cash, investments, receivables, payables, and other liabilities, approximate the fair values of such items due to the short-term nature of these instruments. Refer to *"Note 4 – Fair Value of Financial Instruments"* for further discussion.

***Cash and Cash Equivalents***

Cash and cash equivalents consist of funds deposited with financial institutions and short-term (original maturity of three months or less) liquid investments in money market deposit accounts. Cash equivalents are classified as Level 1 assets and are valued using the net asset value ("NAV") per share of the money market fund.

As of March 31, 2026 and December 31, 2025, cash and cash equivalents consisted of $0.6 million and $0.6 million, respectively. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation ("FDIC") insured limit and therefore is subject to credit risk. All of the Fund's cash deposits are held at large, established, high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote.

***Other Assets***

Other assets generally consist of prepaid expenses, deferred offering costs and unsettled receivables.

***Equity Offering Costs***

Equity offering costs associated with the sale of the Fund's shares of beneficial interest are capitalized at the time of incurrence and subsequently amortized to expense on a straight line basis over the twelve-month period following capitalization.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

***Security Deposits***

Security deposits are collected upon funding equipment financings and are applied in lieu of regular payments at the end of the term.

***Debt Financing Costs***

The Fund records costs related to the issuance of debt obligations as deferred debt financing costs. These costs are deferred and amortized using the straight-line method over stated maturity life of the obligations. Debt financing costs related to secured or unsecured notes are netted with the outstanding principal balance on the Fund's Consolidated Statements of Assets and Liabilities. Debt financing costs related to the KeyBank Credit Facility are recorded as deferred credit facility costs on the Fund's Consolidated Statements of Assets and Liabilities.

***Income Recognition***

*Interest and Dividend Income*

The Fund recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount ("OID") initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Fund may also be entitled to an end-of-term ("EOT") payment. EOT payments to be paid at the termination of the debt agreements are accreted into interest income over the contractual life of the debt based on the effective yield method. The EOT payments receivable is included as a component of the cost basis of the Fund's current debt securities. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, the acceleration of the unaccreted OID and EOT payment is recognized as interest income.

The Fund has a limited number of debt investments in its portfolio that contain a payment- in-kind ("PIK") provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Fund will generally cease accruing PIK interest if there is insufficient value to support the accrual or management does not expect the portfolio company to be able to pay all principal and interest due.

The Fund recorded less than $0.1 million in PIK interest income during the three months ended March 31, 2026 and less than $0.1 million for the three months ended March 31, 2025.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, is amortized into interest income over the contractual life of the loan. The Fund recognizes nonrecurring fees and additional OID and EOT payments received in consideration for contract modifications commencing in the quarter relating to the specific modification.

*Fee Income*

The Fund recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity.

*Non-Accrual Policy*

When a debt security becomes 90 days or more past due, or if management otherwise does not expect that principal, interest, and other obligations due will be collected in full, the Fund will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or the Fund believes the borrower has demonstrated the ability to repay its current and future

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, the Fund may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of March 31, 2026 and December 31, 2025, there were no investments on non-accrual status.

*Net Realized Gains / (Losses)*

Realized gains / (losses) are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written off during the period net of recoveries and realized gains or losses from in-kind redemptions. Net proceeds exclude any prepayment penalties, exit fees, and OID and EOT acceleration. Prepayment penalties and exit fees received at the time of sale or redemption are included in fee income on the Consolidated Statements of Operations. OID and EOT acceleration is included in interest income on the Consolidated Statements of Operations.

*Net Change in Unrealized Appreciation / (Depreciation)*

Net change in unrealized appreciation / (depreciation) reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

***Earnings Per Share***

The Fund's earnings per share ("EPS") amounts have been computed based on the weighted-average number of shares of beneficial interest outstanding for the period. Basic earnings per share is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted-average number of shares outstanding for the period. Diluted EPS is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted-average number of shares of beneficial interest assuming all potential shares had been issued and the additional shares were dilutive.

***Income Taxes***

The Fund intends to elect to be treated, and to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Fund is generally required to distribute at least annually to its shareholders at least the sum of 90% of its investment company taxable income (which generally includes its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and 90% of its net tax-exempt income (if any). The Fund generally will not be subject to U.S. federal income tax on these distributed amounts but will pay U.S. federal income tax at corporate rates on any retained amounts.

The Fund evaluates tax positions taken in the course of preparing the Fund's tax returns to determine whether the tax positions are "more-likely-than-not" to be sustained by the applicable tax authority in accordance with ASC 740, *Income Taxes* ("ASC 740"), as modified by ASC 946. Tax benefits of positions not deemed to meet the more-likely-than-not threshold, or uncertain tax positions, would be recorded as tax expense in the current year. It is the Fund's policy to recognize accrued interest and penalties related to uncertain tax benefits in income tax expense.

The Fund has no material uncertain tax positions as of March 31, 2026 and December 31, 2025. All the Fund's tax returns remain subject to examination by U.S. federal and state tax authorities.

Based on federal excise distribution requirements applicable to RICs, the Fund will be subject to a 4% nondeductible federal excise tax on undistributed taxable income and gains unless the Fund distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income or gain realized, but not distributed, in the preceding years. For this purpose, however, any ordinary income or capital gain net income retained by the Fund and on which the Fund paid corporate income tax is

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

considered to have been distributed. The Fund, at its discretion, may determine to carry forward taxable income or gain and pay a 4% excise tax on the amount by which it falls short of this calendar-year distribution requirement. If the Fund chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to shareholders. The Fund will accrue excise tax on estimated undistributed taxable income and capital gains as required on an annual basis.

***Distributions***

Distributions to shareholders are recorded on the record date. The composition of distributions paid to shareholders from net investment income and capital gains is determined in accordance with U.S. federal income tax regulations, which differ from U.S. GAAP. Distributions to shareholders can be comprised of net investment income, net realized capital gains and return of capital for U.S. federal income tax purposes and are intended to be paid monthly.

**Note 3. Investments**

The Fund provides debt, including senior secured loans, equipment financings and asset-based lending, to growth-oriented companies, including institutional investor-backed companies, primarily in the United States. The Fund's investment strategy includes making investments consisting primarily of secured term loans and equipment financings and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, the Fund may obtain warrants or contingent exit fees at funding from many of its portfolio companies.

***Debt Securities***

The Fund's debt securities primarily consist of direct investments in interest-bearing secured loans and equipment financings to privately held companies based in the United States. Secured loans are generally secured by a blanket first position lien or a blanket second position lien on the assets of the portfolio company. Equipment financings typically include a specific asset first position lien on mission-critical assets as well as a second position lien on the assets of the portfolio company. These debt securities typically have a term of up to 60 months from the original investment date. Certain of the debt securities are "covenant-lite" loans, which generally are loans that do not have a complete set of financial maintenance covenants and have covenants that are incurrence-based, meaning they are only tested and can only be breached following an affirmative action of the borrower rather than by a deterioration in the borrower's financial condition. The equipment financings in the investment portfolio generally have fixed interest rates. The secured loans in the investment portfolio generally have floating interest rates subject to interest rate floors. Both equipment financings and secured loans generally include an EOT payment.

The specific terms of each debt security vary depending on the creditworthiness of the portfolio company and the projected value of the financed assets. Companies with stronger creditworthiness may receive an initial period of lower financing factor, which is analogous to an interest-only period on a traditional term loan. Equipment financings may include upfront interim payments and security deposits. Equipment financing arrangements have various structural protections, including customary default penalties, information and reporting rights, material adverse change or investor abandonment provisions, consent rights for any additions or changes to senior debt, and, as needed, intercreditor agreements with cross-default provisions to protect the Fund's second lien positions.

***Warrant Investments***

In connection with the Fund's debt investments, the Fund may receive warrants in the portfolio company. Warrants received in connection with a debt investment typically include a potentially discounted contract price to exercise, and thus, as a portfolio company appreciates in value, the Fund may achieve additional investment return from this equity interest. The warrants typically contain provisions that protect the Fund as a minority-interest holder, as well as secured or unsecured put rights, or rights to sell such securities back to the portfolio company, upon the occurrence of specified events. In certain cases, the Fund may also obtain follow-up rights in connection with these equity interests, which allow the Fund to participate in future financing rounds.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

***Equity Investments***

In specific circumstances, the Fund may seek to make direct equity investments in situations where it is appropriate to align the interests of the Fund with key management and shareholders of the portfolio company, and to allow for participation in the appreciation in the equity values of the portfolio company. These equity investments are generally made in connection with debt investments. The Fund (alongside Trinity Capital Inc. and other funds or accounts managed by the Sub-Adviser) seeks to maintain fully diluted equity positions in its portfolio companies of 5% to 50% and may have controlling equity interests in some instances.

***Portfolio Composition***

The Fund's portfolio investments are in companies conducting business in a variety of industries. The following table summarizes the composition of the Fund's portfolio investments by industry at cost and fair value and as a percentage of the total portfolio as of March 31, 2026 and December 31, 2025 (dollars in thousands):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Cost** | **Cost** | **Fair Value** | **Fair Value** | **Cost** | **Cost** | **Fair Value** | **Fair Value** |
| **Industry** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** |
| Medical Devices | $21388 | 16.5% | $21301 | 16.2% | $15998 | 13.2% | $16088 | 13.1% |
| Finance and Insurance | 17980 | 13.9% | 18009 | 13.7% | 17918 | 14.8% | 18043 | 14.6% |
| SaaS | 13714 | 10.6% | 13618 | 10.4% | 13246 | 10.9% | 13256 | 10.8% |
| Artificial Intelligence & Automation | 13357 | 10.3% | 13378 | 10.2% | 14516 | 12.0% | 14732 | 12.0% |
| Space Technology | 13163 | 10.2% | 14611 | 11.1% | 12599  | 10.4% | 13602  | 11.0% |
| Energy and Resource Technology | 11681 | 9.0% | 11663 | 8.9% | 10354  | 8.5% | 10380  | 8.4% |
| Healthcare Technology | 8508 | 6.6% | 8594 | 6.5% | 8487  | 7.0% | 8572  | 7.0% |
| Marketing, Media, and Entertainment | 8200 | 6.4% | 8132 | 6.2% | 7085  | 5.9% | 7052  | 5.7% |
| Other Healthcare Services | 6617 | 5.1% | 6708 | 5.1% | 5938  | 4.9% | 6088  | 4.9% |
| Connectivity | 4127 | 3.2% | 4184 | 3.2% | 5438  | 4.5% | 5511  | 4.5% |
| Biotechnology | 3509 | 2.7% | 3561 | 2.7% | 3497  | 2.9% | 3548  | 2.9% |
| Consumer Products & Services | 3154 | 2.4% | 3670 | 2.8% | 3280  | 2.7% | 3512  | 2.8% |
| Diagnostics & Tools | 3139 | 2.4% | 3148 | 2.4% | 1795  | 1.5% | 1814  | 1.5% |
| Food and Agriculture Technologies | 491 | 0.4% | 456 | 0.4% | 634  | 0.5% | 601  | 0.5% |
| Transportation Technology | 348 | 0.3% | 320 | 0.2% | 357  | 0.3% | 328  | 0.3% |
| Total | $129376 | 100.0% | $131353 | 100.0% | 121142  | 100.0% | 123127  | 100.0% |

---

The geographic composition of the Fund's investment portfolio is determined by the location of the corporate headquarters of the portfolio company. The following table summarizes the composition of the Fund's portfolio investments by geographic region of the United States and other countries at cost and fair value and as a percentage of the total portfolio as of March 31, 2026 and December 31, 2025 (dollars in thousands):

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Cost** | **Cost** | **Fair Value** | **Fair Value** | **Cost** | **Cost** | **Fair Value** | **Fair Value** |
|<br>**Geographic Region** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** |
| United States |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;West | $40737 | 31.5% | $41965 | 31.9% | $40554 | 33.5% | $41668 | 33.9% |
| &nbsp;&nbsp;Northeast | 39526 | 30.6% | 39894 | 30.4% | 39148 | 32.3% | 39440 | 32.0% |
| &nbsp;&nbsp;South | 12016 | 9.3% | 12224 | 9.3% | 12580 | 10.4% | 12844 | 10.4% |
| &nbsp;&nbsp;Mountain | 11397 | 8.8% | 11506 | 8.8% | 8764 | 7.2% | 8907 | 7.2% |
| &nbsp;&nbsp;Midwest | 9720 | 7.5% | 9731 | 7.4% | 7132 | 5.9% | 7140 | 5.8% |
| &nbsp;&nbsp;Southeast | 7950 | 6.1% | 7938 | 6.0% | 4748 | 3.9% | 4821 | 3.9% |
| International: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Canada | 3545 | 2.7% | 3535 | 2.7% | 3747 | 3.1% | 3767 | 3.1% |
| &nbsp;&nbsp;Western Europe | 4485 | 3.5% | 4560 | 3.5% | 4469 | 3.7% | 4540 | 3.7% |
| Total | $129376 | 100.0% | $131353 | 100.0% | $121142 | 100.0% | $123127 | 100.0% |

---

The following table summarizes the composition of the Fund's portfolio investments by investment type at cost and fair value and as a percentage of the total portfolio as of March 31, 2026 and December 31, 2025 (dollars in thousands):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Cost** | **Cost** | **Fair Value** | **Fair Value** | **Cost** | **Cost** | **Fair Value** | **Fair Value** |
|<br>**Investment** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** |
| Secured Loans | $97520 | 75.3% | $98153 | 74.8% | $89048 | 73.5% | $90068 | 73.2% |
| Equipment Financings | 28945 | 22.4% | 28919 | 22.0% | 29275 | 24.2% | 29325 | 23.8% |
| Warrants | 2536 | 2.0% | 3567 | 2.7% | 2445 | 2.0% | 3214 | 2.6% |
| Equity | 375 | 0.3% | 714 | 0.5% | 374 | 0.3% | 520 | 0.4% |
| Total | $129376 | 100.0% | $131353 | 100.0% | $121142 | 100.0% | $123127 | 100.0% |

---

***Certain Risk Factors***

In the ordinary course of business, the Fund manages a variety of risks, including market risk, credit risk and liquidity risk. The Fund identifies, measures and monitors risk through various control mechanisms, including investment limits and diversifying exposures and activities across a variety of instruments, markets and counterparties.

Market risk is the risk of potential adverse changes to the value of financial instruments because of changes in market conditions, including as a result of changes in the credit quality of a particular issuer, credit spreads, interest rates, and other movements and volatility in security prices or commodities. In particular, the Fund may invest in issuers that are experiencing or have experienced financial or business difficulties (including difficulties resulting from the initiation or prospect of significant litigation or bankruptcy proceedings), which involves significant risks. The Fund manages its exposure to market risk through the use of risk management strategies and various analytical monitoring techniques.

The Fund's investments are generally comprised of securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.

The Fund's investments consist of growth-oriented companies, many of which have relatively limited operating histories and may experience variation in operating results. Many of these companies conduct business in regulated

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

industries and could be affected by changes in government regulations. Most of the Fund's borrowers will need additional capital to satisfy their continuing working capital needs and other requirements, and in many instances, to service the interest and principal payments on the debt

**Note 4. Fair Value of Financial Instruments**

ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. The Fund accounts for its investments at fair value in accordance with ASC 820. As of March 31, 2026 and December 31, 2025, the Fund's portfolio investments consisted primarily of investments in secured loans and equipment financings. The fair value amounts have been measured as of the reporting date and have not been reevaluated or updated for purposes of these financial statements subsequent to that date. As such, the fair values of these financial instruments subsequent to the reporting date may be different than amounts reported.

In accordance with ASC 820, the Fund has categorized its investments based on the priority of the inputs to the valuation technique into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical investments (Level 1) and the lowest priority to unobservable inputs (Level 3). See "Note 2 – Summary of Significant Accounting Policies."

As required by ASC 820, when the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, unrealized appreciation and depreciation related to such investments categorized within the Level 3 tables below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

The fair value determination of each portfolio investment categorized as Level 3 requires one or more of the following unobservable inputs:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Financial information obtained from each portfolio company, including unaudited statements of operations and balance sheets for the most recent period available as compared to budgeted numbers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current and projected financial condition of the portfolio company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current and projected ability of the portfolio company to service its debt obligations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Type and amount of collateral, if any, underlying the investment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current financial ratios (e.g., fixed charge coverage ratio, interest coverage ratio and net debt/EBITDA ratio) applicable to the investment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current liquidity of the investment and related financial ratios (e.g., current ratio and quick ratio);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Pending debt or capital restructuring of the portfolio company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Projected operating results of the portfolio company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current information regarding any offers to purchase the investment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current ability of the portfolio company to raise any additional financing as needed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in the economic environment, which may have a material impact on the operating results of the portfolio company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Internal occurrences that may have an impact (both positive and negative) on the operating performance of the portfolio company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Qualitative assessment of key management;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Contractual rights, obligations or restrictions associated with the investment; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Time to exit.

The use of significant unobservable inputs creates uncertainty in the measurement of fair value as of the reporting date. The significant unobservable inputs used in the fair value measurement of the Fund's investments, are (i) earnings before interest, tax, depreciation, and amortization ("EBITDA") and revenue multiples (both projected and historic), and (ii) volatility assumptions. Significant increases (decreases) in EBITDA and revenue multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Similarly, significant increases (decreases) in volatility inputs in isolation would result in a significantly higher (lower) fair value assessment. Conversely, significant increases (decreases) in weighted average cost of capital inputs in isolation would result in a significantly lower (higher) fair value measurement. However, due to the nature of certain

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

investments, fair value measurements may be based on other criteria, such as third-party appraisals of collateral and fair values as determined by independent third parties, which are not presented in the tables below.

The following is a summary of the levels within the fair value hierarchy of the Fund's investment portfolio by investment type as of March 31, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value Hierarchy (in thousands)** | **Fair Value Hierarchy (in thousands)** | **Fair Value Hierarchy (in thousands)** | **Fair Value Hierarchy (in thousands)** |
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Secured Loans | $— | $— | $98153 | $98153 |
| Equipment Financings |  |  | 28919 | 28919 |
| Warrants |  |  | 3567 | 3567 |
| Equity |  |  | 714 | 714 |
| &nbsp;&nbsp;&nbsp;Total Investments at fair value | $— | $— | $131353 | $131353 |

---

The following is a summary of the levels within the fair value hierarchy of the Fund's investment portfolio by investment type as of December 31, 2025

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value Hierarchy (in thousands)** | **Fair Value Hierarchy (in thousands)** | **Fair Value Hierarchy (in thousands)** | **Fair Value Hierarchy (in thousands)** |
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Secured Loans | $— | $— | $90068 | $90068 |
| Equipment Financings |  |  | 29325 | 29325 |
| Warrants |  |  | 3214 | 3214 |
| Equity |  |  | 520 | 520 |
| &nbsp;&nbsp;&nbsp;Total Investments at fair value | $— | $— | $123127 | $123127 |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

The methodology for determining the fair value of the Fund's investments is discussed in *"Note 2 – Summary of Significant Accounting Policies."* The following table provides a summary of the significant unobservable inputs used to measure the fair value of the Level 3 portfolio investments as of March 31, 2026.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|<br>**Investment Type** | **Fair Value as of**<br>**March 31, 2026**<br>**(in thousands)** |<br>**Valuation Techniques/**<br>**Methodologies** |<br>**Unobservable**<br>**Inputs** <sup>(1)</sup> |<br>**Range** | |<br>**Weighted**<br>**Average** <sup>(2)</sup> |
| Debt investments | $111115 | Discounted Cash Flows | Hypothetical Market Yield | 5.7% - 30.6% |  | 13.9% |
|  | 14706 | Cost approximates fair value (5) | n/a | n/a |  | n/a |
|  | 1251 | Transaction Precedent | Transaction price | n/a |  | n/a |
| Warrants | 3442 | Market Approach | Revenue Multiple <sup>(3)</sup>  | 0.5x - 49.0x |  | 17.2 x |
|  |  |  | Volatility <sup>(4)</sup> | 43.7% - 146.6% |  | 73.8% |
|  |  |  | Risk-Free Interest Rate | 3.8% - 3.9% |  | 3.8% |
|  |  |  | Estimated Time to Exit (in years) | 2.0 - 4.3 |  | 3.1 |
|  | 125 | Black Scholes | Volatility <sup>(4)</sup> | 60.4% - 125.1% |  | 86.4% |
|  |  |  | Discount for Lack of Marketability | n/a |  | n/a |
|  |  |  | Risk-Free Interest Rate | 3.9% - 4.3% |  | 4.2% |
|  |  |  | Estimated Time to Exit (in years) | 4.4 - 9.5 |  | 8.2 |
| Equity investments | 684 | Market Approach | Revenue Multiple | 3.8x - 49.0x | #NAME? | 41.1 x  |
|  |  |  | Volatility <sup>(4)</sup> | 39.2% - 63.5% |  | 59.3% |
|  |  |  | Risk-Free Interest Rate | 3.8% - 3.8% |  | 3.8% |
|  |  |  | Estimated Time to Exit (in years) | 2.8 - 3.5 |  | 3.3 |
|  | 30 | Cost approximates fair value <sup>(5)</sup> | n/a | n/a |  | n/a |
| &nbsp;&nbsp;&nbsp;**Total Level 3 Investments** | $131353 |  |  |  |  |  |

---

<sup>(1)</sup> The significant unobservable inputs used in the fair value measurement of the Fund's debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Fund's equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model ("OPM") include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing or merger or acquisition events near the measurement date.

<sup>(2)</sup> Weighted averages are calculated based on the fair value of each investment.

<sup>(3)</sup> Represents amounts used when the Fund has determined that market participants would use such multiples when pricing the investments.

<sup>(4)</sup> Represents the range of industry volatility used by market participants when pricing the investment.

<sup>(5)</sup> Includes debt investments originated within the past three months, for which cost approximates fair value, unless events have occurred during the period that would indicate a different valuation is warranted.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

The following table provides a summary of the significant unobservable inputs used to measure the fair value of the Level 3 portfolio investments as of December 31, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|<br>**Investment Type** | **Fair Value as of**<br>**December 31, 2025**<br>**(in thousands)** |<br>**Valuation Techniques/**<br>**Methodologies** |<br>**Unobservable**<br>**Inputs** <sup>(1)</sup> |<br>**Range** |<br>**Weighted**<br>**Average** <sup>(2)</sup> |
| Debt investments | 108598 | Discounted Cash Flows | Hypothetical Market Yield | 9.8% - 30.6% | 13.4% |
|  | 10356  | Cost approximates fair value <sup>(5)</sup> | n/a | n/a | n/a |
|  | 439  | Transaction Precedent <sup>(6)</sup> | Transaction price | n/a | n/a |
| Warrants | 3030 | Market Approach | Revenue Multiple<sup>(3)</sup> | 0.7x - 47.5x | 15.8 x |
|  |  |  | Volatility <sup>(4)</sup> | 43.8% - 113.9% | 71.3% |
|  |  |  | Risk-Free Interest Rate | 3.5% - 3.9% | 3.5% |
|  |  |  | Estimated Time to Exit (in years) | 1.0 - 4.5 | 2.7 |
|  | 183 | Black Scholes | Volatility <sup>(4)</sup> | 61.8% - 128.0% | 84.0% |
|  |  |  | Discount for Lack of Marketability | n/a | n/a |
|  |  |  | Risk-Free Interest Rate | 3.7% - 4.2% | 4.0% |
|  |  |  | Estimated Time to Exit (in years) | 4.7 - 9.8 | 8.4 |
| Equity investments | 491  | Market Approach | Revenue Multiple | 3.7x - 19.4x | 14.3 x |
|  |  |  | Volatility <sup>(4)</sup> | 40.2% - 74.2% | 64.5% |
|  |  |  | Risk-Free Interest Rate | 3.5% - 3.6% | 3.6% |
|  |  |  | Estimated Time to Exit (in years) | 2.3 - 3.8 | 3.3 |
|  | 30 | Cost approximates fair value <sup>(5)</sup> | n/a | n/a | n/a |
| &nbsp;&nbsp;&nbsp;**Total Level 3 Investments** | $123127 |  |  |  |  |

---

<sup>(1)</sup> The significant unobservable inputs used in the fair value measurement of the Fund's debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Fund's equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model ("OPM") include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing or merger or acquisition events near the measurement date.

<sup>(2)</sup> Weighted averages are calculated based on the fair value of each investment.

<sup>(3)</sup> Represents amounts used when the Fund has determined that market participants would use such multiples when pricing the investments.

<sup>(4)</sup> Represents the range of industry volatility used by market participants when pricing the investment.

<sup>(5)</sup> Includes debt investments originated within the past three months, for which cost approximates fair value, unless events have occurred during the period that would indicate a different valuation is warranted.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

The following tables provide a summary of changes in the fair value of the Fund's Level 3 loans and equipment financings (collectively "Debt"), equity and warrant portfolio investments for the three months ended March 31, 2026 (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Three Months Ended March 31, 2026** | **Type of Investment** | **Type of Investment** | **Type of Investment** | **Type of Investment** |
| | **Debt** | **Equity** | **Warrants** | **Total** |
| Fair Value as of December 31, 2025 | $119393 | $520 | $3214 | $123127 |
| &nbsp;&nbsp;&nbsp;Purchases, net of deferred fees | 14530 |  | 103 | 14633 |
| &nbsp;&nbsp;&nbsp;Proceeds from sales and paydowns | (7134) |  | (28) | (7162) |
| &nbsp;&nbsp;&nbsp;Accretion of OID, EOT, and PIK payments | 747 |  |  | 747 |
| &nbsp;&nbsp;&nbsp;Net realized gain/(loss) |  |  | 16 | 16 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation/(depreciation) | (464) | 194 | 262 | (8) |
| Fair Value as of March 31, 2026 | $127072 | $714 | $3567 | $131353 |
| Net change in unrealized appreciation/(depreciation) on Level 3 investments still held as of March 31, 2026 | $(464) | $194 | $278 | $8 |

---

The following table provides a summary of changes in the fair value of the Fund's Level 3 Debt, equity and warrant portfolio investments for the three months ended March 31, 2025 (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Three Months Ended March 31, 2025** | **Type of Investment** | **Type of Investment** | **Type of Investment** | **Type of Investment** |
| | **Debt** | **Equity** | **Warrants** | **Total** |
| Fair Value as of December 31, 2024 | $65834 | $99 | $953 | $66886 |
| &nbsp;&nbsp;&nbsp;Purchases, net of deferred fees | 5792 | 115 | 72 | 5979 |
| &nbsp;&nbsp;&nbsp;Proceeds from sales and paydowns | (2856) |  |  | (2856) |
| &nbsp;&nbsp;&nbsp;Accretion of OID, EOT, and PIK payments | 330 |  |  | 330 |
| &nbsp;&nbsp;&nbsp;Net realized gain/(loss) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation/(depreciation) | 54 | (5) | 12 | 61 |
| Fair Value as of March 31, 2025 | $69154 | $209 | $1037 | $70400 |
| Net change in unrealized appreciation/(depreciation) on Level 3 investments still held as of March 31, 2025 | $54 | $(5) | $12 | $61 |

---

*Fair Value of Financial Instruments Carried at Cost*

As of March 31, 2026 and December 31, 2025, the carrying value of the KeyBank Credit Facility was approximately $43.0 million and $36.7 million, respectively. The carrying value of the KeyBank Credit Facility as of March 31, 2026 and December 31, 2025 approximates the fair value, which was estimated using a market yield approach with Level 3 inputs.

As of March 31, 2026 and December 31, 2025, the carrying value of the 2028 Series A Notes (as defined below) was approximately $24.6 million and $24.6 million, respectively, net of unamortized deferred financing costs of $0.4 million and $0.4 million as of March 31, 2026 and December 31, 2025, respectively. The 2028 Series A Notes have a fixed interest rate as discussed in *"Note 5 – Borrowings."* The fair value of the 2028 Series A Notes as

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

of March 31, 2026 and December 31, 2025 was approximately $24.6 million and $24.6 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

**Note 5. Borrowings**

***KeyBank Credit Facility***

On November 12, 2024, SPV, as borrower, and Trinity Capital Adviser LLC, as servicer, entered into a senior credit facility (as amended from time to time, the "KeyBank Credit Facility" or "Credit Facility") with KeyBank National Association ("KeyBank") as the administrative and syndication agent and Computershare Trust Company, N.A. as the collateral custodian.

The KeyBank Credit Facility includes a commitment of $60.0 million from KeyBank and allows the Fund, through the SPV, to increase the commitment up to $200.0 million, subject to the consent of the administrative agent. Borrowings under the KeyBank Credit Agreement bear interest at a rate equal to the Secured Overnight Financing Rate ("SOFR") plus 3.00% to 3.30%, subject to the number of eligible loans in the collateral pool and the utilization rate. The KeyBank Credit Facility provides for a variable advance rate of up to 62% on eligible first lien loans and up to 47% on eligible second lien loans. In addition, the Fund pays a fee on committed but undrawn amounts under the KeyBank Credit Facility.

The KeyBank Credit Facility includes a two-year revolving period and a three-year amortization period and matures on November 12, 2029, unless extended. Such Credit Facility is collateralized by all investment assets held by the SPV. The KeyBank Credit Agreement contains representations and warranties and affirmative and negative covenants customary for secured financings of this type, including certain financial covenants such as a consolidated tangible net worth requirement and a required asset coverage ratio.

The KeyBank Credit Agreement also contains customary events of default (subject to certain grace periods, as applicable), including but not limited to the nonpayment of principal, interest or fees; breach of covenants; inaccuracy of representations or warranties in any material respect; voluntary or involuntary bankruptcy proceedings; and change of control of the borrower without the prior written consent of KeyBank. As of March 31, 2026, the Fund was in compliance in all material respects with the terms of the KeyBank Credit Facility.

During the three months ended March 31, 2026, the Fund borrowed $14.5 million and made repayments of $8.2 million under the KeyBank Credit Facility. During the three months ended March 31, 2025, the Fund borrowed $1.9 million and made repayments of $1.5 million under the KeyBank Credit Facility.

The Fund incurred approximately $0.9 million of initial and additional financing costs in connection with the KeyBank Credit Facility, which were capitalized and deferred using the straight-line method over the life of the facility. As of March 31, 2026 and December 31, 2025, unamortized deferred financing costs related to the KeyBank Credit Facility were $0.3 million and $0.4 million, respectively. As of March 31, 2026 and December 31, 2025, the Fund had a borrowing availability of approximately $17.0 million and $23.3 million, respectively.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

The summary information regarding the KeyBank Credit Facility is as follows (dollars in thousands):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31, 2026** | **Three Months Ended March 31, 2025** |
| Stated interest expense | $695 | $271 |
| Amortization of deferred financing costs | 80 | 107 |
| &nbsp;&nbsp;Total interest and amortization of deferred financing costs | $775 | $378 |
| Weighted average effective interest rate | 7.9% | 12.8% |
| Weighted average outstanding balance | $39862 | $11969 |

---

***2028 Series A Notes***

On August 1, 2025, the Fund entered into a note purchase agreement (the "2028 Note Purchase Agreement"), governing the issuance of $25.0 million aggregate principal amount of 7.25% Series A Notes due 2028 (the "2028 Series A Notes") in a transaction exempt from registration under the Securities Act. The 2028 Series A Notes bear interest at the rate of 7.25% per annum, payable semi-annually in arrears on February 1 and August 1 of each year, commencing February 1, 2026, and will mature on August 1, 2028.

At the Fund's option, the 2028 Series A Notes may be redeemed in whole or in part, at any time or from time to time, prior to their maturity at the then-applicable redemption price (including a customary "make whole" on any amounts redeemed prior to August 1, 2027), plus any accrued and unpaid interest thereon to, but excluding, the redemption date. In addition, on the occurrence of a "Change in Control," as defined in the 2028 Note Purchase Agreement, the Fund will generally be required to make an offer to prepay the outstanding 2028 Series A Notes at a price equal to 100% of the principal amount of the 2028 Notes being prepaid, plus any accrued and unpaid interest thereon to, but excluding, the repurchase date. The 2028 Note Purchase Agreement contains certain covenants, including maintaining a minimum asset coverage ratio (as calculated under the 1940 Act) of 1.5:1 and providing financial information to the holders of the Notes if the Fund is no longer subject to reporting requirements under the Exchange Act.

As of March 31, 2026, the Fund was in compliance in all material respects with the terms of the 2028 Note Purchase Agreement.

The 2028 Series A Notes are the Fund's general unsecured obligations that rank senior in right of payment to all of the Fund's existing and future indebtedness that is expressly subordinated in right of payment to the 2028 Series A Notes, rank *pari pass*u with all existing and future unsecured unsubordinated indebtedness issued by us, rank effectively junior to any of the Fund's secured indebtedness (including unsecured indebtedness that the Fund may later secure) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Fund's subsidiaries, financing vehicles or similar facilities.

Aggregate offering costs in connection with the 2028 Series A Notes issuance, including fees paid to the placement agent, were approximately $0.5 million, which were capitalized and deferred. As of March 31, 2026, unamortized deferred financing costs related to the 2028 Series A Notes were $0.4 million.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

The components of interest expense and related fees for the 2028 Series A Notes are as follows (in thousands):

---

| | |
|:---|:---|
| | **Three Months Ended<br>March 31, 2026** |
| Stated interest expense | $453 |
| Amortization of deferred financing costs | 56 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total interest and amortization of deferred financing costs | $509 |
| Weighted average effective interest rate | 8.3% |
| Weighted average outstanding balance | $25000 |

---

***Asset Coverage Requirement***

The Fund obtained the approval of its initial shareholders and the Board to permit the Fund to be subject to an 150% asset coverage test under the 1940 Act with respect to the issuance of "senior securities" (as such term is defined in Section 18(g) of the 1940 Act), which generally consist of borrowings under credit facilities or debt securities or preferred shares issued by the Fund (if any).

**Note 6. Commitments and Contingencies**

***Unfunded Commitments***

The Fund's commitments and contingencies consist primarily of unused commitments to extend credit in the form of loans or equipment financings to the Fund's portfolio companies. A portion of these unfunded contractual commitments as of March 31, 2026 and December 31, 2025, are generally dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Fund's credit agreements contain customary lending provisions that allow the Fund relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the Fund. Since a portion of these commitments may expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Fund's disclosure of unfunded contractual commitments as of March 31, 2026 and December 31, 2025, includes only those commitments that are available at the request of the portfolio company and are unencumbered by milestones or additional lending provisions.

The Fund will fund its unfunded commitments, if any, from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under its KeyBank Credit Facility) and maintains adequate liquidity to fund its unfunded commitments through these sources.

As of March 31, 2026, the Fund had aggregate unfunded commitments of $1.7 million to four portfolio companies. As of December 31, 2025, the Fund had aggregate unfunded commitments of $2.2 million to two portfolio companies.

In the normal course of business, the Fund enters into contracts that provide a variety of representations and warranties and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Fund under these arrangements is unknown as it would involve future claims that may be made against the Fund; however, based on the Fund's experience, the risk of loss is remote, and no such claims are expected to occur. As such, the Fund had not accrued any liability in connection with such indemnifications as of March 31, 2026 and December 31, 2025.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

***Expense Limitation Agreement***

The Fund and the Adviser have entered into the Expense Limitation Agreement (as defined below), dated as of August 28, 2025, pursuant to which the Adviser or an affiliate thereof may provide expense support to the Fund in order to reduce operating expenses borne by the Fund's shareholders. Expense support payments may be made in the form of paying expenses directly, reimbursing the Fund for expenses incurred and paid, or waiving a portion of or all fees due by the Fund to the Adviser or an affiliate thereof during each quarterly calculation period. Any such expense limitation payments or waivers are subject to reimbursement by the Fund for three years after the date on which such expense limitation payment or waiver was made. No such expense limitation payments or waivers were made during the three months ended March 31, 2026 and March 31, 2025. See *"Note 11 – Related Party Transactions"* for additional information.

***Organizational and Offering Expense Support and Reimbursement Agreement***

The Fund and the Adviser have entered into the O&O Expense Agreement (as defined below), dated as of August 28, 2025, pursuant to which the Fund may pay for organizational and permissible offering ("O&O") expenses up to a limit of 1.50% of gross equity contributions (including the value of the seed capital as described below). The Adviser, the Administrator or their affiliates will bear any O&O expenses in excess of the 1.50% limit. The Fund may pay O&O expenses in the form of direct payments to third-party vendors. The Fund may also pay O&O expenses to its affiliates and affiliates of the Adviser or the Administrator in the form of reimbursement ("Affiliate O&O Expense Reimbursement"). Affiliate O&O Expense Reimbursement will not be included in the calculation of operating expenses under the Expense Limitation Agreement. Any O&O Expenses subject to Affiliate O&O Expense Reimbursement are reimbursable by the Fund up to three years after the date on which such O&O Expenses were paid on the Fund's behalf, provided that reimbursement does not cause the Fund to exceed the 1.50% limit described above at the time of such reimbursement. No such Affiliate O&O Expense Reimbursements were made during the three months ended March 31, 2026 and March 31, 2025. See *"Note 11 – Related Party Transactions"* for additional information.

***Legal Proceedings***

The Fund may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise. Furthermore, third parties may try to seek to impose liability on the Fund in connection with the activities of its portfolio companies. As of March 31, 2026 and December 31, 2025, there were no material legal matters or material litigation pending of which the Fund is aware.

**Note 7. Shareholders' Equity**

The Fund has the authority to issue an unlimited number of shares of beneficial interest.

***Seed Capital***

On June 28, 2024, during the Fund's private fund stage (prior to the Conversion), the Fund's two initial members, EPCM Holdings LLC (an affiliate of the Adviser) and Trinity Capital Inc. (an affiliate of the Sub-Adviser), made capital commitments of $50.0 million and $10.0 million, respectively, in reliance upon the available exemptions from registration requirements of Section 4(a)(2) of and Regulation D under the Securities Act. These capital commitments have been called by the Fund and funded over time to make certain investments and pay certain expenses, and the related interests in the Fund were converted to 6,013,221 shares of the Fund in connection with the Conversion.

On September 19, 2025, EPCM Holdings LLC transferred 100% of its interests in the Fund to its affiliate, EPH Investments LLC, which is also an affiliate of the Adviser.

***Private Offering***

The Fund conducts a continuous private offering of its shares to investors in reliance on exemptions from the registration requirements of the Securities Act, including the exemptions provided by Section 4(a)(2) of the

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

Securities Act and Regulation D and Regulation S promulgated thereunder (the "Private Offering"). The Fund offers and sells shares to (i) persons who are "accredited investors" within the meaning of Regulation D under the Securities Act and (ii) non-U.S. persons outside the United States in compliance with Regulation S under the Securities Act. Eagle Point Securities LLC, an affiliate of the Adviser, serves as the dealer manager (the "Dealer Manager") for the Private Offering, on a best-efforts basis, pursuant to a dealer manager agreement with the Fund. See "Note 11 – Related Party Transactions" and "Note 14 – Subsequent Events" for additional information.

***Share Repurchase Program***

No shareholder has the right to require the Fund to redeem shares. No public market for shares exists, and none is expected to develop in the future.

Subject to the Board of Trustees' discretion, the Fund intends to offer to repurchase shares from shareholders in each quarter in an amount up to 5% of the shares outstanding, calculated as of the prior calendar quarter end. At the discretion of the Board of Trustees, the Fund may extend multiple offers to repurchase shares in a quarter in an aggregate amount of 5% of the shares outstanding. The Fund's Board may amend, suspend or terminate the share repurchase program at any time if it deems such action to be in the Fund's best interest and the best interest of the shareholders. As a result, share repurchases may not be available each quarter. The Fund intends to conduct repurchase offers in accordance with the requirements of Rule 13e-4 under the Exchange Act and the 1940 Act.

The Fund did not repurchase any shares during the three months ended March 31, 2026.

***Distribution Reinvestment Plan***

The Fund's distribution reinvestment plan ("DRIP") provides for the reinvestment of distributions in the form of shares, unless a shareholder has elected to receive distributions in cash. As a result, if the Fund declares a cash distribution, its shareholders who have not "opted out" of the DRIP by the applicable opt out date will have their cash distribution automatically reinvested into additional shares.

Shares will be issued pursuant to the DRIP at a price equal to 95% of their most recently determined NAV as of the payment date. There is no sales load or other charge for distribution reinvestment, and the plan administrator's fees are paid by the Fund. Participants in the DRIP may purchase fractional shares so that 100% of the distributions are used to acquire shares. The Fund reserves the right to amend or terminate the DRIP.

Brokerage firms and other financial intermediaries may decide not to participate in the Fund's DRIP but may provide a similar distribution reinvestment plan for their clients. During the three months ended March 31, 2026, no shares were issued under the DRIP.

***Distributions***

The Fund intends to authorize and declare ordinary cash distributions on a quarterly basis and pay such distributions on a monthly basis.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**Note 8. Earnings Per Share**

The following table sets forth the computation of the basic and diluted earnings per common share for the three months ended March 31, 2026 (in thousands except shares and per share information). Prior to the Conversion, there were no shares outstanding.

---

| | |
|:---|:---|
| | **Three Months Ended March 31, 2026** |
| Earnings per share - basic and diluted |  |
| Numerator for basic and diluted earnings per share | $1383 |
| Denominator for basic and diluted weighted average shares | 6025475 |
| Earnings/(Loss) per share - basic and diluted | $0.23 |

---

**Note 9. Income Taxes**

The Fund intends to elect to be treated, and to qualify annually as, a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Fund is generally required to distribute at least annually to its shareholders at least the sum of 90% of its investment company taxable income (which generally includes its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and 90% of its net tax-exempt income (if any). The Fund generally will not be subject to U.S. federal income tax on these distributed amounts, but will pay U.S. federal income tax at corporate rates on any retained amounts.

The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the annual earnings estimated by management of the Fund. Net capital gains, if any, are distributed at least annually, although the Fund may decide to retain all or some of those capital gains for investment and pay U.S. federal income tax at corporate rates on those retained amounts. If the Fund chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to shareholders. In the event the Fund's taxable income (including any net capital gains) for a fiscal year falls below the amount of distributions declared and paid with respect to that year, however, a portion of the total amount of those distributions may be deemed a return of capital for tax purposes to the Fund's shareholders.

Because federal income tax regulations differ from GAAP, distributions in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes. Differences may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the financial statements to reflect their appropriate tax character. Temporary differences arise when certain items of income, expense, gain or loss are recognized at some time in the future.

As of March 31, 2026, the Fund had accrued U.S. federal excise tax of less than $0.1 million.

The following table sets forth the tax cost basis and the estimated aggregate gross unrealized appreciation and depreciation from investments for federal income tax purposes as of March 31, 2026 and December 31, 2025 (in thousands):

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Tax Cost of Investments | $129580 | $121346 |

---

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Unrealized appreciation | $3101 | $2644 |
| Unrealized depreciation | (1328) | (862) |
| Net change in unrealized appreciation from investments | $1773 | $1782 |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**Note 10. Financial Highlights**

The following presents financial highlights for the three months ended March 31, 2026 and March 31, 2025 (in thousands except share and per share information):

---

| | |
|:---|:---|
| | **Three Months Ended March 31, 2026** |
| Net asset value, beginning of year/period | $10.24 |
| Results of operations: |  |
| Net investment income | 0.23 |
| Net realized gains (losses) and unrealized appreciation (depreciation) |  |
| Net increase (decrease) in net assets resulting from operations | 0.23 |
| Net decrease in net assets resulting from distributions | (0.26) |
| Net asset value, end of year/period | $10.21 |
| Shares outstanding, end of year/period | 6040715 |
| Weighted average Shares outstanding | 6025475 |
| Total return | 2.2% |

---

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2025** |
| **Ratio/Supplemental Data:** | | |
| Net assets, end of year/period | $61697 | $57646 |
| Ratio of total expenses to average net assets | 21.4% | 8.6% |
| Ratio of net investment income to average net assets | 9.0% | 9.1% |
| Ratio of interest and credit facility expenses to average net assets<sup>(2)</sup> | 8.5% | 2.8% |
| Portfolio turnover rate<sup>(1)</sup> | 5.6% | 4.2% |
| Asset coverage ratio <sup>(2)</sup> | 189.7% | 545.0% |

---

(1)Portfolio turnover rate is calculated using the lesser of year-to-date cash sales/repayments or year-to-date cash purchases over the average of the total investments at fair value.

(2)The calculation is based on outstanding debt of $68.0 million and $12.8 million as of March 31, 2026 and March 31, 2025, respectively.

**Note 11. Related Party Transactions**

***Investment Advisory Agreement and Sub-Advisory Agreement***

The Fund is party to an Investment Advisory Agreement with the Adviser (the "Investment Advisory Agreement") and a Sub-Advisory Agreement with the Sub-Adviser (the "Sub-Advisory Agreement), each dated as of August 28, 2025. The Adviser provides its services under the Investment Advisory Agreement, and the Sub-Adviser provides its services under the Sub-Advisory Agreement. The activities of both of the Adviser and the Sub-Adviser are subject to the supervision and oversight of the Board of Trustees.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

Pursuant to the Investment Advisory Agreement, the Fund pays the Adviser a fee for its services consisting of two components: a base management fee and an incentive fee. Pursuant to the Sub-Advisory Agreement, the Sub-Adviser receives 50% of all fees paid to the Adviser under the Investment Advisory Agreement net of any payments, reimbursements or waivers under the Expense Limitation Agreement.

*Base management fee* 

The base management fee is calculated monthly and payable quarterly in arrears and equals an annual rate of 1.75% of the Fund's Managed Assets (as defined below). The base management fee is calculated based on the Fund's Managed Assets at the end of the most recently completed calendar month, and adjusted for any share issuances or repurchases during the relevant calendar month. "Managed Assets" means the Fund's total assets (including assets attributable to the use of leverage) minus the sum of the Fund's accrued liabilities (other than liabilities incurred for the purpose of creating leverage).

For the three months ended March 31, 2026, the base management fee totaled $0.6 million. As of March 31, 2026, $0.6 million remained payable. These amounts exclude base management fees payable under the Initial Advisory Agreement, as described below.

*Incentive fee* 

The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee, which is referred to as the incentive fee on income, is calculated and payable quarterly in arrears based upon the Fund's "Pre-Incentive Fee Net Investment Income," as defined below, for the immediately preceding quarter. The payment of the incentive fee on income is subject to payment of a preferred return to shareholders each quarter (i.e., a "hurdle rate"), expressed as a rate of return on the value of the Fund's net assets at the end of the immediately preceding quarter, of 2.00%, subject to a "catch up" feature.

For this purpose, "Pre-Incentive Fee Net Investment Income" means (a) interest income, dividend income and any other income (including any other fees, such as commitment, exit/success, origination, structuring, diligence and consulting fees, but excluding fees for providing managerial assistance) accrued during the calendar quarter, minus (b) the Fund's operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement to the Administrator, any interest expense and/or dividends paid on any issued and outstanding debt or preferred shares, but excluding organizational and offering expenses, the incentive fee and any distribution and/or shareholder servicing fee) after giving application to the Expense Limitation Agreement. Pre-Incentive Fee Net Investment Income includes, in the case of investments with a deferred interest feature (such as OID, debt instruments PIK interest and zero-coupon securities), accrued income that the Fund has not yet received in cash. The Adviser is not obligated to return the incentive fee based on income it receives on deferred interest that is later determined to be uncollectible in cash. Pre-Incentive Fee Net Investment Income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation.

Pre-Incentive Fee Net Investment Income, expressed as a rate of return on the value of the Fund's net assets at the end of the immediately preceding calendar quarter, is compared to a hurdle rate of 2.00% (8.00% annualized) of the Fund's net assets at the end of such quarter and subject to a "catch-up" feature as described below. For such purposes, the Fund's quarterly rate of return is determined by dividing Pre-Incentive Fee Net Investment Income by the Fund's net assets at the end of such quarter.

The incentive fee in each calendar quarter is paid to the Adviser as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no incentive fee in any calendar quarter in which Pre-Incentive Fee Net Investment Income does not exceed the hurdle rate of 2.00% (8.00% annualized) of the Fund's net assets at the end of the immediately preceding calendar quarter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 100% of the Fund's Pre-Incentive Fee Net Investment Income with respect to that portion of such Pre-Incentive Fee Net Investment Income, if any, that exceeds the hurdle rate but is less than 2.50% (10.00% annualized) of the Fund's net assets at the end of the immediately preceding calendar quarter. The Fund refers to this portion of its Pre-Incentive Fee Net Investment Income (which exceeds the hurdle rate but is

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

less than 2.50% (10.00% annualized) of the Fund's net assets at the end of the immediately preceding calendar quarter) as the "catch-up." The "catch-up" is meant to provide the Adviser with 10.00% of the Fund's Pre-Incentive Fee Net Investment Income as if a hurdle did not apply; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 20% of the amount of the Fund's Pre-Incentive Fee Net Investment Income, if any, that exceeds 2.50% (10.00% annualized) of the Fund's net assets at the end of the immediately preceding calendar quarter is payable to the Adviser (that is, once the hurdle rate is reached and the catch-up is achieved, 20% of all Pre-Incentive Fee Net Investment Income thereafter is paid to the Adviser).

For the three months ended March 31, 2026, incentive fees based on income totaled $0.4 million. As of March 31, 2026, $0.4 million remained payable. These amounts exclude incentive fees payable under the Initial Advisory Agreement, as described below.

The second part of the incentive fee, which is referred to as the capital gains incentive fee, will be an annual fee that will be determined and payable, in arrears, as of the end of each calendar year (or upon termination of the Investment Advisory Agreement) in an amount equal to 20.00% of cumulative realized capital gains, if any, determined on a cumulative basis from the date of the Fund's election to be regulated as a BDC (based on the fair market value of each investment as of such date) through the end of such calendar year (or upon termination of the Investment Advisory Agreement), computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis from the date of the Fund's election to be regulated as a BDC (based on the fair market value of each investment as of such date) through the end of such calendar year (or upon termination of the Investment Advisory Agreement), less the aggregate amount of any previously paid capital gains incentive fees.

For the three months ended March 31, 2026, the Fund did not record an accrual for incentive fees based on capital gains under GAAP. These amounts exclude incentive fees payable under the Initial Advisory Agreement, as described below.

Additionally, the Fund will accrue, but will not pay, a capital gains incentive fee with respect to unrealized appreciation because a capital gains incentive fee would be owed to the Adviser if the Fund were to sell the relevant investment and realize a capital gain. For the three months ended March 31, 2026, such incentive fee totaled $0.1 million, which remained unrealized. This amount excludes incentive fees payable under the Initial Advisory Agreement, as described below.

The fees that will be payable under the Investment Advisory Agreement will be appropriately adjusted for any share issuances or repurchases during the calendar quarter (based on the actual number of days elapsed relative to the total number of days in such calendar quarter) and except as described above, exclude capital gains, realized loss and unrealized capital appreciation or depreciation.

*Origination Fee*

The Fund also pays the Sub-Adviser (and prior to the Conversion, paid the Initial Manager, as defined below) a fee (the "Origination Fee") equal to 1.00% of the funded amount of each investment acquired or made by the Fund on, under or with respect to an originated investment purchased by the Fund.

For the three months ended March 31, 2026 and March 31, 2025, the Fund incurred $0.1 million and $0.1 million in Origination Fees, respectively. As of March 31, 2026 and December 31, 2025, there were no unpaid Origination Fees included in accrued expenses and other liabilities in the accompanying Consolidated Statement of Assets and Liabilities.

***Private Fund Advisory Agreement***

Prior to the Conversion, during its private fund stage, the Fund was a party to an investment advisory agreement (the "Initial Advisory Agreement"), dated as of June 28, 2024, with Trinity Capital Adviser, as the Fund's sole investment adviser (the "Initial Manager"). The Initial Advisory Agreement was terminated in accordance with its terms in connection with the Conversion and the Fund's election to be regulated as a BDC. Under the Initial Advisory Agreement, the Fund paid the Initial Manager advisory fees, including a base management fee and an incentive fee, on substantially the same terms (including identical fee rates) as the currently effective Investment

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

Advisory Agreement. Under the Initial Advisory Agreement, EPCM Holdings LLC (and subsequently EPH Investments LLC), as the non-managing member, was entitled to a reimbursement of 50% of all advisory fees earned by the Initial Manager.

For the three months ended March 31, 2026, the Fund did not incur management fees and incentive fees representing the Income Incentive Fee and Capital Gains Incentive Fee pursuant to the Initial Advisory Agreement. For the three months ended March 31, 2025, the Fund incurred $0.3 million in base management fees and $0.3 million in incentive fees representing the Income Incentive Fee and Capital Gains Incentive Fee pursuant to the Initial Advisory Agreement. As of March 31, 2026 and December 31, 2025, no fees remained unpaid pursuant to the Initial Advisory Agreement.

***Administration Agreement***

The Fund is party to an Administration Agreement, dated as of August 28, 2025, with the Administrator. Pursuant to the Administration Agreement, the Administrator provides the Fund with office facilities, equipment, clerical, bookkeeping, and record keeping services at such facilities and such other services necessary for the Fund's operations, including but not limited to accounting services, maintenance of financial reports, preparing shareholder reports, preparing and filing tax returns and investor relations support, as set forth in the Administration Agreement.

In consideration of the provision of the services under the Administration Agreement, the Fund reimburses the Administrator for the costs and expenses incurred by the Administrator in performing its obligations and providing personnel (including salaries and related payroll expenses) and facilities under the Administration Agreement. Payments under the Administration Agreement are equal to an amount based upon the Fund's allocable portion of the Administrator's overhead in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions and the Fund's allocable portion of the compensation of the Fund's Chief Financial Officer and Chief Compliance Officer and the Fund's allocable portion of the compensation of any administrative support staff. The Fund's allocable portion of such total compensation is based on an allocation of the time spent on the Fund relative to other matters. To the extent the Administrator outsources any of its functions, the Fund pays the fees on a direct basis, without profit to the Administrator. The Administrator has the ability to delegate responsibilities to sub-administrators. The Administrator has delegated certain administration responsibilities to Harmonic Fund Services, a third-party.

For the three months ended March 31, 2026, the Fund was charged a total of $0.1 million in administration fees pursuant to the Administration Agreement, consisting of less than $0.1 million for services provided by the Administrator and less than $0.1 million for services provided by Harmonic Fund Services, all of which was payable as of March 31, 2026.

***Private Fund Administration Agreement***

Prior to the Conversion, during its private fund stage, the Fund was a party to an Administration Agreement, dated as of June 28, 2024 (the "Initial Administration Agreement"), with the Administrator, which was terminated in accordance with its terms in connection with the Conversion and the Fund's election to be regulated as a BDC. The terms of the Initial Administration Agreement, including all compensation terms, were substantially similar to those of the Administration Agreement.

For the three months ended March 31, 2026, the Fund did not incur administration fees pursuant to the Initial Administration Agreement. For the three months ended March 31, 2025, the Fund was charged less than $0.1 million in administration fees pursuant to the Initial Administration Agreement, consisting of $0.0 million and less than $0.1 million, relating to services provided by the Initial Administrator and Harmonic Fund Services, respectively. As of March 31, 2026 and December 31, 2025, no fees remained unpaid pursuant to the Initial Administration Agreement.

**Due from Affiliate**

As of March 31, 2026 and December 31, 2025, the Fund's "Due from affiliates" balance of less than $0.1 million and $1.3 million, respectively, as reflected on Consolidated Statements as Assets and Liabilities, consisted of

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

a net amount receivable from the Sub-Adviser related to a trade settlements and is expected to be paid in the normal course of business.

***Expense Limitation Agreement***

The Fund has entered into the Expense Limitation Agreement with the Adviser pursuant to which the Adviser or an affiliate thereof may provide expense support to us in order to reduce operating expenses borne by the Fund's shareholders. See "Note 6 – Commitments and Contingencies."

***Organizational and Offering Expense Support and Reimbursement Agreement***

The Fund has entered into the O&O Expense Agreement pursuant to which the Fund may pay for O&O expenses up to a limit of 1.50% of gross equity contributions (including the value of the initial seed portfolio), and the Adviser, the Administrator or their affiliates will bear any O&O expenses in excess of the 1.50% limit. The Fund may also pay Affiliate O&O Expense Reimbursements. See *"Note 6 – Commitments and Contingencies*."

***Dealer Manager Agreement***

The Fund has entered into a Dealer Manager Agreement, dated as of August 28, 2025 (the "Dealer Manager Agreement"), with the Dealer Manager with respect to the Private Offering. Pursuant to the Dealer Manager Agreement, the Dealer Manager will offer and sell the Fund's shares, on a best efforts basis, at NAV plus a sales load of up to 6.75%, which is comprised of a selling commission of up to 6.00% and a dealer manager fee of up to 0.75%. The Fund and the Dealer Manager may also enter into agreements with various brokers-dealers and other financial intermediaries ("Selling Agents") for the sale and servicing of the shares in connection with the Private Offering. The Dealer Manager may reallow a portion or all of the sales load to Selling Agents for selling shares to their customers. The Dealer Manager and/or a Selling Agent may, at its discretion, waive all or a portion of the sales load for the purchase of shares.

***Co-Investments***

The Fund and certain affiliates have received an exemptive relief order (the "Order") from the SEC that permits the Fund to participate in certain negotiated co-investments alongside certain affiliates, including Trinity Capital Inc. or other funds or accounts managed by the Sub-Adviser (or any future investment adviser that controls, is controlled by or is under common control with the Sub-Adviser), in a manner consistent with the Fund's investment objective, positions, policies, strategies, and restrictions as well as regulatory requirements and other pertinent factors, and subject to compliance with the Order. The Order contains certain conditions and requires the Board to maintain oversight of the Fund's participation in the co-investment program. The Order also requires a "required majority" (as defined in Section 57(o) of the 1940 Act) of the Board's eligible trustees to make certain conclusions pursuant to Section 57(f) of the 1940 Act in connection with certain co-investment transactions, including co-investment transactions in which an affiliate is an existing investor in the portfolio company, non-pro rata follow on investments and non-pro rata dispositions of investments.

The Fund may co-invest on a concurrent basis with other accounts managed by certain affiliates of the Adviser and/or Sub-Adviser, subject to compliance with applicable regulations and regulatory guidance.

**Note 12. Segment Reporting**

The Fund has determined that it has a single operating segment in accordance with Topic 280, *Segment Reporting* ("ASC 280"). The Fund's Chief Operating Decision Maker ("CODM") is comprised of each of the Fund's Chief Executive Officers, the Chief Financial Officer and the Chief Operating Officer. While the Fund derives income and capital appreciation by providing debt to growth-oriented companies across various industries, the Fund and the CODM evaluate and monitor performance of the business on a consolidated basis. Further, each investment is evaluated and managed using similar processes and shared operations support functions such as deal origination, underwriting, loan servicing in addition to the administrative functions of human resources, legal,

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

finance and information technology. The accounting policies of the segment align with those outlined in "Note 2 – Summary of Significant Accounting Policies" included in the notes of the consolidated financial statements.

The CODM uses consolidated net investment income and net increase/(decrease) in net assets resulting from operations when allocating resources and assessing the Fund's performance. Net investment income is comprised of consolidated total investment income ("segment revenues") and consolidated total net operating expenses ("significant segment expenses"). The net increase/(decrease) in net assets is comprised of consolidated net investment income and consolidated net realized gain/(loss) from investments and consolidated net change in unrealized appreciation/(depreciation) from investments. These performance metrics are considered the key segment measure of profit or loss received by the CODM. As the Fund's operations comprise of a single reporting segment, the segment assets are reflected on the accompanying Consolidated Statements of Assets and Liabilities as Total Assets, investments held on the Consolidated Statements of Investments, and the significant segment expenses are listed on the accompanying Consolidated Statements of Operations.

**Note 13. Recent Accounting Pronouncements**

In December 2023, the FASB issued Accounting Standards Update ("ASU") No. 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures* ("ASU 2023-09"), which intends to improve the transparency of income tax disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 and is to be adopted on a prospective basis with the option to apply retrospectively. The Fund evaluated the disclosure requirements of ASU 2023-09 and determined that the standard did not have a material effect on the Fund's income tax disclosures or overall consolidated financial statements; therefore, no additional disclosures were required upon adoption.

In November 2024, the Financial Accounting Standards Board ("FASB") issued ASU 2024-03, *Income Statement- Reporting Comprehensive Income- Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses* ("ASU 2024-03") related to expense disclosures. The amendments in ASU 2024-03 require public entities to provide disaggregated disclosure of expenses included within relevant income statement expense captions, as well as additional disclosures about selling expenses. This update will become effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Fund is currently evaluating the impact of adopting this guidance with respect to the consolidated financial statements.

**Note 14. Subsequent Events**

The Fund's management evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. Except as noted below, there have been no subsequent events that occurred during such period that would require recognition or disclosure.

***Private Offering***

On April 1, 2026, the Fund issued and sold 29,670 of its common shares of beneficial interest at a weighted-average offering price of $10.95 per share, resulting in net proceeds to the Fund of $0.3 million.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

*Except where the context suggests otherwise, the terms "we," "us," "our," and "the Fund" refer to Eagle Point Trinity Senior Secured Lending Company, a Delaware statutory trust, and its consolidated subsidiaries and predecessor entities. The information contained in this section should be read in conjunction with our consolidated financial statements and related notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q.*

**Forward-Looking Statements**

This quarterly report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. Any statements about our expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as "anticipate," "believes," "can," "could," "may," "predicts," "potential," "should," "will," "estimate," "plans," "projects," "continuing," "ongoing," "expects," "intends" and similar words or phrases. Accordingly, these statements are only predictions and involve estimates, known and unknown risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Our actual results could differ materially from those anticipated in such forward-looking statements as a result of several factors discussed under Item 1A. "Risk Factors" of Part II of this quarterly report and Item 1A. "Risk Factors" of Part I of our Registration Statement on Form 10, filed with the SEC on August 28, 2025, including but not limited to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our future operating results;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our business prospects and the prospects of the companies in which we may invest;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks related to investments in growth-oriented companies, other venture capital-backed companies and generally U.S. companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in our investment objectives and strategy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the use of leverage;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in political, economic, social and/or industry conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• uncertainty surrounding domestic and/or global financial and/or political stability;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in interest rates, inflation rates, trade policies and/or the general economy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in laws, regulations, policies, tax rates and similar matters;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks related to the uncertainty of the value of our portfolio investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of market volatility and disruptions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to deploy capital and make and/or exit investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to raise and access capital;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to make distributions and/or repurchase offers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of information technology system failures, data security breaches, data privacy compliance, network disruptions, and cybersecurity attacks; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to maintain our status as a business development company ("BDC") under the Investment Company Act of 1940, as amended (the "1940 Act"), and qualify annually for tax treatment as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code").

Additionally, there may be other risks that are otherwise described from time to time in the reports that we file with the SEC. Any forward-looking statements in this Quarterly Report on Form 10-Q should be considered in light

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

of various important factors, including the risks and uncertainties listed above, as well as others. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout this quarterly report. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. Because we are an investment company, the forward-looking statements and projections contained in this quarterly report are excluded from the safe harbor protections provided by Section 27A(b)(2)(B) of the Securities Act, and Section 21E of the Exchange Act (the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995).

***Overview***

We are a "perpetual-life", externally managed, non-diversified closed-end management investment company that has elected to be regulated as a BDC under the 1940 Act. We were initially formed as a Delaware limited liability company on May 3, 2024, commenced operations as a private fund exempt from the definition of "investment company" under Section 3(c)(7) of the 1940 Act on June 28, 2024, and converted into a Delaware statutory trust on August 28, 2025 in connection with our election to be regulated as a BDC.

Our investment objective is to generate current income and, to a lesser extent, capital appreciation.

We seek to achieve our investment objective by making investments consisting primarily of senior secured term loans, equipment financings and to a lesser extent, asset-based lending, working capital loans, equity and equity-related investments. We make senior secured loans typically to institutionally-backed growth-oriented companies for growth capital. Our equipment financings involve loans for general or specific use, including acquiring equipment, that are secured by the equipment or other assets of the portfolio company and provide the borrower with growth capital. In addition, we may obtain warrants or contingent exit fees at funding from many of our portfolio companies, providing an additional potential source of investment return. The warrants entitle us to purchase preferred or common equity of a portfolio company, and we typically target the amount of such warrants to scale in proportion to the amount of the debt or equipment financing. Contingent exit fees are cash fees payable upon the consummation of certain trigger events, such as a successful change of control or initial public offering of the portfolio company. In addition, we may obtain rights to purchase additional shares of our portfolio companies in subsequent equity financing round.

We target investments in growth-oriented companies with institutional investor support, experienced management teams, promising products and offerings, and large expanding markets. We define "growth-oriented companies" as companies that have significant ownership and active participation by sponsors and expected annual revenues of up to $100 million. These companies typically are private companies that have begun to have success selling their products to the market and need additional capital to expand their operations and sales. Despite often achieving growing revenues, these types of companies typically have limited financing options to fund their growth. Equity, being dilutive in nature, is generally the most expensive form of capital available, while traditional bank financing is rarely available, given the lifecycle stage of these companies. Financing from us bridges this financing gap, providing companies with growth capital, which may result in improved profitability, less dilution for all equity investors, and increased enterprise value.

Under normal market conditions, we expect to invest at least 80% of our total assets (net assets plus borrowings for investment purposes) in senior secured lending instruments (measured at the time of investment). Senior Secured Lending instruments refers to fixed or floating rate debt instruments which (1) are legally entitled to a priority right of repayment in full prior to the repayment of subordinated indebtedness and/or equity interests and (2) hold a security interest against some or all assets which have been pledged in favor of the persons which have furnished such Senior Secured Lending instruments (or direct or indirect assignees, participants, syndicates or other successors thereto). Our investments in equity or equity-related instruments (or instruments convertible into equity or equity-related instruments) that were "attached" to or otherwise acquired by us in conjunction with an investment in Senior Secured Lending instruments shall count towards the numerator in determining our compliance with this 80%

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

investment policy. In addition, any investments consistent with the foregoing that are held through a subsidiary, special purpose vehicle, joint venture, or other similar structuring vehicle shall count towards the numerator.

***Critical Accounting Estimates and Policies***

The preparation of our financial statements in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ materially. Our critical accounting estimates, including those relating to valuation of investments and income recognition, are described below. Please refer to "Note 2 – Summary of Significant Accounting Policies" in the notes to the consolidated financial statements included in this Quarterly Report on Form 10-Q for a discussion of our significant accounting policies.

*Valuation of Investments*

The most significant estimate inherent in the preparation of our consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded. There is no single method for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. Rule 2a-5 under the 1940 Act establishes requirements for determining fair value in good faith for purposes of the 1940 Act. Pursuant to Rule 2a-5, the Board of Trustees has designated the Adviser to serve as the "valuation designee" to perform fair value determinations in respect of our portfolio investments that do not have readily available market quotations.

We account for our investments in accordance with U.S. GAAP, and fair value our investment portfolio in accordance with the provisions of the FASB ASC Topic 820, Fair Value Measurements and Disclosures of the Financial Accounting Standards Board's Accounting Standards Codification, as amended, which defines fair value, establishes a framework for measuring fair value and requires enhanced disclosures about fair value measurements. Fair value is the estimated amount that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date (i.e., the exit price).

In determining the value of publicly-traded securities (if any), such securities are generally valued utilizing the official closing price from the applicable exchange at the measurement date. Public non-traded securities are typically valued based on recent market transactions involving the same security on or around the measurement date. If observable transactions are limited (or if there are none), the Adviser will consider utilizing broker quotations or an independent valuation agent. Privately placed investments are fair valued in accordance with the Adviser's valuation policies and procedures. The Adviser may either engage independent valuation firms on a discretionary basis or receive (on a non-reliance basis) the Sub-Adviser valuations and the reports of independent valuation firms engaged by the Sub-Adviser and its affiliates. In addition to the techniques described above, the Adviser may from time to time use other valuation techniques and methodologies when determining fair value measurements. A third-party firm's advice is only one factor considered in the valuation of an investment, and the Adviser does not rely on such advice in determining the fair value of our investments in accordance with the 1940 Act.

Our investment portfolio is valued no less frequently than monthly. Fair valuations are ultimately determined by the Adviser in accordance with the Adviser's valuation policies and procedures. Our Board of Trustees oversees the valuation designee and the process that it uses to determine the fair value of our assets. In this regard, the Board of Trustees receives periodic and, as applicable, prompt reporting regarding certain material valuation matters, as required by Rule 2a-5 under the 1940 Act. We have the sole right to change the frequency of determination of the net asset value ("NAV") at the Board of Trustees' discretion.

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of our financial instruments, consisting of cash, investments,

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments.

*Income Recognition*

We recognize interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount ("OID") initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. Interest income from payment-in-kind ("PIK") represents contractually deferred interest added to the loan balance recorded on an accrual basis to the extent such amounts are expected to be collected.

In addition, we may also be entitled to an end-of-term ("EOT") payment. EOT payments to be paid at the termination of the debt agreement are accreted into interest income over the contractual life of the debt based on the effective yield method. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, the acceleration of the unaccreted OID and EOT is recognized as interest income.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are accreted into interest income over the contractual life of the loan. We recognize nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.

We record dividend income on an accrual basis to the extent amounts are expected to be collected. Dividend income is recorded when dividends are declared by the portfolio company or at such other time that an obligation exists for the portfolio company to make a distribution.

We recognize one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity.

***Portfolio Composition and Investment Activity***

*Portfolio Composition*

As of March 31, 2026 our investment portfolio had an aggregate fair value of approximately $131.4 million and was comprised of approximately $98.2 million in secured loans, $28.9 million in equipment financings, and $4.3 million in equity and warrants, across 71 portfolio companies. As of December 31, 2025, our investment portfolio had an aggregate fair value of approximately $123.1 million and was comprised of approximately $90.1 million in secured loans, $29.3 million in equipment financings, and $3.7 million in equity and warrants, across 66 portfolio companies.

A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments are shown in the following table as of March 31, 2026 and December 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
|<br>**Type** | **Cost** | **Fair Value** | **Cost** | **Fair Value** |
| Secured Loans | 75.3% | 74.8% | 73.5% | 73.2% |
| Equipment Financings | 22.4% | 22.0% | 24.2% | 23.8% |
| Warrants | 2.0% | 2.7% | 2.0% | 2.6% |
| Equity | 0.3% | 0.5% | 0.3% | 0.4% |
| &nbsp;&nbsp;&nbsp;Total | 100.0% | 100.0% | 100.0% | 100.0% |

---

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

The following table shows the composition of our investment portfolio by geographic region at cost and fair value as a percentage of total investments as of March 31, 2026 and December 31, 2025. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
|<br>**Geographic Region** | **Cost** | **Fair Value** | **Cost** | **Fair Value** |
| United States |  |  |  |  |
| &nbsp;&nbsp;&nbsp;West | 31.5% | 31.9% | 33.5% | 33.9% |
| &nbsp;&nbsp;&nbsp;Northeast | 30.6% | 30.4% | 32.3% | 32.0% |
| &nbsp;&nbsp;&nbsp;South | 9.3% | 9.3% | 10.4% | 10.4% |
| &nbsp;&nbsp;&nbsp;Mountain | 8.8% | 8.8% | 7.2% | 7.2% |
| &nbsp;&nbsp;&nbsp;Midwest | 7.5% | 7.4% | 5.9% | 5.8% |
| &nbsp;&nbsp;&nbsp;Southeast | 6.1% | 6.0% | 3.9% | 3.9% |
| International: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Canada | 2.7% | 2.7% | 3.1% | 3.1% |
| &nbsp;&nbsp;&nbsp;Western Europe | 3.5% | 3.5% | 3.7% | 3.7% |
| &nbsp;&nbsp;&nbsp;Total | 100.0% | 100.0% | 100.0% | 100.0% |

---

Set forth below is a table showing the industry composition of our investment portfolio at cost and fair value as a percentage of total investments as of March 31, 2026 and December 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
|<br>**Industry** | **Cost** | **Fair Value** | **Cost** | **Fair Value** |
| Medical Devices | 16.5% | 16.2% | 13.2% | 13.1% |
| Finance and Insurance | 13.9% | 13.7% | 14.8% | 14.6% |
| SaaS | 10.6% | 10.4% | 10.9% | 10.8% |
| Artificial Intelligence & Automation | 10.3% | 10.2% | 12.0% | 12.0% |
| Space Technology | 10.2% | 11.1% | 10.4% | 11.0% |
| Energy and Resource Technology | 9.0% | 8.9% | 8.5% | 8.4% |
| Healthcare Technology | 6.6% | 6.5% | 7.0% | 7.0% |
| Marketing, Media, and Entertainment | 6.4% | 6.2% | 5.9% | 5.7% |
| Other Healthcare Services | 5.1% | 5.1% | 4.9% | 4.9% |
| Connectivity | 3.2% | 3.2% | 4.5% | 4.5% |
| Biotechnology | 2.7% | 2.7% | 2.9% | 2.9% |
| Consumer Products & Services | 2.4% | 2.8% | 2.7% | 2.8% |
| Diagnostics & Tools | 2.4% | 2.4% | 1.5% | 1.5% |
| Food and Agriculture Technologies | 0.4% | 0.4% | 0.5% | 0.5% |
| Transportation Technology | 0.3% | 0.2% | 0.3% | 0.3% |
| &nbsp;&nbsp;&nbsp;Total | 100.0% | 100.0% | 100.0% | 100.0% |

---

As of both March 31, 2026 and December 31, 2025, the debt, including loans and equipment financings, in our portfolio had an average time to maturity of approximately 3.2 years and 3.3 years, respectively. Additional information regarding our portfolio is set forth in the Consolidated Schedule of Investments and the related notes thereto included with this Quarterly Report on Form 10-Q.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

*Concentrations of Credit Risk*

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment's carrying amount. Industry and sector concentrations will vary from period to period based on portfolio activity.

As of March 31, 2026 and December 31, 2025, the Fund's ten largest portfolio companies represented approximately 30.2% and 33.1%, respectively, of the total fair value of the Fund's investments in portfolio companies. As of both March 31, 2026 and December 31, 2025, the Fund had thirteen and twelve portfolio companies that represented 5% or more of the Fund's net assets, respectively.

*Investment Activity*

During the three months ended March 31, 2026, we invested approximately $10.0 million in 6 new portfolio companies and approximately $4.6 million in 10 existing portfolio companies, excluding deferred fees. During the three months ended March 31, 2026, we received an aggregate of $7.2 million in proceeds from repayments and sales of our investments, including proceeds of approximately $4.2 million from early repayments on our debt investments, $3.0 million from scheduled/amortizing debt payments, and $0.0 million from warrant and equity exits.

During the year ended December 31, 2025, we invested approximately $58.3 million in 28 new portfolio companies and approximately $16.7 million in 40 existing portfolio companies, excluding deferred fees. During the year ended December 31, 2025, we received an aggregate of $23.1 million in proceeds from repayments and sales of our investments, including proceeds of approximately $12.3 million from early repayments on our debt investments and $10.8 million from scheduled/amortizing debt payments.

The following table provides a summary of the changes in the investment portfolio for the three months ended March 31, 2026 and the year ended December 31, 2025 (in thousands):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31, 2026** | **Year Ended December 31, 2025** |
| **Beginning Portfolio, at fair value** | $123127 | $66886 |
| &nbsp;&nbsp;&nbsp;Purchases, net of deferred fees | 14633 | 75036 |
| &nbsp;&nbsp;&nbsp;Proceeds received from sales and paydowns | (7162) | (23070) |
| &nbsp;&nbsp;&nbsp;Accretion of OID, EOT, and PIK payments | 747 | 1828 |
| &nbsp;&nbsp;&nbsp;Net realized gain/(loss) | 16 | 933 |
| &nbsp;&nbsp;&nbsp;Net change in unrealized appreciation/(depreciation) | (8) | 1514 |
| **Ending Portfolio, at fair value** | $131353 | $123127 |

---

The level of our investment activity can vary substantially from period to period depending on many factors, including the amount of debt, including loans and equipment financings, and equity capital required by growth-oriented companies, the general economic environment and market conditions and the competitive environment for the types of investments we make.

*Portfolio Asset Quality*

The Sub-Adviser's portfolio management team uses an ongoing investment risk rating system to characterize and monitor our outstanding loans and equipment financings. The portfolio management team monitors and, when appropriate, recommends changes to the investment risk ratings. The Sub-Adviser reviews the recommendations and/or changes to the investment risk ratings, which are submitted to and reviewed by the Adviser and ultimately presented to the audit committee of our Board of Trustees.

For our investment risk rating system, we review seven different criteria and, based on our review of such criteria, we assign a risk rating on a scale of 1 to 5, as set forth in the following illustration.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**INVESTMENT RISK RATING**

![Image_0.jpg](ept-20260331_g1.jpg)

---

| | |
|:---|:---|
| **We review 7 different criteria on a scale of 1-5 against specific benchmark.** | **We review 7 different criteria on a scale of 1-5 against specific benchmark.** |
| **Risk Rating Score** | **Designation** |
| **4.0 - 5.0** | **Very Strong Performance** |
| **3.0 - 3.9** | **Strong Performance** |
| **2.0 - 2.9** | **Performing** |
| **1.6 - 1.9** | **Watch** |
| **1.0 - 1.5** | **Default/Workout** |

---

The following table shows the distribution of our secured loan and equipment financing investments on the 1 to 5 investment risk rating scale range at fair value as of March 31, 2026 and December 31, 2025 (dollars in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
|<br>**Investment Risk Rating**<br>**Scale Range** |<br>**Designation** | **Investments at**<br>**Fair Value** | **Percentage of**<br>**Total Portfolio** | **Investments at**<br>**Fair Value** | **Percentage of**<br>**Total Portfolio** |
| 4.0 - 5.0 | Very Strong Performance | $3487 | 2.7% | $3693 | 3.1% |
| 3.0 - 3.9 | Strong Performance | 43650 | 34.4% | 39410 | 33.0% |
| 2.0 - 2.9 | Performing | 79935 | 62.9% | 76290 | 63.9% |
| 1.6 - 1.9 | Watch |  | —% |  | —% |
| 1.0 - 1.5 | Default/Workout |  | —% |  | —% |
| Total Debt Investments |  | $127072 | 100.0% | $119393 | 100.0% |

---

As of March 31, 2026 and December 31, 2025, our debt investments had a weighted average risk rating score of 2.9 and 2.9, respectively.

***Debt Investments on Non-Accrual Status***

When a debt security becomes 90 days or more past due, or if our management otherwise does not expect that principal, interest, and other obligations due will be collected in full, we will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or we believe the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, we may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of March 31, 2026 and December 31, 2025 no loans or equipment financings loans were on non-accrual status.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

***Results of Operations***

The following discussion and analysis of our results of operations encompasses our consolidated results for the three and three months ended March 31, 2026 and March 31, 2025.

*Investment Income*

The following table sets forth the components of investment income (in thousands):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**<br>**March 31, 2026** | **Three Months Ended**<br>**March 31, 2025** |
| Stated interest income | $3610 | $2162 |
| Amortization of OID and EOT | 730 | 309 |
| Prepayment penalty and related fees | 226 |  |
| Other fee income | 62 | 23 |
| &nbsp;&nbsp;&nbsp;Total investment income | $4628 | $2494 |

---

For the three months ended March 31, 2026, total investment income was approximately $4.6 million, respectively, which represents an approximate effective yield of 14.6% on the average investments during the year. For the three months ended March 31, 2025, total investment income was approximately $2.5 million, which represents an approximate effective yield of 14.5% on the average investments during the year. The increase in investment income for the three months ended March 31, 2026 was due to increases in each underlying component of investment income. Stated interest income and amortization of OID and EOT increased due to a higher principal value of income producing debt investments. Prepayment penalty and related fee income increased due to a higher volume of early repayments. Other fee income increased as a result of portfolio activity.

*Net Operating Expenses* 

Our operating expenses are comprised of interest and fees on our borrowings, management fees and incentive fees, professional fees, general and administrative expenses. Our operating expenses totaled approximately $3.3 million for the three months ended March 31, 2026. For the three months ended March 31, 2025, our operating expenses totaled approximately $1.2 million. The increase in our operating expenses for the three months ended March 31, 2026 is discussed with respect to each component of such expenses below.

*Interest Expense and Other Debt Financing Costs*

Our interest expense and other debt financing costs are primarily comprised of interest and fees related to secured borrowings under the KeyBank Credit Agreement and 2028 Series A Notes. Interest expense and other debt financing costs on our borrowings totaled approximately $1.3 million and $0.4 million, respectively, for the three months ended March 31, 2026 and March 31, 2025. Our weighted average effective interest rate, comprised of interest and amortization of fees and discount, was approximately 7.9% and 12.8%, respectively, for the three months ended March 31, 2026 and March 31, 2025. The increase in interest expense for the three months ended March 31, 2026 was primarily due to increased borrowings under the KeyBank Credit Facility and the incurrence of additional indebtedness under the 2028 Series A Notes.

*Management Fees and Incentive Fees*

Base management fees for the three months ended March 31, 2026 and March 31, 2025 totaled approximately $0.6 million and $0.3 million, respectively. Incentive fees for the three months ended March 31, 2026 and March 31, 2025 totaled approximately $0.5 million and $0.4 million, respectively. The increase in base management fees for the three months ended March 31, 2026 was due to an increase in managed assets. The increase in incentive fees for the three months ended March 31, 2026 was primarily driven by higher pre-incentive fee net investment income and an increase in unrealized capital appreciation.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

*Professional Fees Expenses*

Professional fees expenses, consisting of legal fees, accounting fees and third-party valuation fees, totaled approximately $0.5 million and $0.1 million, respectively, for the three months ended March 31, 2026 and March 31, 2025. The increase in professional fees for the three months ended March 31, 2026 was driven by increases in legal, administrative, audit and valuation expenses.

*Administrative Services Expenses and General and Administrative Expenses*

Administrative services expenses primarily consists of administrative fees and general and administrative expenses include insurance premiums, rent, state taxes and various other expenses related to our ongoing operations. Our administrative services expenses and general and administrative expenses totaled approximately $0.4 million and $0.1 million for the three months ended March 31, 2026 and March 31, 2025, respectively.These amounts are presented within professional fees on the Consolidated Statements of Operations. The increase in administrative services expenses and general and administrative expenses for the three months ended March 31, 2026 was primarily due to increases in administrative services expenses.

*Net Investment Income*

For the three months ended March 31, 2026, we recognized approximately $4.6 million in total investment income as compared to approximately $3.3 million in total expenses, resulting in net investment income of approximately $1.4 million. For the three months ended March 31, 2025, we recognized approximately $2.5 million in total investment income as compared to approximately $1.2 million in total expenses, resulting in net investment income of approximately $1.3 million.

*Net Realized Gains and Losses*

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written off during the period.

The net realized gains (losses) from the sales, repayments, or exits of investments for the three months ended March 31, 2026 were comprised of the following (in thousands):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2025** |
| Net realized gain/(loss) on investments: |  |  |
| &nbsp;&nbsp;&nbsp;Gross realized gains | $16 | $— |
| &nbsp;&nbsp;&nbsp;Gross realized losses |  |  |
| &nbsp;&nbsp;&nbsp;Total net realized gains/(losses) on investments | $16 | $— |

---

*Net Change in Unrealized Appreciation / (Depreciation) from Investments*

Net change in unrealized appreciation/(depreciation) from investments primarily reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

Net unrealized appreciation and depreciation on investments for the three months ended March 31, 2026 and March 31, 2025 is comprised of the following (in thousands):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2025** |
| Gross unrealized appreciation | $1075 | $329 |
| Gross unrealized depreciation | (1068) | (268) |
| Net unrealized appreciation/(depreciation) reclassified related to net realized gains or losses | (15) |  |
| Total net unrealized gains/(losses) on investments | $(8) | $61 |

---

During the three months ended March 31, 2026, our net unrealized depreciation totaled approximately less than $0.1 million, which included net unrealized depreciation of $0.5 million from our debt investments plus net unrealized appreciation of $0.5 million from our warrant and equity investments.

During the three months ended March 31, 2025, our net unrealized appreciation totaled approximately less than $0.1 million, which included net unrealized appreciation of less than $500,000.0 million from our debt investments and $0.0 million from our warrant and equity investments.

*Net Increase (Decrease) in Net Assets Resulting from Operations*

Net increase in net assets resulting from operations during the three months ended March 31, 2026 and March 31, 2025, totaled approximately $1.4 million and $1.3 million, respectively.

*Net Increase (Decrease) in Net Assets Resulting from Operations and Earnings Per Share*

For the three months ended March 31, 2026, basic and diluted net increase in net assets per common share was $0.23.

***Financial Condition, Liquidity and Capital Resources***

Our liquidity and capital resources are generated primarily from the net proceeds of offerings of our securities and borrowings under the KeyBank Credit Agreement, as well as cash flows from our operations, including investment sales and repayments and income earned on investments and cash equivalents. Our primary use of our funds includes investments in portfolio companies, payments of interest on our outstanding debt, and payments of fees and other operating expenses we incur. We also expect to use our funds to pay distributions to our shareholders. We have used, and expect to continue to use, our borrowings, including under the KeyBank Credit Agreement or any future credit facility, as well as proceeds from the turnover of our portfolio, to finance our investment objectives and activities.

From time to time, we may enter into additional credit facilities, increase the size of our existing KeyBank Credit Agreement, or issue additional securities in private or public offerings. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions, and other factors.

During the three months ended March 31, 2026, we experienced a net decrease in cash and cash equivalents in the amount of less than $0.1 million, which is the net result of $5.0 million of cash provided by financing activities, offset by $5.0 million of cash used in operating activities.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

During the three months ended March 31, 2025, we experienced a net decrease in cash and cash equivalents in the amount of $1.7 million, which is the net result of $0.4 million of cash provided by financing activities, offset by $2.1 million of cash used in operating activities.

As of March 31, 2026 and March 31, 2025, we had cash and cash equivalents of $0.6 million and $0.6 million, respectively. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation ("FDIC") insured limit and therefore is subject to credit risk. All of the Fund's cash deposits are held at large established high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote.

As of March 31, 2026 and December 31, 2025 we had approximately $17.0 million and $23.3 million, respectively, of available borrowings under the KeyBank Credit Agreement, subject to its terms and regulatory requirements. Cash and cash equivalents, taken together with available borrowings under the KeyBank Credit Agreement, as of March 31, 2026, are expected to be sufficient for our investing activities and to conduct our operations in the near term and long term.

Refer to "Note 5 – Borrowings" in the notes to our consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information, including a discussion of our borrowings.

*Asset Coverage Requirements*

In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. On March 25, 2025, the Board, including a "required majority" (as such term is defined in Section 57(o) of the 1940 Act) and our initial shareholder approved the application to us of the 150% minimum asset coverage ratio set forth in Section 61(a)(2) of the 1940 Act. As a result, we are generally permitted to borrow $2 for every $1 of investor equity (subject to any additional or more restrictive debt limitations under the terms of our existing financing agreements).

As of March 31, 2026, our asset coverage ratio was approximately 189.7% and our asset coverage ratio per unit was approximately $1.9. As of December 31, 2025, our asset coverage ratio was approximately 198.5% and our asset coverage ratio per unit was $2.0.

***Commitments***

Our commitments and contingencies consist primarily of unfunded commitments to extend credit in the form of loans to our portfolio companies. A portion of these unfunded contractual commitments as of March 31, 2026 and December 31, 2025 are dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, our credit agreements with our portfolio companies generally contain customary lending provisions that allow us relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the Fund. Since a portion of these commitments may expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, our disclosure of unfunded contractual commitments includes only those which are available at the request of the portfolio company and unencumbered by milestones. We will fund future unfunded commitments from the same sources we use to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under the KeyBank Credit Agreement).

In the normal course of business, we enter into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to us under these arrangements is unknown as it would involve future claims that may be made against us; however, based on our experience, the risk of loss is remote and no such claims are expected to occur. As such, we have not accrued any liability in connection with such indemnifications.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

***Contractual Obligations***

A summary of our contractual payment obligations as of March 31, 2026, is as follows (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** | **Payments Due by Period** | |
| | **Less than 1 year** | **1-3 years** | **4-5 years** | **After 5 years** |<br>**Total** |
| KeyBank Credit Facility | $— | $— | $43000 | $— | $43000 |
| 2028 Series A Notes | $— | $25000 | $— | $— | $25000 |
| Total Contractual Obligations | $— | $25000 | $43000 | $— | $68000 |

---

***Recent Developments***

On April 1, 2026, the Fund issued and sold 29,670 of its shares, for aggregate proceeds to the Fund of $0.3 million.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

We are subject to financial market risks, including valuation risk and interest rate risk. Uncertainty with respect to the economic effects of the overall market conditions has introduced significant volatility in the financial markets, and the effect of the volatility could materially impact our market risks, including those listed below.

***Valuation Risk***

Our investments may not have readily available market quotations (as such term is defined in Rule 2a-5), and those investments which do not have readily available market quotations are valued at fair value as determined in good faith by the Adviser, as our valuation designee, in accordance with its valuation policies and procedures. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and it is possible that the difference could be material.

In accordance with Rule 2a-5, our Adviser, as our valuation designee, periodically assesses and manages material risks associated with the determination of the fair value of our investments.

***Interest Rate Risk***

Interest rate sensitivity and risk refer to the change in earnings that may result from changes in the level of interest rates. To the extent that we borrow money to make investments, including under the KeyBank Credit Facility or any future financing arrangement, our net investment income will be affected by the difference between the rate at which we borrow funds and the rate at which we invest these funds. In periods of rising interest rates, our cost of borrowing funds would increase, which may reduce our net investment income. As a result, there can be no assurance that a significant change in market interest rates, including as a result of inflation, will not have a material adverse effect on our net investment income. Inflation is likely to continue in the near to medium-term, particularly in the United States and Europe, with the possibility that monetary policy may tighten in response. Persistent inflationary pressures could affect our portfolio companies' profit margins.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

As of March 31, 2026 approximately 77.2% of our debt investments based on outstanding principal balance represented floating-rate investments based on U.S. Prime Rate ("Prime") or Secured Overnight Financing Rate ("SOFR"), and approximately 22.8% of our debt investments based on outstanding principal balance represented fixed rate investments. In addition, borrowings under the KeyBank Credit Agreement bear interest at a rate equal to SOFR plus an applicable spread.

Based on our Consolidated Statements of Operations as of March 31, 2026, the following table shows the annualized impact on net income of hypothetical base rate changes in the Prime Rate on our debt investments (considering interest rate floors for floating-rate instruments) and the hypothetical base rate changes in the SOFR on our KeyBank Credit Agreement, assuming that there are no changes in our investment and borrowing structure (in thousands):

---

| | | | |
|:---|:---|:---|:---|
| **Basis Point Change** | **Interest Income** | **Interest Expense** | **Net Investment Income (Loss)** |
| Up 300 basis points | $2585 | $(1101) | $1484 |
| Up 200 basis points | $1724 | $(734) | $990 |
| Up 100 basis points | $720 | $(367) | $353 |
| Down 100 basis points | $(33) | $367 | $334 |
| Down 200 basis points | $— | $734 | $734 |
| Down 300 basis points | $— | $1101 | $1101 |

---

***Currency Risk***

Any investments we make that are denominated in a foreign currency will be subject to risks associated with changes in currency exchange rates. These risks include the possibility of significant fluctuations in the foreign currency markets, the imposition or modification of foreign exchange controls and potential illiquidity in the secondary market. These risks will vary depending upon the currency or currencies involved. As of March 31, 2026, we had three foreign domiciled portfolio companies. Our exposure to currency risk related to these debt investments is minimal as payments from such portfolio companies are primarily received in U.S. dollars. No other investments as of March 31, 2026 were subject to currency risk.

***Hedging***

We may hedge against interest rate and currency exchange rate fluctuations by using standard hedging instruments such as futures, options and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in benefits of lower interest rates with respect to our portfolio of investments with fixed interest rates. We may also borrow funds in local currency as a way to hedge our non-U.S. denominated investments.

**Item 4. Controls and Procedures**

***Evaluation of Disclosure Controls and Procedures***

As of the end of the period covered by this report, our management carried out an evaluation, under the supervision and with the participation of our Co-Chief Executive Officers and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our Co-Chief Executive Officers and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of March 31, 2026. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

***Changes in Internal Control Over Financial Reporting***

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the three months ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**PART II: OTHER INFORMATION**

**Item 1. Legal Proceedings**

We are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us. From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Furthermore, third parties may seek to impose liability on us in connection with the activities of our portfolio companies. Our business is also subject to extensive regulation, which may result in regulatory proceedings against us. While the outcome of any future legal or regulatory proceedings cannot be predicted with certainty, we do not expect that any such future proceedings will have a material effect upon our financial condition or results of operations.

**Item 1A. Risk Factors**

An investment in our securities involves a high degree of risk. There have been no material changes to the risk factors previously reported under Item 1A. "Risk Factors" in our Registration Statement on Form 10, filed with the SEC on August 28, 2025. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may materially affect our business, financial condition and/or operating results.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

***Private Offering***

We are conducting a continuous private offering of our shares to investors in reliance on exemptions from the registration requirements of the Securities Act, including the exemption provided by Section 4(a)(2) of the Securities Act and Regulation D and Regulation S promulgated thereunder (the "Private Offering"). We are offering and selling our shares to (i) persons who are "accredited investors" within the meaning of Regulation D under the Securities Act and (ii) non-U.S. persons outside the United States in compliance with Regulation S under the Securities Act.

The following summarizes the total shares issued and proceeds received related to subscriptions for the Private Offering in the fiscal quarter ended March 31, 2026:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On March 2, 2026, the Fund issued and sold 22,860 of shares for aggregate proceeds of approximately $0.2 million.

Each purchaser of shares was required to represent that it (i) is either an "accredited investor" as defined in Rule 501 of Regulation D under the Securities Act or, in the case of shares sold outside the United States, not a "U.S. person" in accordance with Regulation S of the Securities Act and (ii) was acquiring the shares for investment and not with a view to resell or distribute. We did not engage in general solicitation or advertising, and did not offer securities to the public, in connection with such issuances and sales.

***Share Repurchase Program***

No shareholder has the right to require us to redeem shares. No public market for shares exists, and none is expected to develop in the future. Consequently, shareholders may not be able to liquidate their investment other than as a result of repurchases of shares by us.

Subject to the Board of Trustee's discretion, we intend to offer to repurchase shares from shareholders in each quarter in an amount up to 5% of our shares outstanding, calculated as of the prior calendar quarter end. At the discretion of the Board of Trustees, we may extend multiple offers to repurchase shares in a quarter in an aggregate amount of 5% of our shares outstanding. The Fund's Board may amend, suspend or terminate the share repurchase program at any time if it deems such action to be in the Fund's best interest and the best interest of the shareholders.

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

As a result, share repurchases may not be available each quarter. We intend to conduct repurchase offers in accordance with the requirements of Rule 13e-4 under the Exchange Act and the 1940 Act.

During the three months ended March 31, 2026, we did not repurchase any of our shares.

***Distribution Reinvestment Plan***

During the three months ended March 31, 2026, no shares were issued pursuant to the Fund's distribution reinvestment plan,

**Item 3. Defaults Upon Senior Securities**

None.

**Item 4. Mine Safety Disclosures**

Not Applicable.

**Item 5. Other Information**

***Rule 10b5-1 Trading Plans***

During the fiscal quarter ended March 31, 2026, none of the Fund's trustees or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Fund shares that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement."

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**Item 6. Exhibits**

The following exhibits are filed as part of this Quarterly Report on Form 10-Q or hereby incorporated by reference to exhibits previously filed with the SEC:

---

| | |
|:---|:---|
| **Exhibit**<br>**Number** | **Description of Exhibits** |
| 3.1 | <u>[Certificate of Conversion (incorporated by reference to Exhibit 3.1 to the Fund's Registration Statement on Form 10 filed August 28, 2025).](https://www.sec.gov/Archives/edgar/data/2027033/000110465925084742/tm2523604d1_ex3-1.htm)</u> |
| 3.2 | <u>[Certificate of Trust (incorporated by reference to Exhibit 3.2 to the Fund's Registration Statement on Form 10 filed August 28, 2025).](https://www.sec.gov/Archives/edgar/data/2027033/000110465925084742/tm2523604d1_ex3-2.htm)</u> |
| 3.3 | <u>[Declaration of Trust (incorporated by reference to Exhibit 3.3 to the Fund's Registration Statement on Form 10 filed August 28, 2025).](https://www.sec.gov/Archives/edgar/data/2027033/000110465925084742/tm2523604d1_ex3-3.htm)</u> |
| 3.4 | <u>[Bylaws (incorporated by reference to Exhibit 3.4 to the Fund's Registration Statement on Form 10 filed August 28, 2025).](https://www.sec.gov/Archives/edgar/data/2027033/000110465925084742/tm2523604d1_ex3-4.htm)</u> |
| 4.1 | <u>[Form of Subscription Agreement (incorporated by reference to Exhibit 4.1 to Amendment No. 1 to the Fund's Registration Statement on Form 10 filed October 27, 2025.](https://www.sec.gov/Archives/edgar/data/2027033/000110465925102225/tm2529291d1_ex4-1.htm)</u> |
| 31.1\* | <u>[Certification of Co-Principal Executive Officer Pursuant to Rules 13a 14(a) and 15d 14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](exhibit3111.htm)</u> |
| 31.2\* | <u>[Certification of Co-Principal Executive Officer Pursuant to Rules 13a 14(a) and 15d 14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](exhibit3121.htm)</u> |
| 31.3\* | <u>[Certification of Principal Financial Officer Pursuant to Rules 13a 14(a) and 15d 14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](exhibit3131.htm)</u> |
| 32.1\*\* | <u>[Certification of Co-Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit3211.htm)</u> |
| 32.2\*\* | <u>[Certification of Co-Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit3221.htm)</u> |
| 32.3\*\* | <u>[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit3231.htm)</u> |
| 101.INS | Inline XBRL Instance Document-the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document with Embedded Linkbase Documents |
| 104 | Cover Page formatted as Inline XBRL and contained in Exhibit 101 |

---

________

\*Filed herewith

\*\*Furnished herewith

------

<u>[**Table of Contents**](#i0ccf65f3dff14a6588f8857707bc3ee6_7)</u>

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY** | **EAGLE POINT TRINITY SENIOR SECURED LENDING COMPANY** |
| Dated: May 15, 2026 | By: | /s/ Thomas Majewski |
|  |  | Thomas Majewski |
|  |  | Co-Chief Executive Officer |
|  |  | (Co-Principal Executive Officer) |
| Dated: May 15, 2026 | By: | /s/ Kyle Brown |
|  |  | Kyle Brown |
|  |  | Co-Chief Executive Officer |
|  |  | (Co-Principal Executive Officer) |

---

---

| | | |
|:---|:---|:---|
| Dated: May 15, 2026 | By: | /s/ Kenneth P. Onorio |
|  |  | Kenneth P. Onorio |
|  |  | Chief Financial Officer and Chief Accounting Officer |
|  |  | (Principal Financial and Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Thomas P. Majewski, Co-Chief Executive Officer of Eagle Point Trinity Senior Secured Lending Company,

certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Eagle Point Trinity Senior Secured Lending Company

(the "registrant") for the quarter ended March 31, 2026;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a

material fact necessary to make the statements made, in light of the circumstances under which such statements

were made, not misleading with respect to the period covered by this Quarterly Report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly

present in all material respects the financial condition, results of operations, and cash flows of the registrant as of,

and for, the periods presented in this Quarterly Report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls

and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial

reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

*a)*Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be

designed under our supervision, to ensure that material information relating to the registrant, including its

consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in

which this Quarterly Report is being prepared;

*b)*Designed such internal control over financial reporting, or caused such internal control over financial reporting

to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial

reporting and the preparation of financial statements for external purposes in accordance with generally accepted

accounting principles;

*c)*Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our

conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered

by this report based on such evaluation; and

*d)*Disclosed in this report any change in the registrant's internal control over financial reporting that occurred

during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual

report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over

financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal

control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of

directors (or persons performing equivalent functions):

*a)*All significant deficiencies and material weaknesses in the design or operation of internal control over financial

reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and

report financial information; and

*b)*Any fraud, whether or not material, that involves management or other employees who have a significant role in

the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: May 15, 2026 | By: | /s/ Thomas P. Majewski |
|  |  | **Thomas P. Majewski** |
|  |  | **Co-Chief Executive Officer** |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Kyle Brown, Co-Chief Executive Officer of Eagle Point Trinity Senior Secured Lending Company, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Eagle Point Trinity Senior Secured Lending Company

(the "registrant") for the quarter ended March 31, 2026;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a

material fact necessary to make the statements made, in light of the circumstances under which such statements

were made, not misleading with respect to the period covered by this Quarterly Report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly

present in all material respects the financial condition, results of operations, and cash flows of the registrant as of,

and for, the periods presented in this Quarterly Report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls

and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial

reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

*a)*Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be

designed under our supervision, to ensure that material information relating to the registrant, including its

consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in

which this Quarterly Report is being prepared;

*b)*Designed such internal control over financial reporting, or caused such internal control over financial reporting

to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial

reporting and the preparation of financial statements for external purposes in accordance with generally accepted

accounting principles;

*c)*Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our

conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered

by this report based on such evaluation; and

*d)*Disclosed in this report any change in the registrant's internal control over financial reporting that occurred

during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual

report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over

financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal

control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of

directors (or persons performing equivalent functions):

*a)*All significant deficiencies and material weaknesses in the design or operation of internal control over financial

reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and

report financial information; and

*b)*Any fraud, whether or not material, that involves management or other employees who have a significant role in

the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: May 15, 2026 | By: | /s/ Kyle Brown |
|  |  | **Kyle Brown** |
|  |  | **Co-Chief Executive Officer** |

---

## Exhibit 31.3

**Exhibit 31.3**

**CERTIFICATION PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Kenneth P. Onorio, Chief Financial Officer and Chief Accounting Officer of Eagle Point Trinity Senior Secured

Lending Company, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Eagle Point Trinity Senior Secured Lending Company

(the "registrant") for the quarter ended March 31, 2026;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a

material fact necessary to make the statements made, in light of the circumstances under which such statements

were made, not misleading with respect to the period covered by this Quarterly Report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly

present in all material respects the financial condition, results of operations, and cash flows of the registrant as of,

and for, the periods presented in this Quarterly Report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls

and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial

reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

*a)* Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be

designed under our supervision, to ensure that material information relating to the registrant, including its

consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in

which this Quarterly Report is being prepared;

*b)* Designed such internal control over financial reporting, or caused such internal control over financial reporting

to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial

reporting and the preparation of financial statements for external purposes in accordance with generally accepted

accounting principles;

*c)* Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report

our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period

covered by this report based on such evaluation; and

*d)* Disclosed in this report any change in the registrant's internal control over financial reporting that occurred

during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual

report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over

financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal

control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of

directors (or persons performing equivalent functions):

*a)* All significant deficiencies and material weaknesses in the design or operation of internal control over financial

reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and

report financial information; and

*b)* Any fraud, whether or not material, that involves management or other employees who have a significant role

in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: May 15, 2026 | By: | /s/ Kenneth Onorio |
|  |  | **Kenneth Onorio** |
|  |  | **Chief Financial Officer and**<br>**Chief Accounting Officer**<br>|

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002, the undersigned, as Co-Chief Executive Officer of Eagle Point Trinity Senior Secured

Lending Company (the "Company"), does hereby certify that to the undersigned's knowledge:

1) the Company's Form 10-Q for the quarter ended March 31, 2026, fully complies with the requirements of

Section 13(a) or 15(d) as applicable of the Securities Exchange Act of 1934, as amended; and

2) the information contained in the Company's Form 10-Q for the quarter ended March 31, 2026, fairly presents,

in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: May 15, 2026 | By: | /s/ Thomas P. Majewski |
|  |  | **Thomas P. Majewski** |
|  |  | **Co-Chief Executive Officer** |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002, the undersigned, as Co-Chief Executive Officer of Eagle Point Trinity Senior Secured

Lending Company (the "Company"), does hereby certify that to the undersigned's knowledge:

1) the Company's Form 10-Q for the quarter ended March 31, 2026, fully complies with the requirements of

Section 13(a) or 15(d) as applicable of the Securities Exchange Act of 1934, as amended; and

2) the information contained in the Company's Form 10-Q for the quarter ended March 31, 2026, fairly presents,

in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: May 15, 2026 | By: | /s/ Kyle Brown |
|  |  | **Kyle Brown** |
|  |  | **Co-Chief Executive Officer** |

---

## Exhibit 32.3

**Exhibit 32.3**

**CERTIFICATION PURSUANT TO**

**SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002, the undersigned, as Chief Financial Officer and Chief Accounting Officer of Eagle

Point Trinity Senior Secured Lending Company (the "Company"), does hereby certify that to the undersigned's

knowledge:

1) the Company's Form 10-Q for the quarter ended March 31, 2026, fully complies with the requirements of

Section 13(a) or 15(d) as applicable of the Securities Exchange Act of 1934, as amended; and

2) the information contained in the Company's Form 10-Q for the quarter ended March 31, 2026, fairly presents,

in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: May 15, 2026 | By: | /s/ Kenneth Onorio |
|  |  | **Kenneth Onorio** |
|  |  | **Chief Financial Officer and**<br>**Chief Accounting Officer**<br>|

---